<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://everyticker.com/quote/PAVM/pavmed-s-phoenix-moment-how-a-clean-cap-table-creates-leverage-to-a-60b-medicare-catalyst-nasdaq-pavm</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:36Z</news:publication_date>
      <news:title>PAVmed&#x27;s Phoenix Moment: How a Clean Cap Table Creates Leverage to a $60B Medicare Catalyst (NASDAQ:PAVM)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ARBE/arbe-robotics-surviving-the-valley-of-death-on-a-bridge-of-non-automotive-revenue-nasdaq-arbe</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-06T00:00:12Z</news:publication_date>
      <news:title>Arbe Robotics: Surviving the Valley of Death on a Bridge of Non-Automotive Revenue (NASDAQ:ARBE)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TNON/tenon-medical-s-multi-product-gambit-a-micro-cap-si-joint-specialist-at-the-tipping-point-nasdaq-tnon</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:56:24Z</news:publication_date>
      <news:title>Tenon Medical&#x27;s Multi-Product Gambit: A Micro-Cap SI Joint Specialist at the Tipping Point (NASDAQ:TNON)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AIRI/air-industries-group-record-backlog-meets-balance-sheet-cliff-nasdaq-airi</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:52:03Z</news:publication_date>
      <news:title>Air Industries Group: Record Backlog Meets Balance Sheet Cliff (NASDAQ:AIRI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/UTMD/utmd-s-hidden-earnings-lever-how-a-2-million-amortization-roll-off-and-86-million-cash-war-chest-transform-risk-reward-nasdaq-utmd</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:49:00Z</news:publication_date>
      <news:title>UTMD&#x27;s Hidden Earnings Lever: How a $2 Million Amortization Roll-Off and $86 Million Cash War Chest Transform Risk/Reward (NASDAQ:UTMD)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GBFH/gbfh-s-digital-pivot-can-gaming-fintech-justify-a-100-valuation-premium</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:47:02Z</news:publication_date>
      <news:title>GBFH&#x27;s Digital Pivot: Can Gaming FinTech Justify a 100% Valuation Premium?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GLXZ/merger-arbitrage-meets-operational-turnaround-galaxy-gaming-s-asymmetric-risk-reward-at-1-81-nasdaq-glxz</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:46:13Z</news:publication_date>
      <news:title>Merger Arbitrage Meets Operational Turnaround: Galaxy Gaming&#x27;s Asymmetric Risk/Reward at $1.81 (NASDAQ:GLXZ)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ELBM/electra-s-cobalt-refinery-a-fully-funded-bet-on-north-american-ev-supply-chain-independence-nasdaq-elbm</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:45:51Z</news:publication_date>
      <news:title>Electra&#x27;s Cobalt Refinery: A Fully Funded Bet on North American EV Supply Chain Independence (NASDAQ:ELBM)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CISO/ciso-global-s-software-pivot-a-micro-cap-s-race-against-time-and-cash-nasdaq-ciso</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:44:37Z</news:publication_date>
      <news:title>CISO Global&#x27;s Software Pivot: A Micro-Cap&#x27;s Race Against Time and Cash (NASDAQ:CISO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ORGN/origin-materials-a-micro-cap-race-against-time-to-prove-pet-cap-viability-nasdaq-orgn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:42:39Z</news:publication_date>
      <news:title>Origin Materials: A Micro-Cap Race Against Time to Prove PET Cap Viability (NASDAQ:ORGN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ALOV/alov-s-liquidity-arbitrage-a-pre-deal-spac-trading-below-trust-value-with-proven-deal-makers-at-the-helm</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:41:22Z</news:publication_date>
      <news:title>ALOV&#x27;s Liquidity Arbitrage: A Pre-Deal SPAC Trading Below Trust Value with Proven Deal-Makers at the Helm</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CGNT/margin-inflection-meets-ai-moat-cognyte-s-investigative-analytics-platform-trades-at-a-bargain-valuation-nasdaq-cgnt</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:39:51Z</news:publication_date>
      <news:title>Margin Inflection Meets AI Moat: Cognyte&#x27;s Investigative Analytics Platform Trades at a Bargain Valuation (NASDAQ:CGNT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DOYU/douyu-s-strategic-retreat-trading-market-share-for-margin-survival-in-china-s-gaming-livestreaming-wars-nasdaq-doyu</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:39:06Z</news:publication_date>
      <news:title>DouYu&#x27;s Strategic Retreat: Trading Market Share for Margin Survival in China&#x27;s Gaming Livestreaming Wars (NASDAQ:DOYU)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SY/so-young-s-vertical-integration-flywheel-from-platform-to-profit-powerhouse-nasdaq-sy</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:38:25Z</news:publication_date>
      <news:title>So-Young&#x27;s Vertical Integration Flywheel: From Platform to Profit Powerhouse (NASDAQ:SY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/VIOT/viomi-s-global-water-gambit-can-ai-driven-focus-unlock-sustainable-growth-nasdaq-viot</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:36:32Z</news:publication_date>
      <news:title>Viomi&#x27;s Global Water Gambit: Can AI-Driven Focus Unlock Sustainable Growth? (NASDAQ:VIOT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/KNOP/shuttle-market-tightening-meets-capital-allocation-crossroads-at-knot-offshore-partners-nyse-knop</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:35:53Z</news:publication_date>
      <news:title>Shuttle Market Tightening Meets Capital Allocation Crossroads at KNOT Offshore Partners (NYSE:KNOP)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MAZE/maze-therapeutics-precision-medicine-platform-faces-first-mover-trap-in-130b-kidney-disease-market-nasdaq-maze</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:32:54Z</news:publication_date>
      <news:title>Maze Therapeutics: Precision Medicine Platform Faces First-Mover Trap in $130B Kidney Disease Market (NASDAQ:MAZE)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ENLV/enlivex-a-228m-biotech-trading-below-crypto-book-value-faces-its-reckoning-nasdaq-enlv</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:30:02Z</news:publication_date>
      <news:title>Enlivex: A $228M Biotech Trading Below Crypto Book Value Faces Its Reckoning (NASDAQ:ENLV)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PAYS/paysign-s-pharma-driven-margin-inflection-why-723-basis-points-is-just-the-beginning-nasdaq-pays</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:29:38Z</news:publication_date>
      <news:title>Paysign&#x27;s Pharma-Driven Margin Inflection: Why 723 Basis Points Is Just the Beginning (NASDAQ:PAYS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ZH/zhihu-s-ai-gamble-can-a-profitable-content-community-escape-its-own-disruption-nyse-zh</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:29:09Z</news:publication_date>
      <news:title>Zhihu&#x27;s AI Gamble: Can a Profitable Content Community Escape Its Own Disruption? (NYSE:ZH)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BZUN/baozun-s-strategic-transformation-completes-a-two-engine-growth-story-at-an-inflection-point-nasdaq-bzun</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:22:59Z</news:publication_date>
      <news:title>Baozun&#x27;s Strategic Transformation Completes: A Two-Engine Growth Story at an Inflection Point (NASDAQ:BZUN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/WDH/waterdrop-s-ai-native-transformation-a-profitable-insurtech-at-7x-earnings-nasdaq-wdh</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:22:42Z</news:publication_date>
      <news:title>Waterdrop&#x27;s AI-Native Transformation: A Profitable Insurtech at 7x Earnings (NASDAQ:WDH)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NXL/fda-roulette-why-nexalin-s-6-5m-valuation-is-a-binary-bet-on-neurostimulation-s-future-nasdaq-nxl</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:20:31Z</news:publication_date>
      <news:title>FDA Roulette: Why Nexalin&#x27;s $6.5M Valuation Is a Binary Bet on Neurostimulation&#x27;s Future (NASDAQ:NXL)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/INTZ/balance-sheet-repair-meets-critical-infrastructure-opportunity-at-intrusion-inc-nasdaq-intz</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:20:10Z</news:publication_date>
      <news:title>Balance Sheet Repair Meets Critical Infrastructure Opportunity at Intrusion Inc. (NASDAQ:INTZ)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MDCX/mdcx-a-clinical-stage-biotech-with-promising-data-and-a-perilous-cash-runway-nasdaq-mdcx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:17:05Z</news:publication_date>
      <news:title>MDCX: A Clinical-Stage Biotech with Promising Data and a Perilous Cash Runway (NASDAQ:MDCX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/JUVF/juvf-the-community-bank-value-trap-why-a-6-dividend-and-15-roe-may-not-be-enough-otcqx-juvf</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:17:04Z</news:publication_date>
      <news:title>JUVF: The Community Bank Value Trap - Why a 6% Dividend and 15% ROE May Not Be Enough (OTCQX:JUVF)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TGS/tgs-argentina-s-southern-energy-monopoly-is-building-a-3-9-billion-growth-engine-nyse-tgs</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:13:52Z</news:publication_date>
      <news:title>TGS: Argentina&#x27;s Southern Energy Monopoly Is Building a $3.9 Billion Growth Engine (NYSE:TGS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/UTGN/utg-inc-when-investment-gains-mask-a-declining-insurance-franchise-otc-utgn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:12:21Z</news:publication_date>
      <news:title>UTG, Inc.: When Investment Gains Mask a Declining Insurance Franchise (OTC:UTGN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FXNC/first-national-corporation-post-merger-margin-expansion-meets-scale-reality-nasdaq-fxnc</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:12:10Z</news:publication_date>
      <news:title>First National Corporation: Post-Merger Margin Expansion Meets Scale Reality (NASDAQ:FXNC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/OVLY/oak-valley-bancorp-s-local-moat-meets-concentration-risk-in-california-s-central-valley-nasdaq-ovly</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:07:35Z</news:publication_date>
      <news:title>Oak Valley Bancorp&#x27;s Local Moat Meets Concentration Risk in California&#x27;s Central Valley (NASDAQ:OVLY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/KANP/kaanapali-land-a-maui-land-bank-at-a-binary-crossroads-otc-kanp</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:06:49Z</news:publication_date>
      <news:title>Kaanapali Land: A Maui Land Bank at a Binary Crossroads (OTC:KANP)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PFSB/pfs-bancorp-post-conversion-portfolio-shift-drives-85-earnings-surge-amid-funding-headwinds-otc-pfsb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:06:40Z</news:publication_date>
      <news:title>PFS Bancorp: Post-Conversion Portfolio Shift Drives 85% Earnings Surge Amid Funding Headwinds (OTC:PFSB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NIKA/a-398-million-going-concern-nika-pharmaceuticals-pre-revenue-pipeline-and-the-illusion-of-value-otcqb-nika</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:02:28Z</news:publication_date>
      <news:title>A $398 Million Going Concern: NIKA Pharmaceuticals&#x27; Pre-Revenue Pipeline and the Illusion of Value (OTCQB:NIKA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SELF/global-self-storage-a-self-managed-niche-player-s-dividend-dilemma-nasdaq-self</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:01:54Z</news:publication_date>
      <news:title>Global Self Storage: A Self-Managed Niche Player&#x27;s Dividend Dilemma (NASDAQ:SELF)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/KC/kingsoft-cloud-s-ai-inflection-from-cloud-commodity-to-intelligent-computing-powerhouse-nasdaq-kc</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T23:01:29Z</news:publication_date>
      <news:title>Kingsoft Cloud&#x27;s AI Inflection: From Cloud Commodity to Intelligent Computing Powerhouse (NASDAQ:KC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TELA/tela-bio-s-commercial-rebuild-execution-risk-meets-differentiated-technology-in-a-race-against-cash-burn-nasdaq-tela</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:58:00Z</news:publication_date>
      <news:title>TELA Bio&#x27;s Commercial Rebuild: Execution Risk Meets Differentiated Technology in a Race Against Cash Burn (NASDAQ:TELA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ECBK/ecb-bancorp-a-mutual-conversion-s-promise-meets-the-brutal-math-of-scale-nasdaq-ecbk</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:56:32Z</news:publication_date>
      <news:title>ECB Bancorp: A Mutual Conversion&#x27;s Promise Meets the Brutal Math of Scale (NASDAQ:ECBK)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/WYY/fedramp-daas-and-the-3b-bet-why-widepoint-s-2026-inflection-hinges-on-one-contract-nasdaq-wyy</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:55:02Z</news:publication_date>
      <news:title>FedRAMP, DaaS, and the $3B Bet: Why WidePoint&#x27;s 2026 Inflection Hinges on One Contract (NASDAQ:WYY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/EDAP/edap-s-hifu-gambit-robotic-focal-therapy-at-an-execution-inflection-point-nasdaq-edap</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:53:36Z</news:publication_date>
      <news:title>EDAP&#x27;s HIFU Gambit: Robotic Focal Therapy at an Execution Inflection Point (NASDAQ:EDAP)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NKTX/nktx-s-295m-lifeline-can-engineered-nk-cells-crack-the-autoimmune-code</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:49:07Z</news:publication_date>
      <news:title>NKTX&#x27;s $295M Lifeline: Can Engineered NK Cells Crack the Autoimmune Code?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MDV/modiv-industrial-the-40-nav-discount-that-can-t-last-nyse-mdv</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:48:04Z</news:publication_date>
      <news:title>Modiv Industrial: The 40% NAV Discount That Can&#x27;t Last (NYSE:MDV)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TOPP/topp-s-niche-logistics-model-crumbles-under-scale-disadvantages-and-capital-misallocation-nyse-topp</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:44:09Z</news:publication_date>
      <news:title>TOPP&#x27;s Niche Logistics Model Crumbles Under Scale Disadvantages and Capital Misallocation (NYSE:TOPP)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DYAI/dyai-s-commercial-inflection-a-capital-efficient-bet-on-precision-fermentation-s-25b-opportunity-nasdaq-dyai</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:43:43Z</news:publication_date>
      <news:title>DYAI&#x27;s Commercial Inflection: A Capital-Efficient Bet on Precision Fermentation&#x27;s $25B Opportunity (NASDAQ:DYAI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ALIS/alis-a-10-ai-infrastructure-wager-with-a-ticking-clock-and-asymmetric-upside-nasdaq-alis</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:40:26Z</news:publication_date>
      <news:title>ALIS: A $10 AI Infrastructure Wager With a Ticking Clock and Asymmetric Upside (NASDAQ:ALIS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/EQ/equillium-s-95-million-bet-on-a-single-molecule-why-eq504-is-the-entire-story-nasdaq-eq</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:39:08Z</news:publication_date>
      <news:title>Equillium&#x27;s $95 Million Bet on a Single Molecule: Why EQ504 Is the Entire Story (NASDAQ:EQ)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ARMP/armata-s-phage-gamble-phase-3-promise-meets-cash-crunch-nasdaq-armp</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:38:05Z</news:publication_date>
      <news:title>Armata&#x27;s Phage Gamble: Phase 3 Promise Meets Cash Crunch (NASDAQ:ARMP)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PLNH/margin-recovery-meets-experiential-moat-planet-13-s-path-from-cash-burn-to-profitability-otc-plnh</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:35:55Z</news:publication_date>
      <news:title>Margin Recovery Meets Experiential Moat: Planet 13&#x27;s Path from Cash Burn to Profitability (OTC:PLNH)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/REED/reed-s-turnaround-trap-can-a-premium-ginger-brand-escape-the-scale-crisis-nyse-american-reed</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:31:17Z</news:publication_date>
      <news:title>Reed&#x27;s Turnaround Trap: Can a Premium Ginger Brand Escape the Scale Crisis? (NYSE American:REED)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GCTS/gct-semiconductor-s-5g-gambit-surviving-the-valley-of-death-to-capture-a-niche-nasdaq-gcts</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:29:59Z</news:publication_date>
      <news:title>GCT Semiconductor&#x27;s 5G Gambit: Surviving the Valley of Death to Capture a Niche (NASDAQ:GCTS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BYSI/beyondspring-s-plinabulin-promise-meets-cash-flow-reality-a-binary-bet-on-china-approval-nasdaq-bysi</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:26:37Z</news:publication_date>
      <news:title>BeyondSpring&#x27;s Plinabulin Promise Meets Cash-Flow Reality: A Binary Bet on China Approval (NASDAQ:BYSI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PMN/promis-neurosciences-a-precision-alzheimer-s-bet-with-binary-2027-catalyst</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:26:23Z</news:publication_date>
      <news:title>ProMIS Neurosciences: A Precision Alzheimer&#x27;s Bet With Binary 2027 Catalyst</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MXCT/maxcyte-s-2-billion-pipeline-meets-the-valley-of-death-why-2026-is-the-prove-it-year-nasdaq-mxct</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:25:10Z</news:publication_date>
      <news:title>MaxCyte&#x27;s $2 Billion Pipeline Meets the Valley of Death: Why 2026 Is the Prove-It Year (NASDAQ:MXCT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/RITE/mineralrite-s-432m-asset-gamble-a-19m-option-on-tailings-recovery-with-a-14-billion-share-dilution-bomb-otc-rite</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:22:02Z</news:publication_date>
      <news:title>MineralRite&#x27;s $432M Asset Gamble: A $19M Option on Tailings Recovery with a 14-Billion-Share Dilution Bomb (OTC:RITE)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PARK/park-dental-partners-a-doctor-governed-dso-at-the-crossroads-of-regional-moats-and-national-scale-nasdaq-park</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:18:49Z</news:publication_date>
      <news:title>Park Dental Partners: A Doctor-Governed DSO at the Crossroads of Regional Moats and National Scale (NASDAQ:PARK)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TCBS/texas-community-bancshares-a-strategic-transformation-priced-for-skepticism-nasdaq-tcbs</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:17:23Z</news:publication_date>
      <news:title>Texas Community Bancshares: A Strategic Transformation Priced for Skepticism (NASDAQ:TCBS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CATO/same-store-sales-growth-masks-a-profitability-crisis-at-the-cato-corporation-nyse-cato</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:17:17Z</news:publication_date>
      <news:title>Same-Store Sales Growth Masks a Profitability Crisis at The Cato Corporation (NYSE:CATO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/XCUR/exicure-s-4-19-distress-call-a-micro-cap-s-binary-bet-on-blood-cancer-data-nasdaq-xcur</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:15:42Z</news:publication_date>
      <news:title>Exicure&#x27;s $4.19 Distress Call: A Micro-Cap&#x27;s Binary Bet on Blood Cancer Data (NASDAQ:XCUR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/WSM/williams-sonoma-the-omni-channel-moat-meets-ai-amplification-nyse-wsm</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:15:36Z</news:publication_date>
      <news:title>Williams-Sonoma: The Omni-Channel Moat Meets AI Amplification (NYSE:WSM)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DC/dakota-gold-s-homestake-revival-from-exploration-to-production-in-america-s-richest-gold-district-nyseam-dc</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:11:35Z</news:publication_date>
      <news:title>Dakota Gold&#x27;s Homestake Revival: From Exploration to Production in America&#x27;s Richest Gold District (NYSEAM:DC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PGEN/precigen-s-single-product-gambit-from-gene-therapy-r-d-to-cash-flow-on-papzimeos-alone-nasdaq-pgen</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:11:31Z</news:publication_date>
      <news:title>Precigen&#x27;s Single-Product Gambit: From Gene Therapy R&amp;D to Cash Flow on Papzimeos Alone (NASDAQ:PGEN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MRAI/marpai-s-turnaround-gamble-can-a-relaunched-pbm-save-a-cash-strapped-tpa-otcqx-mrai</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:10:12Z</news:publication_date>
      <news:title>Marpai&#x27;s Turnaround Gamble: Can a Relaunched PBM Save a Cash-Strapped TPA? (OTCQX:MRAI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LUCD/medicare-s-verdict-will-define-lucid-diagnostics-a-binary-bet-on-reimbursement-at-the-crossroads-of-cancer-prevention-nasdaq-lucd</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:06:39Z</news:publication_date>
      <news:title>Medicare&#x27;s Verdict Will Define Lucid Diagnostics: A Binary Bet on Reimbursement at the Crossroads of Cancer Prevention (NASDAQ:LUCD)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TTAN/servicetitan-s-ai-flywheel-how-vertical-dominance-and-margin-inflection-create-asymmetric-upside-nasdaq-ttan</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:03:54Z</news:publication_date>
      <news:title>ServiceTitan&#x27;s AI Flywheel: How Vertical Dominance and Margin Inflection Create Asymmetric Upside (NASDAQ:TTAN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/XYF/x-financial-surviving-the-regulatory-cliff-that-reshaped-china-s-online-lending-nyse-xyf</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T22:00:28Z</news:publication_date>
      <news:title>X Financial: Surviving the Regulatory Cliff That Reshaped China&#x27;s Online Lending (NYSE:XYF)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FNWD/regulatory-repair-meets-margin-inflection-at-finward-bancorp-nasdaq-fnwd</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:57:13Z</news:publication_date>
      <news:title>Regulatory Repair Meets Margin Inflection at Finward Bancorp (NASDAQ:FNWD)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/IMMX/immx-s-breakthrough-gamble-can-a-single-car-t-asset-justify-a-400m-bet-on-a-5-8b-untapped-market-nasdaq-immx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:56:13Z</news:publication_date>
      <news:title>IMMX&#x27;s Breakthrough Gamble: Can a Single CAR-T Asset Justify a $400M Bet on a $5.8B Untapped Market? (NASDAQ:IMMX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ATOS/atossa-s-endoxifen-gambit-bypassing-tamoxifen-s-fatal-flaw-while-rare-disease-options-compound-nasdaq-atos</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:55:35Z</news:publication_date>
      <news:title>Atossa&#x27;s Endoxifen Gambit: Bypassing Tamoxifen&#x27;s Fatal Flaw While Rare Disease Options Compound (NASDAQ:ATOS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PLRZ/plrz-s-identity-crisis-nasal-spray-biotech-or-conglomerate-in-disguise</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:54:13Z</news:publication_date>
      <news:title>PLRZ&#x27;s Identity Crisis: Nasal Spray Biotech or Conglomerate in Disguise?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HIT/health-in-tech-s-ai-underwriting-engine-capturing-the-900b-self-funded-market-nasdaq-hit</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:51:52Z</news:publication_date>
      <news:title>Health In Tech&#x27;s AI Underwriting Engine: Capturing the $900B Self-Funded Market (NASDAQ:HIT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CELC/gedatolisib-s-unprecedented-efficacy-meets-a-5-billion-market-celcuity-s-bridge-to-commercialization-nasdaq-celc</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:50:50Z</news:publication_date>
      <news:title>Gedatolisib&#x27;s Unprecedented Efficacy Meets a $5 Billion Market: Celcuity&#x27;s Bridge to Commercialization (NASDAQ:CELC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DERM/emrosi-s-inflection-journey-medical-s-path-from-going-concern-warning-to-dermatology-profits-nasdaq-derm</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:46:42Z</news:publication_date>
      <news:title>Emrosi&#x27;s Inflection: Journey Medical&#x27;s Path From Going Concern Warning to Dermatology Profits (NASDAQ:DERM)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/JBS/jbs-n-v-when-global-scale-meets-cyclical-pain-why-the-world-s-largest-protein-producer-trades-at-a-discount-and-what-could-close-it-nyse-jbs</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:46:25Z</news:publication_date>
      <news:title>JBS N.V.: When Global Scale Meets Cyclical Pain—Why the World&#x27;s Largest Protein Producer Trades at a Discount and What Could Close It (NYSE:JBS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PVCT/provectus-biopharmaceuticals-a-20-million-call-option-on-a-uniquely-positioned-immunotherapy-platform-otc-pvct</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:46:19Z</news:publication_date>
      <news:title>Provectus Biopharmaceuticals: A $20 Million Call Option on a Uniquely Positioned Immunotherapy Platform (OTC:PVCT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SCOR/balance-sheet-repair-meets-cross-platform-measurement-comscore-s-accredited-standard-faces-the-ai-test-nasdaq-scor</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:41:09Z</news:publication_date>
      <news:title>Balance Sheet Repair Meets Cross-Platform Measurement: Comscore&#x27;s Accredited Standard Faces the AI Test (NASDAQ:SCOR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NDLS/noodles-company-a-leaner-machine-running-on-borrowed-time-nasdaq-ndls</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:40:33Z</news:publication_date>
      <news:title>Noodles &amp; Company: A Leaner Machine Running on Borrowed Time (NASDAQ:NDLS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/IPHA/innate-pharma-s-500-million-gamble-three-drugs-to-survive-or-thrive-nasdaq-ipha</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:38:18Z</news:publication_date>
      <news:title>Innate Pharma&#x27;s $500 Million Gamble: Three Drugs to Survive or Thrive (NASDAQ:IPHA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HWH/hwh-international-a-spac-s-melting-ice-cube-propped-up-by-related-parties-nasdaq-hwh</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:37:07Z</news:publication_date>
      <news:title>HWH International: A SPAC&#x27;s Melting Ice Cube Propped Up by Related Parties (NASDAQ:HWH)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/UBFO/merger-completion-ends-united-security-s-standalone-struggle-what-cwbc-integration-means-for-investors-nasdaq-ubfo</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:33:24Z</news:publication_date>
      <news:title>Merger Completion Ends United Security&#x27;s Standalone Struggle: What CWBC Integration Means for Investors (NASDAQ:UBFO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/VNJA/vanjia-corporation-otc-vnja-a-79-million-development-stage-bet-on-houston-affordable-housing-execution</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:32:45Z</news:publication_date>
      <news:title>VANJIA CORPORATION (OTC:VNJA): A $79 Million Development-Stage Bet on Houston Affordable Housing Execution</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GIGM/gigamedia-a-29-million-cash-pile-trading-at-a-45-discount-with-a-free-option-on-turnaround-nasdaq-gigm</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:31:30Z</news:publication_date>
      <news:title>GigaMedia: A $29 Million Cash Pile Trading at a 45% Discount With a Free Option on Turnaround (NASDAQ:GIGM)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AACG/ata-creativity-global-niche-dominance-meets-scale-reality-in-china-s-art-education-market-nasdaq-aacg</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:27:58Z</news:publication_date>
      <news:title>ATA Creativity Global: Niche Dominance Meets Scale Reality in China&#x27;s Art Education Market (NASDAQ:AACG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/WYFI/whitefiber-s-gpu-gold-rush-a-pure-play-ai-infrastructure-bet-at-the-edge-of-execution-nasdaq-wyfi</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:27:51Z</news:publication_date>
      <news:title>WhiteFiber&#x27;s GPU Gold Rush: A Pure-Play AI Infrastructure Bet at the Edge of Execution (NASDAQ:WYFI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CRGO/freightos-solutions-first-gamble-can-workflow-ownership-deliver-profits-in-a-volatile-freight-market-nasdaq-crgo</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:26:42Z</news:publication_date>
      <news:title>Freightos&#x27; Solutions-First Gamble: Can Workflow Ownership Deliver Profits in a Volatile Freight Market? (NASDAQ:CRGO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MPTI/defense-moats-meet-margin-recovery-m-tron-industries-nasdaq-mpti-positions-for-platform-expansion</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:26:39Z</news:publication_date>
      <news:title>Defense Moats Meet Margin Recovery: M-tron Industries (NASDAQ:MPTI) Positions for Platform Expansion</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/RMTI/margin-inflection-meets-market-share-gains-at-rockwell-medical-nasdaq-rmti</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:20:42Z</news:publication_date>
      <news:title>Margin Inflection Meets Market Share Gains at Rockwell Medical (NASDAQ:RMTI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CGTX/capital-efficiency-meets-dual-path-neurodegeneration-cognition-therapeutics-nasdaq-cgtx-bets-its-future-on-oral-synaptic-protection</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:18:18Z</news:publication_date>
      <news:title>Capital Efficiency Meets Dual-Path Neurodegeneration: Cognition Therapeutics (NASDAQ:CGTX) Bets Its Future on Oral Synaptic Protection</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MTA/metalla-royalty-s-harvest-phase-a-600m-bet-on-portfolio-inflection-vs-scale-reality-nyse-mta</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:18:06Z</news:publication_date>
      <news:title>Metalla Royalty&#x27;s Harvest Phase: A $600M Bet on Portfolio Inflection vs. Scale Reality (NYSE:MTA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GUER/guerrilla-rf-s-narrow-path-to-profitability-margin-gains-meet-capital-constraints-nasdaq-guer</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:14:24Z</news:publication_date>
      <news:title>Guerrilla RF&#x27;s Narrow Path to Profitability: Margin Gains Meet Capital Constraints (NASDAQ:GUER)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AAPG/apoptosis-dominance-meets-cash-burn-reality-at-ascentage-pharma-nasdaq-aapg</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:12:52Z</news:publication_date>
      <news:title>Apoptosis Dominance Meets Cash Burn Reality at Ascentage Pharma (NASDAQ:AAPG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PRZO/defense-pivot-meets-financial-precipice-parazero-s-high-risk-drone-gambit-nasdaq-przo</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:11:08Z</news:publication_date>
      <news:title>Defense Pivot Meets Financial Precipice: ParaZero&#x27;s High-Risk Drone Gambit (NASDAQ:PRZO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FORTY/formula-systems-sapiens-windfall-masks-core-margin-challenge-at-crossroads-nasdaq-forty</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:09:27Z</news:publication_date>
      <news:title>Formula Systems: Sapiens Windfall Masks Core Margin Challenge at Crossroads (NASDAQ:FORTY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MCHX/marchex-s-ai-inflection-onestack-completion-and-archenia-deal-transform-a-45m-niche-player-into-a-scalable-growth-story-nasdaq-mchx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:08:01Z</news:publication_date>
      <news:title>Marchex&#x27;s AI Inflection: OneStack Completion and Archenia Deal Transform a $45M Niche Player into a Scalable Growth Story (NASDAQ:MCHX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/OP/from-dry-bulk-to-digital-assets-oceanpal-s-120m-bet-on-ai-infrastructure-meets-nasdaq-survival-crisis-nasdaq-svrn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:07:55Z</news:publication_date>
      <news:title>From Dry Bulk to Digital Assets: OceanPal&#x27;s $120M Bet on AI Infrastructure Meets Nasdaq Survival Crisis (NASDAQ:SVRN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CLGN/collplant-s-asymmetric-gamble-a-6-million-bet-on-regenerative-medicine-s-future-nasdaq-clgn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:05:15Z</news:publication_date>
      <news:title>CollPlant&#x27;s Asymmetric Gamble: A $6 Million Bet on Regenerative Medicine&#x27;s Future (NASDAQ:CLGN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SYPR/sypris-solutions-defense-backlog-meets-liquidity-crisis-as-margin-collapse-signals-distress-nasdaq-sypr</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:03:56Z</news:publication_date>
      <news:title>Sypris Solutions: Defense Backlog Meets Liquidity Crisis as Margin Collapse Signals Distress (NASDAQ:SYPR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DXYN/survival-to-thrival-the-dixie-group-s-60m-turnaround-bet-on-luxury-flooring-otcqb-dxyn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:03:04Z</news:publication_date>
      <news:title>Survival to Thrival: The Dixie Group&#x27;s $60M Turnaround Bet on Luxury Flooring (OTCQB:DXYN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LHAI/lhai-when-206-growth-destroys-value-the-ibuyer-model-s-fatal-flaw-nasdaq-lhai</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T21:01:17Z</news:publication_date>
      <news:title>LHAI: When 206% Growth Destroys Value – The iBuyer Model&#x27;s Fatal Flaw (NASDAQ:LHAI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FBLA/fb-bancorp-a-capital-rich-community-bank-stuck-in-profitability-purgatory-nasdaq-fbla</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:59:42Z</news:publication_date>
      <news:title>FB Bancorp: A Capital-Rich Community Bank Stuck in Profitability Purgatory (NASDAQ:FBLA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NYXH/nyxoah-s-high-wire-act-can-a-superior-sleep-apnea-device-survive-its-own-cash-burn-nasdaq-nyxh</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:56:28Z</news:publication_date>
      <news:title>Nyxoah&#x27;s High-Wire Act: Can a Superior Sleep Apnea Device Survive Its Own Cash Burn? (NASDAQ:NYXH)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/VTSI/virtra-s-federal-funding-freeze-why-record-backlog-and-subscription-growth-mask-an-inflection-point-nasdaq-vtsi</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:55:47Z</news:publication_date>
      <news:title>VirTra&#x27;s Federal Funding Freeze: Why Record Backlog and Subscription Growth Mask an Inflection Point (NASDAQ:VTSI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GLPG/galapagos-nv-a-eur3b-cash-shell-at-the-inflection-point-of-transformation-nasdaq-glpg</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:55:21Z</news:publication_date>
      <news:title>Galapagos NV: A €3B Cash Shell at the Inflection Point of Transformation (NASDAQ:GLPG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/IRAB/irab-s-150m-bet-on-u-s-critical-minerals-a-spac-s-asymmetric-play-on-geopolitical-desperation-nyse-irab</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:54:36Z</news:publication_date>
      <news:title>IRAB&#x27;s $150M Bet on U.S. Critical Minerals: A SPAC&#x27;s Asymmetric Play on Geopolitical Desperation (NYSE:IRAB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ACTU/phase-2-success-meets-financial-cliff-actuate-therapeutics-binary-bet-on-elraglusib-nasdaq-actu</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:54:31Z</news:publication_date>
      <news:title>Phase 2 Success Meets Financial Cliff: Actuate Therapeutics&#x27; Binary Bet on Elraglusib (NASDAQ:ACTU)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DARE/dare-bioscience-s-503b-gambit-can-a-creative-commercial-bridge-solve-the-biotech-funding-trap-nasdaq-dare</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:49:51Z</news:publication_date>
      <news:title>Daré Bioscience&#x27;s 503B Gambit: Can a Creative Commercial Bridge Solve the Biotech Funding Trap? (NASDAQ:DARE)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SPRO/spero-s-single-asset-gambit-why-tebipenem-hbr-s-oral-carbapenem-moat-could-redefine-antibiotic-economics-nasdaq-spro</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:49:41Z</news:publication_date>
      <news:title>Spero&#x27;s Single-Asset Gambit: Why Tebipenem HBr&#x27;s Oral Carbapenem Moat Could Redefine Antibiotic Economics (NASDAQ:SPRO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ABOS/acumen-pharmaceuticals-a-binary-bet-on-oligomer-selectivity-amidst-a-cash-crucible-nasdaq-abos</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:49:24Z</news:publication_date>
      <news:title>Acumen Pharmaceuticals: A Binary Bet on Oligomer Selectivity Amidst a Cash Crucible (NASDAQ:ABOS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/UPB/upstream-bio-s-tslp-receptor-gambit-why-a-50-stock-drop-creates-a-high-stakes-biotech-asymmetry-nasdaq-upb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:45:56Z</news:publication_date>
      <news:title>Upstream Bio&#x27;s TSLP Receptor Gambit: Why a 50% Stock Drop Creates a High-Stakes Biotech Asymmetry (NASDAQ:UPB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AMPG/amplitech-s-5g-gambit-margin-pain-for-market-position-at-nasdaq-ampg</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:44:55Z</news:publication_date>
      <news:title>AmpliTech&#x27;s 5G Gambit: Margin Pain for Market Position at NASDAQ:AMPG</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SCVL/shoe-station-group-a-retail-transformation-at-the-crossroads-of-execution-and-value-nasdaq-scvl</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:41:55Z</news:publication_date>
      <news:title>Shoe Station Group: A Retail Transformation at the Crossroads of Execution and Value (NASDAQ:SCVL)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FRSX/frsx-a-5-6m-bet-on-stereo-vision-s-last-stand-against-lidar-s-cash-inferno-nasdaq-frsx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:39:12Z</news:publication_date>
      <news:title>FRSX: A $5.6M Bet on Stereo Vision&#x27;s Last Stand Against LiDAR&#x27;s Cash Inferno (NASDAQ:FRSX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NSYS/restructuring-success-and-fiber-optic-moat-create-asymmetric-upside-at-nortech-systems-nasdaq-nsys</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:39:12Z</news:publication_date>
      <news:title>Restructuring Success and Fiber Optic Moat Create Asymmetric Upside at Nortech Systems (NASDAQ:NSYS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LE/lands-end-debt-free-pivot-to-licensing-growth-creates-asymmetric-risk-reward-nasdaq-le</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:33:17Z</news:publication_date>
      <news:title>Lands&#x27; End: Debt-Free Pivot to Licensing Growth Creates Asymmetric Risk/Reward (NASDAQ:LE)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PIII/p3-health-partners-a-130-million-turnaround-bet-running-on-financial-fumes-nasdaq-piii</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:32:02Z</news:publication_date>
      <news:title>P3 Health Partners: A $130 Million Turnaround Bet Running on Financial Fumes (NASDAQ:PIII)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GANX/gain-therapeutics-a-79m-bet-on-protein-misfolding-science-with-a-ticking-clock-nasdaq-ganx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:29:45Z</news:publication_date>
      <news:title>Gain Therapeutics: A $79M Bet on Protein Misfolding Science With a Ticking Clock (NASDAQ:GANX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/VRM/vroom-s-subprime-resurrection-a-post-bankruptcy-auto-lender-faces-credit-reality-nasdaq-vrm</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:25:56Z</news:publication_date>
      <news:title>Vroom&#x27;s Subprime Resurrection: A Post-Bankruptcy Auto Lender Faces Credit Reality (NASDAQ:VRM)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BTCS/btcs-s-ethereum-gambit-block-building-scale-vs-defi-borrowing-risk-nasdaq-btcs</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:24:40Z</news:publication_date>
      <news:title>BTCS&#x27;s Ethereum Gambit: Block Building Scale vs. DeFi Borrowing Risk (NASDAQ:BTCS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/KYTX/kytx-s-race-to-first-approval-why-kyverna-s-cash-advantage-could-define-the-autoimmune-car-t-winner-nasdaq-kytx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:22:34Z</news:publication_date>
      <news:title>KYTX&#x27;s Race to First Approval: Why Kyverna&#x27;s Cash Advantage Could Define the Autoimmune CAR T Winner (NASDAQ:KYTX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NEXA/nexa-s-integrated-polymetallic-model-margin-resilience-meets-project-driven-upside-nyse-nexa</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:21:02Z</news:publication_date>
      <news:title>Nexa&#x27;s Integrated Polymetallic Model: Margin Resilience Meets Project-Driven Upside (NYSE:NEXA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/APVO/zero-crs-zero-margin-for-error-aptevo-s-clinical-promise-meets-financial-reality-nasdaq-apvo</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:19:00Z</news:publication_date>
      <news:title>Zero CRS, Zero Margin for Error: Aptevo&#x27;s Clinical Promise Meets Financial Reality (NASDAQ:APVO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/WRAP/pre-escalation-pivot-meets-survival-test-at-wrap-technologies-nasdaq-wrap</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:15:26Z</news:publication_date>
      <news:title>Pre-Escalation Pivot Meets Survival Test at Wrap Technologies (NASDAQ:WRAP)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/WATT/energous-wireless-power-s-regulatory-moat-meets-an-inflection-point-nasdaq-watt</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:13:25Z</news:publication_date>
      <news:title>Energous: Wireless Power&#x27;s Regulatory Moat Meets an Inflection Point (NASDAQ:WATT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FMFG/farmers-merchants-bancshares-a-discounted-community-bank-facing-credit-and-technology-crosswinds-otc-fmfg</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:13:00Z</news:publication_date>
      <news:title>Farmers &amp; Merchants Bancshares: A Discounted Community Bank Facing Credit and Technology Crosswinds (OTC:FMFG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AGX/argan-s-power-play-how-a-debt-free-epc-specialist-captures-the-ai-driven-energy-supercycle-nyse-agx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:08:55Z</news:publication_date>
      <news:title>Argan&#x27;s Power Play: How a Debt-Free EPC Specialist Captures the AI-Driven Energy Supercycle (NYSE:AGX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/IINN/inspira-technologies-49-5m-in-orders-vs-3m-in-cash-a-binary-bet-on-execution-nasdaq-iinn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:07:58Z</news:publication_date>
      <news:title>Inspira Technologies: $49.5M in Orders vs. $3M in Cash—A Binary Bet on Execution (NASDAQ:IINN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SKYX/skyx-platforms-when-safety-becomes-standard-nasdaq-skyx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:07:34Z</news:publication_date>
      <news:title>SKYX Platforms: When Safety Becomes Standard (NASDAQ:SKYX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/INVE/identiv-s-iot-pivot-margin-inflection-meets-smart-label-transformation-nasdaq-inve</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:01:07Z</news:publication_date>
      <news:title>Identiv&#x27;s IoT Pivot: Margin Inflection Meets Smart Label Transformation (NASDAQ:INVE)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MBOT/microbot-medical-s-disposable-robotics-gamble-fda-clearance-meets-middle-east-risk-at-the-zero-revenue-inflection-point-nasdaq-mbot</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T20:00:27Z</news:publication_date>
      <news:title>Microbot Medical&#x27;s Disposable Robotics Gamble: FDA Clearance Meets Middle East Risk at the Zero-Revenue Inflection Point (NASDAQ:MBOT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/IKT/inhibikase-nasdaq-ikt-a-73m-phase-3-bet-on-pulmonary-arterial-hypertension-with-tolerability-edge-and-execution-risk</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T19:55:57Z</news:publication_date>
      <news:title>Inhibikase (NASDAQ:IKT): A $73M Phase 3 Bet on Pulmonary Arterial Hypertension with Tolerability Edge and Execution Risk</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ULTA/ulta-beauty-s-unleashed-strategy-from-investment-cycle-to-ecosystem-moat-nasdaq-ulta</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T19:55:01Z</news:publication_date>
      <news:title>Ulta Beauty&#x27;s Unleashed Strategy: From Investment Cycle to Ecosystem Moat (NASDAQ:ULTA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SNWV/ultramist-s-land-grab-how-sanuwave-health-nasdaq-snwv-turns-industry-chaos-into-profitable-growth</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T19:53:32Z</news:publication_date>
      <news:title>UltraMIST&#x27;s Land Grab: How SANUWAVE Health (NASDAQ:SNWV) Turns Industry Chaos Into Profitable Growth</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/RANI/rani-s-obesity-gambit-a-clinically-validated-platform-meets-capital-reality-nasdaq-rani</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T19:47:45Z</news:publication_date>
      <news:title>Rani&#x27;s Obesity Gambit: A Clinically Validated Platform Meets Capital Reality (NASDAQ:RANI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LINK/interlink-electronics-a-micro-cap-sensor-play-s-costly-quest-for-scale-nasdaq-link</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T19:44:45Z</news:publication_date>
      <news:title>Interlink Electronics: A Micro-Cap Sensor Play&#x27;s Costly Quest for Scale (NASDAQ:LINK)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ZNTL/zentalis-pharmaceuticals-a-binary-bet-on-azenosertib-trading-below-cash-value-nasdaq-zntl</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T19:42:22Z</news:publication_date>
      <news:title>Zentalis Pharmaceuticals: A Binary Bet on Azenosertib Trading Below Cash Value (NASDAQ:ZNTL)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DBVT/dbv-technologies-two-blas-one-shot-at-a-670k-patient-pediatric-peanut-allergy-market-nasdaq-dbvt</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T19:39:36Z</news:publication_date>
      <news:title>DBV Technologies: Two BLAs, One Shot at a $670K-Patient Pediatric Peanut Allergy Market (NASDAQ:DBVT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NMAX/affiliate-fee-inflection-meets-multi-platform-scale-newsmax-s-transformation-from-ad-driven-upstart-to-carriage-fee-powerhouse-nyse-nmax</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T19:37:18Z</news:publication_date>
      <news:title>Affiliate Fee Inflection Meets Multi-Platform Scale: Newsmax&#x27;s Transformation from Ad-Driven Upstart to Carriage-Fee Powerhouse (NYSE:NMAX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ORMP/oramed-s-118m-scilex-payday-masks-a-deeper-transformation-from-failed-oral-insulin-to-healthcare-investment-platform-nasdaq-ormp</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T19:37:03Z</news:publication_date>
      <news:title>Oramed&#x27;s $118M Scilex Payday Masks a Deeper Transformation: From Failed Oral Insulin to Healthcare Investment Platform (NASDAQ:ORMP)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CVSI/cv-sciences-regulatory-countdown-can-diversification-outrun-the-hemp-deadline-otc-cvsi</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T19:35:55Z</news:publication_date>
      <news:title>CV Sciences&#x27; Regulatory Countdown: Can Diversification Outrun the Hemp Deadline? (OTC:CVSI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ANF/abercrombie-fitch-margin-resilience-meets-capital-returns-in-a-two-speed-retail-turnaround-nyse-anf</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T19:32:17Z</news:publication_date>
      <news:title>Abercrombie &amp; Fitch: Margin Resilience Meets Capital Returns in a Two-Speed Retail Turnaround (NYSE:ANF)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CMCL/caledonia-mining-s-600m-escape-forward-can-zimbabwean-grit-deliver-a-multi-asset-future-nyse-cmcl</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T19:29:29Z</news:publication_date>
      <news:title>Caledonia Mining&#x27;s $600M Escape Forward: Can Zimbabwean Grit Deliver a Multi-Asset Future? (NYSE:CMCL)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BTGO/the-regulatory-moat-paradox-bitgo-s-path-from-volume-to-value-nasdaq-btgo</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T19:29:11Z</news:publication_date>
      <news:title>The Regulatory Moat Paradox: BitGo&#x27;s Path From Volume to Value (NASDAQ:BTGO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SFRX/seafarer-exploration-a-dying-company-with-a-lottery-ticket-on-the-ocean-floor-otc-sfrx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T19:24:08Z</news:publication_date>
      <news:title>Seafarer Exploration: A Dying Company with a Lottery Ticket on the Ocean Floor (OTC:SFRX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LOW/lowe-s-10-billion-pro-gamble-trading-margin-for-market-dominance-in-the-250-billion-contractor-economy-nyse-low</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T19:17:47Z</news:publication_date>
      <news:title>Lowe&#x27;s $10 Billion Pro Gamble: Trading Margin for Market Dominance in the $250 Billion Contractor Economy (NYSE:LOW)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ABUS/arbutus-biopharma-a-950-million-inflection-point-in-the-race-for-hepatitis-b-functional-cure-nasdaq-abus</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T19:17:42Z</news:publication_date>
      <news:title>Arbutus Biopharma: A $950 Million Inflection Point in the Race for Hepatitis B Functional Cure (NASDAQ:ABUS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PHUN/phunware-s-100m-ai-gambit-can-a-micro-cap-mobile-pioneer-rewrite-its-story-nasdaq-phun</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T19:15:35Z</news:publication_date>
      <news:title>Phunware&#x27;s $100M AI Gambit: Can a Micro-Cap Mobile Pioneer Rewrite Its Story? (NASDAQ:PHUN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AVTX/avalo-therapeutics-a-400m-bet-on-a-single-phase-2-readout-in-hidradenitis-suppurativa-nasdaq-avtx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T19:09:05Z</news:publication_date>
      <news:title>Avalo Therapeutics: A $400M Bet on a Single Phase 2 Readout in Hidradenitis Suppurativa (NASDAQ:AVTX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TBPH/theravance-biopharma-from-pipeline-dreams-to-cash-flow-reality-nasdaq-tbph</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T19:08:32Z</news:publication_date>
      <news:title>Theravance Biopharma: From Pipeline Dreams to Cash-Flow Reality (NASDAQ:TBPH)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GMHS/margin-expansion-at-the-cost-of-relevance-gamehaus-holdings-strategic-gamble-in-a-winner-take-most-market-nasdaq-gmhs</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T18:57:52Z</news:publication_date>
      <news:title>Margin Expansion at the Cost of Relevance: Gamehaus Holdings&#x27; Strategic Gamble in a Winner-Take-Most Market (NASDAQ:GMHS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BLRX/biolinerx-s-lean-turnaround-three-oncology-shots-on-goal-at-a-12m-annual-burn-nasdaq-blrx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T18:53:35Z</news:publication_date>
      <news:title>BioLineRx&#x27;s Lean Turnaround: Three Oncology Shots on Goal at a $12M Annual Burn (NASDAQ:BLRX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PYXS/micvo-s-promise-meets-the-cash-clock-pyxis-oncology-s-high-stakes-bet-on-a-novel-adc-nasdaq-pyxs</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T18:45:55Z</news:publication_date>
      <news:title>MICVO&#x27;s Promise Meets the Cash Clock: Pyxis Oncology&#x27;s High-Stakes Bet on a Novel ADC (NASDAQ:PYXS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CABA/cabaletta-bio-s-2-96-bet-can-a-cash-strapped-car-t-pioneer-reset-autoimmunity-before-the-clock-runs-out-nasdaq-caba</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T18:43:54Z</news:publication_date>
      <news:title>Cabaletta Bio&#x27;s $2.96 Bet: Can a Cash-Strapped CAR-T Pioneer Reset Autoimmunity Before the Clock Runs Out? (NASDAQ:CABA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CMMB/chemomab-s-ccl24-breakthrough-meets-a-cash-crunch-a-high-risk-high-reward-bet-on-fibrosis-nasdaq-cmmb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T18:39:08Z</news:publication_date>
      <news:title>Chemomab&#x27;s CCL24 Breakthrough Meets a Cash Crunch: A High-Risk, High-Reward Bet on Fibrosis (NASDAQ:CMMB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/XLO/xilio-s-masked-immunotherapy-platform-partnership-validation-meets-survival-finance-nasdaq-xlo</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T18:38:53Z</news:publication_date>
      <news:title>Xilio&#x27;s Masked Immunotherapy Platform: Partnership Validation Meets Survival Finance (NASDAQ:XLO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/WRD/weride-s-global-robotaxi-blueprint-why-the-asset-light-model-could-drive-profitability-first-nasdaq-wrd</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T18:35:04Z</news:publication_date>
      <news:title>WeRide&#x27;s Global Robotaxi Blueprint: Why the Asset-Light Model Could Drive Profitability First (NASDAQ:WRD)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BALY/bally-s-4-billion-bet-can-a-regional-casino-roll-up-transform-into-a-digital-gaming-powerhouse-before-debt-comes-due-nyse-baly</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T18:28:49Z</news:publication_date>
      <news:title>Bally&#x27;s $4 Billion Bet: Can a Regional Casino Roll-Up Transform Into a Digital Gaming Powerhouse Before Debt Comes Due? (NYSE:BALY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AMBA/ambarella-s-edge-ai-inflection-record-growth-meets-profitability-crossroads-nasdaq-amba</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T18:27:36Z</news:publication_date>
      <news:title>Ambarella&#x27;s Edge AI Inflection: Record Growth Meets Profitability Crossroads (NASDAQ:AMBA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MAIA/maia-biotechnology-a-33m-lifeline-for-a-telomere-targeting-breakthrough-in-third-line-nsclc-nasdaq-maia</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T18:26:22Z</news:publication_date>
      <news:title>MAIA Biotechnology: A $33M Lifeline for a Telomere-Targeting Breakthrough in Third-Line NSCLC (NASDAQ:MAIA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SMTC/semtech-s-debt-to-data-center-pivot-a-niche-semiconductor-play-at-the-ai-inflection-point-nasdaq-smtc</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T18:18:04Z</news:publication_date>
      <news:title>Semtech&#x27;s Debt-to-Data-Center Pivot: A Niche Semiconductor Play at the AI Inflection Point (NASDAQ:SMTC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/COCH/envoy-medical-s-300m-gamble-can-a-fully-implanted-cochlear-implant-justify-its-survival-risk-nasdaq-coch</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T18:17:11Z</news:publication_date>
      <news:title>Envoy Medical&#x27;s $300M Gamble: Can a Fully Implanted Cochlear Implant Justify Its Survival Risk? (NASDAQ:COCH)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MOJO/mojo-s-micro-scale-miracle-can-a-two-person-army-conquer-the-coconut-water-wars-otcqb-mojo</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T18:11:34Z</news:publication_date>
      <news:title>MOJO&#x27;s Micro-Scale Miracle: Can a Two-Person Army Conquer the Coconut Water Wars? (OTCQB:MOJO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/RMBI/rmbi-s-merger-gamble-can-a-2-6-billion-community-bank-fix-its-credit-cracks-nasdaq-rmbi</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T18:07:13Z</news:publication_date>
      <news:title>RMBI&#x27;s Merger Gamble: Can a $2.6 Billion Community Bank Fix Its Credit Cracks? (NASDAQ:RMBI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ULBI/defense-led-growth-meets-operational-turnaround-at-ultralife-nasdaq-ulbi</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T17:59:49Z</news:publication_date>
      <news:title>Defense-Led Growth Meets Operational Turnaround at Ultralife (NASDAQ:ULBI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HTLM/htlm-s-export-led-transformation-margin-inflection-meets-retail-resurrection-nasdaq-htlm</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T17:54:20Z</news:publication_date>
      <news:title>HTLM&#x27;s Export-Led Transformation: Margin Inflection Meets Retail Resurrection (NASDAQ:HTLM)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PRKR/parkervision-a-patent-litigation-lottery-ticket-with-90-of-the-prize-money-already-promised-away-nasdaq-prkr</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T17:54:20Z</news:publication_date>
      <news:title>ParkerVision: A Patent Litigation Lottery Ticket With 90% of the Prize Money Already Promised Away (NASDAQ:PRKR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GTEC/margin-expansion-meets-tariff-overhang-greenland-technologies-mispriced-core-nasdaq-gtec</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T17:48:21Z</news:publication_date>
      <news:title>Margin Expansion Meets Tariff Overhang: Greenland Technologies&#x27; Mispriced Core (NASDAQ:GTEC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SBXE/silverbox-corp-v-a-276-million-call-option-on-spac-experience-trading-at-a-discount-nyse-sbxe</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T17:37:53Z</news:publication_date>
      <news:title>SilverBox Corp V: A $276 Million Call Option on SPAC Experience Trading at a Discount (NYSE:SBXE)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MOB/fcc-exemption-meets-geopolitical-tailwinds-mobilicom-s-79b-cybersecurity-gamble-nasdaq-mob</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T17:32:30Z</news:publication_date>
      <news:title>FCC Exemption Meets Geopolitical Tailwinds: Mobilicom&#x27;s $79B Cybersecurity Gamble (NASDAQ:MOB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CNTX/context-therapeutics-a-three-drug-tce-bet-racing-against-its-own-cash-clock-nasdaq-cntx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T17:28:13Z</news:publication_date>
      <news:title>Context Therapeutics: A Three-Drug TCE Bet Racing Against Its Own Cash Clock (NASDAQ:CNTX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AARD/aardvark-therapeutics-when-scientific-promise-meets-clinical-reality-nasdaq-aard</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T17:26:48Z</news:publication_date>
      <news:title>Aardvark Therapeutics: When Scientific Promise Meets Clinical Reality (NASDAQ:AARD)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NRXP/nrx-pharmaceuticals-three-drug-approvals-and-a-clinic-network-converge-on-a-13m-patient-crisis-nasdaq-nrxp</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T17:22:48Z</news:publication_date>
      <news:title>NRx Pharmaceuticals: Three Drug Approvals and a Clinic Network Converge on a $13M Patient Crisis (NASDAQ:NRXP)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SRZN/surrozen-s-ophthalmology-gamble-a-wnt-pathway-bet-on-the-brink-of-dilution-or-breakthrough-nasdaq-srzn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T17:21:46Z</news:publication_date>
      <news:title>Surrozen&#x27;s Ophthalmology Gamble: A Wnt Pathway Bet on the Brink of Dilution or Breakthrough (NASDAQ:SRZN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/STRO/sutro-biopharma-s-platform-gambit-can-a-cell-free-adc-moat-survive-the-2025-reset-nasdaq-stro</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T17:21:07Z</news:publication_date>
      <news:title>Sutro Biopharma&#x27;s Platform Gambit: Can a Cell-Free ADC Moat Survive the 2025 Reset? (NASDAQ:STRO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BATL/battalion-oil-s-high-stakes-balancing-act-operational-excellence-meets-financial-fragility-in-the-delaware-basin-nyse-american-batl</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T17:16:23Z</news:publication_date>
      <news:title>Battalion Oil&#x27;s High-Stakes Balancing Act: Operational Excellence Meets Financial Fragility in the Delaware Basin (NYSE American:BATL)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GRO/brazil-s-fertilizer-independence-play-why-gro-offers-asymmetric-upside-at-the-execution-inflection-point</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T17:15:35Z</news:publication_date>
      <news:title>Brazil&#x27;s Fertilizer Independence Play: Why $GRO Offers Asymmetric Upside at the Execution Inflection Point</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/EVTL/vertical-aerospace-a-233-million-bet-on-battery-moats-and-a-financing-tightrope-nyse-evtl</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T17:15:27Z</news:publication_date>
      <news:title>Vertical Aerospace: A $233 Million Bet on Battery Moats and a Financing Tightrope (NYSE:EVTL)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LFT/balance-sheet-repair-meets-credit-reality-lument-finance-trust-s-multifamily-gambit-nyse-lft</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T17:13:30Z</news:publication_date>
      <news:title>Balance Sheet Repair Meets Credit Reality: Lument Finance Trust&#x27;s Multifamily Gambit (NYSE:LFT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FTCI/ftc-solar-s-constructibility-edge-meets-liquidity-cliff-a-race-against-time-nasdaq-ftci</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T17:10:52Z</news:publication_date>
      <news:title>FTC Solar&#x27;s Constructibility Edge Meets Liquidity Cliff: A Race Against Time (NASDAQ:FTCI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SFD/vertical-integration-optimization-meets-packaged-meats-dominance-at-smithfield-foods-nasdaq-sfd</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T17:09:55Z</news:publication_date>
      <news:title>Vertical Integration Optimization Meets Packaged Meats Dominance at Smithfield Foods (NASDAQ:SFD)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CDNL/cardinal-infrastructure-group-building-a-regional-moat-through-acquisition-fueled-growth-nasdaq-cdnl</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T17:09:25Z</news:publication_date>
      <news:title>Cardinal Infrastructure Group: Building a Regional Moat Through Acquisition-Fueled Growth (NASDAQ:CDNL)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/WILC/geopolitical-chaos-forges-a-margin-champion-why-willi-food-s-resilience-commands-a-premium-nasdaq-wilc</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T16:44:33Z</news:publication_date>
      <news:title>Geopolitical Chaos Forges a Margin Champion: Why Willi-Food&#x27;s Resilience Commands a Premium (NASDAQ:WILC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/UTSI/utstarcom-a-cash-burning-microcap-s-futile-quest-for-relevance-in-the-ai-era-nasdaq-utsi</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T16:43:53Z</news:publication_date>
      <news:title>UTStarcom: A Cash-Burning Microcap&#x27;s Futile Quest for Relevance in the AI Era (NASDAQ:UTSI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CDLR/cadeler-s-fleet-doubling-meets-offshore-wind-s-vessel-supply-crunch-a-2027-earnings-inflection-story-nyse-cdlr</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T16:39:44Z</news:publication_date>
      <news:title>Cadeler&#x27;s Fleet Doubling Meets Offshore Wind&#x27;s Vessel Supply Crunch: A 2027 Earnings Inflection Story (NYSE:CDLR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ACHV/achv-a-single-drug-two-markets-and-a-race-against-the-clock-nasdaq-achv</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T16:37:30Z</news:publication_date>
      <news:title>ACHV: A Single Drug, Two Markets, and a Race Against the Clock (NASDAQ:ACHV)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LITB/lightinthebox-s-profitability-pivot-can-a-niche-apparel-play-survive-the-temu-onslaught-nyse-litb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T16:37:24Z</news:publication_date>
      <news:title>LightInTheBox&#x27;s Profitability Pivot: Can a Niche Apparel Play Survive the Temu Onslaught? (NYSE:LITB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LEAT/leatt-s-protective-equipment-platform-how-strategic-diversification-created-41-growth-and-a-fortress-balance-sheet-nasdaq-leat</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T16:32:19Z</news:publication_date>
      <news:title>Leatt&#x27;s Protective Equipment Platform: How Strategic Diversification Created 41% Growth and a Fortress Balance Sheet (NASDAQ:LEAT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CMPS/compass-pathways-clinical-validation-meets-commercial-acceleration-in-the-psychedelic-mental-health-revolution-nasdaq-cmps</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T16:27:09Z</news:publication_date>
      <news:title>COMPASS Pathways: Clinical Validation Meets Commercial Acceleration in the Psychedelic Mental Health Revolution (NASDAQ:CMPS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HOUR/amazon-s-shadow-why-hour-loop-s-profitability-faces-a-structural-squeeze-nasdaq-hour</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T16:16:18Z</news:publication_date>
      <news:title>Amazon&#x27;s Shadow: Why Hour Loop&#x27;s Profitability Faces a Structural Squeeze (NASDAQ:HOUR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/EFOI/efoi-s-last-stand-can-a-micro-cap-led-specialist-survive-its-own-turnaround-nasdaq-efoi</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T16:13:23Z</news:publication_date>
      <news:title>EFOI&#x27;s Last Stand: Can a Micro-Cap LED Specialist Survive Its Own Turnaround? (NASDAQ:EFOI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PESI/perma-fix-environmental-when-operational-leverage-meets-a-multi-decade-cleanup-catalyst-nasdaq-pesi</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T16:13:06Z</news:publication_date>
      <news:title>Perma-Fix Environmental: When Operational Leverage Meets a Multi-Decade Cleanup Catalyst (NASDAQ:PESI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TBTC/table-trac-s-niche-moat-small-scale-dominance-in-underserved-casinos-meets-big-scale-consolidation-risk-otcqx-tbtc</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T16:11:46Z</news:publication_date>
      <news:title>Table Trac&#x27;s Niche Moat: Small-Scale Dominance in Underserved Casinos Meets Big-Scale Consolidation Risk (OTCQX:TBTC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BIOA/bioage-s-pipeline-in-a-pill-gamble-why-a-single-nlrp3-inhibitor-must-justify-a-777m-valuation-nasdaq-bioa</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T16:11:28Z</news:publication_date>
      <news:title>BioAge&#x27;s &quot;Pipeline in a Pill&quot; Gamble: Why a Single NLRP3 Inhibitor Must Justify a $777M Valuation (NASDAQ:BIOA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CRMZ/creditriskmonitor-s-bankruptcy-tailwind-meets-transformation-inflection-otcpk-crmz</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T16:08:36Z</news:publication_date>
      <news:title>CreditRiskMonitor&#x27;s Bankruptcy Tailwind Meets Transformation Inflection (OTCPK:CRMZ)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GIII/g-iii-apparel-s-brand-pivot-trading-scale-for-margin-control-amid-portfolio-transformation-nasdaq-giii</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T16:08:26Z</news:publication_date>
      <news:title>G-III Apparel&#x27;s Brand Pivot: Trading Scale for Margin Control Amid Portfolio Transformation (NASDAQ:GIII)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CVR/chicago-rivet-a-98-year-old-turnaround-on-borrowed-time-nysemkt-cvr</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T16:05:04Z</news:publication_date>
      <news:title>Chicago Rivet: A 98-Year-Old Turnaround on Borrowed Time (NYSEMKT:CVR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GME/gamestop-s-9b-cash-pivot-can-a-declining-retailer-become-berkshire-hathaway-2-0-nyse-gme</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T16:02:53Z</news:publication_date>
      <news:title>GameStop&#x27;s $9B Cash Pivot: Can a Declining Retailer Become Berkshire Hathaway 2.0? (NYSE:GME)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BCDA/biocardia-s-1-20-dilemma-when-clinical-signals-collide-with-a-2-5-million-bank-account-nasdaq-bcda</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T16:01:45Z</news:publication_date>
      <news:title>BioCardia&#x27;s $1.20 Dilemma: When Clinical Signals Collide With a $2.5 Million Bank Account (NASDAQ:BCDA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NGNE/ngne-s-rett-syndrome-gamble-can-gene-regulation-technology-justify-the-high-stakes-bet</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T15:58:53Z</news:publication_date>
      <news:title>NGNE&#x27;s Rett Syndrome Gamble: Can Gene Regulation Technology Justify the High-Stakes Bet?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BRZE/braze-s-ai-inflection-how-reinforcement-learning-and-margin-expansion-converge-at-23-68-nasdaq-brze</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T15:58:42Z</news:publication_date>
      <news:title>Braze&#x27;s AI Inflection: How Reinforcement Learning and Margin Expansion Converge at $23.68 (NASDAQ:BRZE)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GHBWF/glass-house-brands-california-s-low-cost-cannabis-fortress-at-a-regulatory-inflection-point-otcqx-ghbwf</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T15:54:29Z</news:publication_date>
      <news:title>Glass House Brands: California&#x27;s Low-Cost Cannabis Fortress at a Regulatory Inflection Point (OTCQX:GHBWF)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LODE/comstock-s-zero-landfill-solar-recycling-a-capital-efficient-inflection-at-3-58-nasdaq-lode</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T15:52:47Z</news:publication_date>
      <news:title>Comstock&#x27;s Zero-Landfill Solar Recycling: A Capital-Efficient Inflection at $3.58 (NASDAQ:LODE)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GUTS/fractyl-health-s-guts-a-binary-bet-on-the-post-glp-1-off-ramp-moment</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T15:51:24Z</news:publication_date>
      <news:title>Fractyl Health&#x27;s $GUTS: A Binary Bet on the Post-GLP-1 &quot;Off-Ramp&quot; Moment</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PATH/uipath-s-agentic-automation-inflection-why-first-time-profitability-is-just-the-beginning-nyse-path</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T15:42:07Z</news:publication_date>
      <news:title>UiPath&#x27;s Agentic Automation Inflection: Why First-Time Profitability Is Just the Beginning (NYSE:PATH)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/VHC/virnetx-s-government-gambit-a-patent-troll-s-last-stand-at-zero-trust-nyse-vhc</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T15:38:58Z</news:publication_date>
      <news:title>VirnetX&#x27;s Government Gambit: A Patent Troll&#x27;s Last Stand at Zero Trust (NYSE:VHC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BMEA/biomea-fusion-s-metabolic-gambit-first-mover-advantage-meets-survival-risk-nasdaq-bmea</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T15:33:58Z</news:publication_date>
      <news:title>Biomea Fusion&#x27;s Metabolic Gambit: First-Mover Advantage Meets Survival Risk (NASDAQ:BMEA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BRIA/bria-tariff-resilience-and-japan-expansion-test-a-concentrated-lingerie-supplier-nyseamerican-bria</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T15:28:21Z</news:publication_date>
      <news:title>BRIA: Tariff Resilience and Japan Expansion Test a Concentrated Lingerie Supplier (NYSEAMERICAN:BRIA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/WVVI/willamette-valley-vineyards-premium-margins-meet-scale-deficits-in-a-declining-industry-nasdaq-wvvi</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T15:27:32Z</news:publication_date>
      <news:title>Willamette Valley Vineyards: Premium Margins Meet Scale Deficits in a Declining Industry (NASDAQ:WVVI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BDCI/bdci-s-250m-clock-why-betsy-cohen-s-bitcoin-spac-faces-a-high-stakes-deal-sprint</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T15:25:36Z</news:publication_date>
      <news:title>BDCI&#x27;s $250M Clock: Why Betsy Cohen&#x27;s Bitcoin SPAC Faces a High-Stakes Deal Sprint</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CRIS/curis-inc-nasdaq-cris-emavusertib-s-clinical-promise-meets-a-1-2-billion-deficit-at-the-edge-of-solvency</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T15:23:32Z</news:publication_date>
      <news:title>Curis Inc. (NASDAQ:CRIS): Emavusertib&#x27;s Clinical Promise Meets a $1.2 Billion Deficit at the Edge of Solvency</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TIGO/millicom-s-strategic-metamorphosis-tower-monetization-and-portfolio-upgrade-drive-margin-inflection-nasdaq-tigo</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T15:21:53Z</news:publication_date>
      <news:title>Millicom&#x27;s Strategic Metamorphosis: Tower Monetization and Portfolio Upgrade Drive Margin Inflection (NASDAQ:TIGO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ABSI/absci-s-platform-validation-play-why-abs-201-s-clinical-readouts-will-define-the-ai-drug-creation-thesis-nasdaq-absi</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T15:20:53Z</news:publication_date>
      <news:title>Absci&#x27;s Platform Validation Play: Why ABS-201&#x27;s Clinical Readouts Will Define the AI Drug Creation Thesis (NASDAQ:ABSI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SFCX/sfcx-a-40-million-shell-game-with-no-revenue-no-cash-and-a-going-concern-warning-otc-sfcx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T15:10:05Z</news:publication_date>
      <news:title>SFCX: A $40 Million Shell Game With No Revenue, No Cash, and a Going Concern Warning (OTC:SFCX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HMR/heidmar-s-maritime-scaling-trap-93-revenue-growth-meets-profitability-cliff-nasdaq-hmr</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T15:09:24Z</news:publication_date>
      <news:title>Heidmar&#x27;s Maritime Scaling Trap: 93% Revenue Growth Meets Profitability Cliff (NASDAQ:HMR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/WPP/wpp-s-elevate28-a-turnaround-bet-on-ai-driven-integration-nyse-wpp</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T15:05:20Z</news:publication_date>
      <news:title>WPP&#x27;s Elevate28: A Turnaround Bet on AI-Driven Integration (NYSE:WPP)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NOAH/noah-holdings-ai-driven-transformation-meets-deep-value-discount-nyse-noah</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T15:03:58Z</news:publication_date>
      <news:title>Noah Holdings: AI-Driven Transformation Meets Deep Value Discount (NYSE:NOAH)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FDSB/fifth-district-bancorp-post-conversion-capital-meets-sub-scale-reality-in-new-orleans-banking-nasdaq-fdsb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T14:57:03Z</news:publication_date>
      <news:title>Fifth District Bancorp: Post-Conversion Capital Meets Sub-Scale Reality in New Orleans Banking (NASDAQ:FDSB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ITRG/integra-resources-florida-canyon-s-cash-flow-engine-fuels-a-de-risked-gold-growth-pipeline-nyse-itrg</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T14:56:42Z</news:publication_date>
      <news:title>Integra Resources: Florida Canyon&#x27;s Cash Flow Engine Fuels a De-Risked Gold Growth Pipeline (NYSE:ITRG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CJAX/cjax-s-65-rally-masks-a-deeper-crisis-why-this-micro-cap-oil-play-remains-a-going-concern-otc-cjax</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T14:52:09Z</news:publication_date>
      <news:title>CJAX&#x27;s 65% Rally Masks a Deeper Crisis: Why This Micro-Cap Oil Play Remains a Going Concern (OTC:CJAX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/RANG/range-capital-acquisition-tim-rotolo-s-115m-test-against-time-and-capital-constraints-nasdaq-rang</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T14:50:16Z</news:publication_date>
      <news:title>Range Capital Acquisition: Tim Rotolo&#x27;s $115M Test Against Time and Capital Constraints (NASDAQ:RANG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SCTH/ai-ultraprod-acquisition-transforms-securetech-from-shell-to-growth-story-but-execution-risks-loom-otcqb-scth</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T14:45:39Z</news:publication_date>
      <news:title>AI UltraProd Acquisition Transforms SecureTech From Shell to Growth Story, But Execution Risks Loom (OTCQB:SCTH)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DRIO/dariohealth-s-platform-pivot-meets-strategic-inflection-point-nasdaq-drio</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T14:40:04Z</news:publication_date>
      <news:title>DarioHealth&#x27;s Platform Pivot Meets Strategic Inflection Point (NASDAQ:DRIO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TGEN/tecogen-s-data-center-gamble-can-a-niche-chp-player-capture-the-ai-cooling-boom-nyse-tgen</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T14:32:36Z</news:publication_date>
      <news:title>Tecogen&#x27;s Data Center Gamble: Can a Niche CHP Player Capture the AI Cooling Boom? (NYSE:TGEN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MDAI/fda-clearance-imminent-why-spectral-ai-s-government-backed-burn-diagnostic-is-poised-for-commercial-inflection-nasdaq-mdai</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T14:29:58Z</news:publication_date>
      <news:title>FDA Clearance Imminent: Why Spectral AI&#x27;s Government-Backed Burn Diagnostic Is Poised for Commercial Inflection (NASDAQ:MDAI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TIGR/up-fintech-s-quality-revolution-why-the-market-still-misprices-tiger-brokers-global-transformation-nasdaq-tigr</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T14:25:24Z</news:publication_date>
      <news:title>UP Fintech&#x27;s Quality Revolution: Why the Market Still Misprices Tiger Brokers&#x27; Global Transformation (NASDAQ:TIGR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ARGX/vyvgart-s-4b-inflection-argenx-transforms-into-self-funding-immunology-leader-nasdaq-argx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T14:20:53Z</news:publication_date>
      <news:title>VYVGART&#x27;s $4B Inflection: argenx Transforms into Self-Funding Immunology Leader (NASDAQ:ARGX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/STG/stg-s-silver-economy-pivot-profitable-niche-play-in-china-s-rmb-2-8-trillion-senior-learning-market</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T14:19:21Z</news:publication_date>
      <news:title>STG&#x27;s Silver Economy Pivot: Profitable Niche Play in China&#x27;s RMB 2.8 Trillion Senior Learning Market</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ZKH/zkh-group-ai-powered-mro-platform-hits-profitability-inflection-point-nasdaq-zkh</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T14:15:45Z</news:publication_date>
      <news:title>ZKH Group: AI-Powered MRO Platform Hits Profitability Inflection Point (NASDAQ:ZKH)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LZM/lifezone-metals-a-clean-tech-moonshot-running-out-of-runway-nyse-lzm</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T14:13:21Z</news:publication_date>
      <news:title>Lifezone Metals: A Clean Tech Moonshot Running Out of Runway (NYSE:LZM)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LAC/lithium-americas-when-2-billion-of-government-money-meets-zero-revenue</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T14:09:17Z</news:publication_date>
      <news:title>Lithium Americas: When $2 Billion of Government Money Meets Zero Revenue</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AEBI/aebi-schmidt-post-merger-synergy-surge-meets-integration-execution-risk-nasdaq-aebi</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T14:08:55Z</news:publication_date>
      <news:title>AEBI Schmidt: Post-Merger Synergy Surge Meets Integration Execution Risk (NASDAQ:AEBI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LX/lexinfintech-s-regulatory-rebirth-why-a-52-profit-surge-amid-revenue-decline-signals-deep-value-nasdaq-lx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T14:03:35Z</news:publication_date>
      <news:title>LexinFintech&#x27;s Regulatory Rebirth: Why a 52% Profit Surge Amid Revenue Decline Signals Deep Value (NASDAQ:LX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SIG/signet-jewelers-turnaround-execution-meets-compelling-capital-returns-nyse-sig</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T14:03:01Z</news:publication_date>
      <news:title>Signet Jewelers: Turnaround Execution Meets Compelling Capital Returns (NYSE:SIG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LIEN/the-niche-lending-premium-why-chicago-atlantic-bdc-s-28-discount-to-nav-masks-a-superior-credit-franchise-nasdaq-lien</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T14:02:40Z</news:publication_date>
      <news:title>The Niche Lending Premium: Why Chicago Atlantic BDC&#x27;s 28% Discount to NAV Masks a Superior Credit Franchise (NASDAQ:LIEN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NRXS/the-cpt-code-inflection-why-neuraxis-s-pediatric-neuromodulation-monopoly-is-approaching-a-tipping-point-nasdaq-nrxs</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T13:55:51Z</news:publication_date>
      <news:title>The CPT Code Inflection: Why Neuraxis&#x27;s Pediatric Neuromodulation Monopoly Is Approaching a Tipping Point (NASDAQ:NRXS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ALVO/manufacturing-stumbles-meet-pipeline-power-alvotech-s-biosimilar-execution-test-nasdaq-alvo</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T13:50:31Z</news:publication_date>
      <news:title>Manufacturing Stumbles Meet Pipeline Power: Alvotech&#x27;s Biosimilar Execution Test (NASDAQ:ALVO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ACRV/acrivon-s-proteomics-platform-shows-clinical-validation-while-trading-below-cash-nasdaq-acrv</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T13:46:04Z</news:publication_date>
      <news:title>Acrivon&#x27;s Proteomics Platform Shows Clinical Validation While Trading Below Cash (NASDAQ:ACRV)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ARCO/margin-inflection-meets-digital-moat-why-arcos-dorados-nyse-arco-is-poised-for-a-profitability-renaissance</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T13:39:33Z</news:publication_date>
      <news:title>Margin Inflection Meets Digital Moat: Why Arcos Dorados (NYSE:ARCO) Is Poised for a Profitability Renaissance</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MLCI/mount-logan-capital-nasdaq-mlci-a-post-merger-transformation-story-trading-at-0-5x-book-value</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T13:38:43Z</news:publication_date>
      <news:title>Mount Logan Capital (NASDAQ:MLCI): A Post-Merger Transformation Story Trading at 0.5x Book Value</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TSHA/taysha-gene-therapies-a-clinical-inflection-point-meets-commercial-readiness-nasdaq-tsha</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T13:32:56Z</news:publication_date>
      <news:title>Taysha Gene Therapies: A Clinical Inflection Point Meets Commercial Readiness (NASDAQ:TSHA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PICS/picpay-s-efficiency-arbitrage-why-a-128-credit-surge-and-r-20-cost-to-serve-create-an-asymmetric-bet-nasdaq-pics</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T13:27:28Z</news:publication_date>
      <news:title>PicPay&#x27;s Efficiency Arbitrage: Why a 128% Credit Surge and R$20 Cost-to-Serve Create an Asymmetric Bet (NASDAQ:PICS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/RBRK/rubrik-s-dual-engine-cyber-resilience-platform-meets-ai-operations-inflection-nasdaq-rbrk</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T13:23:59Z</news:publication_date>
      <news:title>Rubrik&#x27;s Dual Engine: Cyber Resilience Platform Meets AI Operations Inflection (NASDAQ:RBRK)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SLGL/sgt-610-or-bust-sol-gel-technologies-250m-dermatology-gamble-nasdaq-slgl</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T13:23:37Z</news:publication_date>
      <news:title>SGT-610 or Bust: Sol-Gel Technologies&#x27; $250M Dermatology Gamble (NASDAQ:SLGL)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MREO/mereo-biopharma-a-51-million-option-ticket-on-rare-disease-pipeline-regeneration-nasdaq-mreo</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T13:23:04Z</news:publication_date>
      <news:title>Mereo BioPharma: A $51 Million Option Ticket on Rare Disease Pipeline Regeneration (NASDAQ:MREO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PLBC/plumas-bancorp-acquisition-driven-growth-meets-concentration-risk-in-rural-banking-nasdaq-plbc</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T13:18:48Z</news:publication_date>
      <news:title>Plumas Bancorp: Acquisition-Driven Growth Meets Concentration Risk in Rural Banking (NASDAQ:PLBC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MOV/movado-group-a-debt-free-fortress-positioned-for-the-fashion-watch-resurgence-nyse-mov</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T13:16:56Z</news:publication_date>
      <news:title>Movado Group: A Debt-Free Fortress Positioned for the Fashion Watch Resurgence (NYSE:MOV)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BIOF/blue-biofuels-a-45m-pre-revenue-bet-on-cellulosic-technology-ready-for-scale-but-starved-for-capital-otc-biof</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T13:14:40Z</news:publication_date>
      <news:title>Blue Biofuels: A $45M Pre-Revenue Bet on Cellulosic Technology Ready for Scale but Starved for Capital (OTC:BIOF)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/RICK/rick-s-capital-allocation-revolution-how-a-legal-crisis-is-accelerating-the-transformation-to-a-free-cash-flow-machine-nasdaq-rick</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T13:13:28Z</news:publication_date>
      <news:title>RICK&#x27;s Capital Allocation Revolution: How a Legal Crisis Is Accelerating the Transformation to a Free-Cash-Flow Machine (NASDAQ:RICK)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BRAG/proprietary-content-drives-margin-inflection-at-bragg-gaming-nasdaq-brag</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T13:10:52Z</news:publication_date>
      <news:title>Proprietary Content Drives Margin Inflection at Bragg Gaming (NASDAQ:BRAG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TRC/tejon-ranch-california-s-hidden-land-giant-converts-dirt-into-cash-flow-nyse-trc</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T13:10:14Z</news:publication_date>
      <news:title>Tejon Ranch: California&#x27;s Hidden Land Giant Converts Dirt into Cash Flow (NYSE:TRC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AVAH/aveanna-healthcare-margin-inflection-meets-pediatric-home-care-dominance-nasdaq-avah</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T13:03:51Z</news:publication_date>
      <news:title>Aveanna Healthcare: Margin Inflection Meets Pediatric Home Care Dominance (NASDAQ:AVAH)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LRMR/larimar-therapeutics-a-binary-bet-on-disease-modification-in-friedreich-s-ataxia-nasdaq-lrmr</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T13:03:24Z</news:publication_date>
      <news:title>Larimar Therapeutics: A Binary Bet on Disease Modification in Friedreich&#x27;s Ataxia (NASDAQ:LRMR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BABA/alibaba-s-ai-gambit-why-a-50-billion-bet-on-cloud-and-quick-commerce-is-reshaping-china-s-tech-landscape-nyse-baba</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T12:54:35Z</news:publication_date>
      <news:title>Alibaba&#x27;s AI Gambit: Why a $50 Billion Bet on Cloud and Quick Commerce Is Reshaping China&#x27;s Tech Landscape (NYSE:BABA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GLTO/damora-therapeutics-a-5-billion-mutcalr-pivot-with-best-in-class-potential-and-a-fortress-balance-sheet-nasdaq-glto</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T12:53:48Z</news:publication_date>
      <news:title>Damora Therapeutics: A $5 Billion mutCALR Pivot With Best-in-Class Potential and a Fortress Balance Sheet (NASDAQ:GLTO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SLS/two-shots-on-goal-sellas-life-sciences-binary-bet-on-wt1-and-cdk9-at-clinical-inflection-nasdaq-sls</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T12:51:14Z</news:publication_date>
      <news:title>Two Shots on Goal: SELLAS Life Sciences&#x27; Binary Bet on WT1 and CDK9 at Clinical Inflection (NASDAQ:SLS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/UAMY/uamy-the-only-u-s-antimony-vertically-integrated-player-capturing-the-critical-minerals-supercycle-nyse-uamy</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T12:49:00Z</news:publication_date>
      <news:title>UAMY: The Only U.S. Antimony Vertically Integrated Player Capturing the Critical Minerals Supercycle (NYSE:UAMY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/INBX/inbx-a-multi-valent-oncology-platform-on-the-brink-of-validation-nasdaq-inbx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T12:38:04Z</news:publication_date>
      <news:title>INBX: A Multi-Valent Oncology Platform on the Brink of Validation (NASDAQ:INBX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SKYH/sky-harbour-s-vertical-integration-play-building-a-moat-in-a-supply-starved-market-nyse-skyh</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T12:36:29Z</news:publication_date>
      <news:title>Sky Harbour&#x27;s Vertical Integration Play: Building a Moat in a Supply-Starved Market (NYSE:SKYH)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SLDB/sgt-3-s-second-act-why-solid-biosciences-gene-therapy-platform-could-redefine-duchenne-treatment-nasdaq-sldb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T12:32:15Z</news:publication_date>
      <news:title>SGT-3&#x27;s Second Act: Why Solid Biosciences&#x27; Gene Therapy Platform Could Redefine Duchenne Treatment (NASDAQ:SLDB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ACCS/access-newswire-s-subscription-pivot-margin-inflection-meets-ai-driven-arpu-expansion-nasdaq-accs</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T12:26:12Z</news:publication_date>
      <news:title>ACCESS Newswire&#x27;s Subscription Pivot: Margin Inflection Meets AI-Driven ARPU Expansion (NASDAQ:ACCS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TYGO/tigo-energy-s-turnaround-how-open-architecture-and-repowering-are-driving-92-growth-with-43-margins-nasdaq-tygo</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T12:20:27Z</news:publication_date>
      <news:title>Tigo Energy&#x27;s Turnaround: How Open Architecture and Repowering Are Driving 92% Growth With 43% Margins (NASDAQ:TYGO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CXM/sprinklr-s-ai-native-turnaround-why-enterprise-concentration-and-platform-unification-are-setting-up-a-misunderstood-inflection-point-nasdaq-cxm</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T12:19:34Z</news:publication_date>
      <news:title>Sprinklr&#x27;s AI-Native Turnaround: Why Enterprise Concentration and Platform Unification Are Setting Up a Misunderstood Inflection Point (NASDAQ:CXM)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BLTH/american-battery-materials-a-12-million-bet-on-america-s-lithium-independence-or-a-ticket-to-zero-otc-blth</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T12:14:15Z</news:publication_date>
      <news:title>American Battery Materials: A $12 Million Bet on America&#x27;s Lithium Independence or a Ticket to Zero? (OTC:BLTH)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MBIO/mustang-bio-s-binary-gamble-a-6-million-call-option-on-car-t-survival-nasdaq-mbio</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T12:14:12Z</news:publication_date>
      <news:title>Mustang Bio&#x27;s Binary Gamble: A $6 Million Call Option on CAR T Survival (NASDAQ:MBIO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GNLX/genelux-s-systemic-oncolytic-gamble-clinical-promise-meets-cash-crunch-nasdaq-gnlx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T12:09:31Z</news:publication_date>
      <news:title>Genelux&#x27;s Systemic Oncolytic Gamble: Clinical Promise Meets Cash Crunch (NASDAQ:GNLX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/STKS/stks-a-leveraged-bet-on-benihana-powered-scale-in-a-discretionary-downturn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T12:09:27Z</news:publication_date>
      <news:title>STKS: A Leveraged Bet on Benihana-Powered Scale in a Discretionary Downturn</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/KSS/kohl-s-corporation-nyse-kss-why-the-5x-p-e-multiple-is-a-turnaround-test-not-a-value-signal</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T12:04:28Z</news:publication_date>
      <news:title>Kohl&#x27;s Corporation (NYSE:KSS): Why the 5x P/E Multiple Is a Turnaround Test, Not a Value Signal</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SNAL/snal-a-gaming-zombie-s-stablecoin-lifeline-or-ark-s-last-stand</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T12:00:28Z</news:publication_date>
      <news:title>SNAL: A Gaming Zombie&#x27;s Stablecoin Lifeline or ARK&#x27;s Last Stand?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SATL/satlogic-s-sovereign-pivot-how-delaware-domicile-and-cost-leadership-unlock-defense-market-dominance-nasdaq-satl</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T11:53:27Z</news:publication_date>
      <news:title>Satlogic&#x27;s Sovereign Pivot: How Delaware Domicile and Cost Leadership Unlock Defense Market Dominance (NASDAQ:SATL)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/S/sentinelone-s-ai-security-inflection-why-platform-consolidation-is-driving-sustainable-profitability-at-1-billion-scale-nyse-s</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T11:48:11Z</news:publication_date>
      <news:title>SentinelOne&#x27;s AI Security Inflection: Why Platform Consolidation Is Driving Sustainable Profitability at $1 Billion Scale (NYSE:S)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BKKT/bakkt-s-infrastructure-gambit-a-debt-free-turnaround-bet-on-the-stablecoin-revolution-nyse-bkkt</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T11:39:35Z</news:publication_date>
      <news:title>Bakkt&#x27;s Infrastructure Gambit: A Debt-Free Turnaround Bet on the Stablecoin Revolution (NYSE:BKKT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ZURA/zura-bio-s-135m-lifeline-two-phase-2-trials-to-justify-a-572m-clinical-stage-gamble-nasdaq-zura</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T11:39:17Z</news:publication_date>
      <news:title>Zura Bio&#x27;s $135M Lifeline: Two Phase 2 Trials to Justify a $572M Clinical-Stage Gamble (NASDAQ:ZURA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SBLK/star-bulk-s-supply-crunch-arbitrage-why-scale-and-scrubs-create-asymmetric-upside-nasdaq-sblk</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T11:37:25Z</news:publication_date>
      <news:title>Star Bulk&#x27;s Supply Crunch Arbitrage: Why Scale and Scrubs Create Asymmetric Upside (NASDAQ:SBLK)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ETON/eton-pharmaceuticals-building-a-profitable-rare-disease-empire-one-acquisition-at-a-time-nasdaq-eton</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T11:34:16Z</news:publication_date>
      <news:title>Eton Pharmaceuticals: Building a Profitable Rare Disease Empire One Acquisition at a Time (NASDAQ:ETON)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BFRI/from-transfer-pricing-to-transformation-biofrontera-s-path-to-profitability-and-pipeline-upside-nasdaq-bfri</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T11:29:42Z</news:publication_date>
      <news:title>From Transfer Pricing to Transformation: Biofrontera&#x27;s Path to Profitability and Pipeline Upside (NASDAQ:BFRI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ASMB/assembly-biosciences-a-29-option-on-virology-s-next-wave-with-gilead-as-both-catalyst-and-constraint-nasdaq-asmb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T11:27:22Z</news:publication_date>
      <news:title>Assembly Biosciences: A $29 Option on Virology&#x27;s Next Wave—With Gilead as Both Catalyst and Constraint (NASDAQ:ASMB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/IDN/intellicheck-s-vertical-pivot-from-retail-headwinds-to-banking-tailwinds-drives-first-time-profitability-nasdaq-idn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T11:21:49Z</news:publication_date>
      <news:title>Intellicheck&#x27;s Vertical Pivot: From Retail Headwinds to Banking Tailwinds Drives First-Time Profitability (NASDAQ:IDN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ALMS/alumis-phase-3-triumph-meets-valuation-reality-a-high-stakes-bet-on-tyk2-dominance-nasdaq-alms</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T11:21:45Z</news:publication_date>
      <news:title>Alumis&#x27; Phase 3 Triumph Meets Valuation Reality: A High-Stakes Bet on TYK2 Dominance (NASDAQ:ALMS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/RCAT/red-cat-holdings-manufacturing-scale-meets-gps-denied-tech-in-the-pentagon-s-drone-wars-nasdaq-rcat</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T11:19:50Z</news:publication_date>
      <news:title>Red Cat Holdings: Manufacturing Scale Meets GPS-Denied Tech in the Pentagon&#x27;s Drone Wars (NASDAQ:RCAT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NCNA/nuc-7738-or-bust-nucana-s-binary-bet-on-chemo-immunotherapy-synergy-nasdaq-ncna</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T11:15:48Z</news:publication_date>
      <news:title>NUC-7738 or Bust: NuCana&#x27;s Binary Bet on Chemo-Immunotherapy Synergy (NASDAQ:NCNA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/RLMD/relmada-s-250m-bladder-cancer-gambit-why-best-in-class-phase-2-data-creates-asymmetric-upside-nasdaq-rlmd</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T11:13:26Z</news:publication_date>
      <news:title>Relmada&#x27;s $250M Bladder Cancer Gambit: Why Best-in-Class Phase 2 Data Creates Asymmetric Upside (NASDAQ:RLMD)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ECOR/high-margin-platform-meets-diversification-inflection-at-electrocore-nasdaq-ecor</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T11:13:22Z</news:publication_date>
      <news:title>High-Margin Platform Meets Diversification Inflection at electroCore (NASDAQ:ECOR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/WWR/westwater-resources-a-78-million-bet-on-america-s-graphite-independence-with-a-broken-financing-engine-nasdaq-wwr</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T11:08:09Z</news:publication_date>
      <news:title>Westwater Resources: A $78 Million Bet on America&#x27;s Graphite Independence—With a Broken Financing Engine (NASDAQ:WWR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ZNOG/zion-oil-gas-a-424-million-call-option-on-israel-s-onshore-potential-funded-by-faith-otcqx-znog</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T11:07:15Z</news:publication_date>
      <news:title>Zion Oil &amp; Gas: A $424 Million Call Option on Israel&#x27;s Onshore Potential, Funded by Faith (OTCQX:ZNOG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BFRG/bullfrog-ai-a-22-million-bet-on-survival-in-the-ai-drug-discovery-arms-race-nasdaq-bfrg</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T11:03:35Z</news:publication_date>
      <news:title>BullFrog AI: A $22 Million Bet on Survival in the AI Drug Discovery Arms Race (NASDAQ:BFRG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LUNR/lunr-s-1b-inflection-can-a-vertically-integrated-space-prime-justify-5x-revenue-growth</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T11:00:39Z</news:publication_date>
      <news:title>LUNR&#x27;s $1B Inflection: Can a Vertically Integrated Space Prime Justify 5x Revenue Growth?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MSAI/multisensor-ai-s-saas-pivot-outrunning-hardware-decline-and-cash-burn-in-a-9b-industrial-monitoring-market-nasdaq-msai</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:58:50Z</news:publication_date>
      <news:title>MultiSensor AI&#x27;s SaaS Pivot: Outrunning Hardware Decline and Cash Burn in a $9B Industrial Monitoring Market (NASDAQ:MSAI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SNOW/snowflake-s-ai-pivot-can-a-data-warehousing-pioneer-justify-its-premium-in-the-age-of-agentic-intelligence-nyse-snow</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:58:41Z</news:publication_date>
      <news:title>Snowflake&#x27;s AI Pivot: Can a Data Warehousing Pioneer Justify Its Premium in the Age of Agentic Intelligence? (NYSE:SNOW)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NLST/netlist-ai-memory-boom-meets-binary-supply-risk-at-a-critical-inflection-point-otc-nlst</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:56:28Z</news:publication_date>
      <news:title>Netlist: AI Memory Boom Meets Binary Supply Risk at a Critical Inflection Point (OTC:NLST)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NBY/from-eyedrops-to-crypto-novabay-s-162m-bet-on-sky-tokens-redefines-risk-reward-nyse-nby</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:53:50Z</news:publication_date>
      <news:title>From Eyedrops to Crypto: NovaBay&#x27;s $162M Bet on SKY Tokens Redefines Risk-Reward (NYSE:NBY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ELDN/eledon-pharmaceuticals-a-kidney-transplant-breakthrough-meets-the-financing-cliff-nasdaq-eldn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:49:57Z</news:publication_date>
      <news:title>Eledon Pharmaceuticals: A Kidney Transplant Breakthrough Meets the Financing Cliff (NASDAQ:ELDN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AWX/avalon-holdings-a-micro-cap-conglomerate-stuck-in-no-man-s-land-nyseamerican-awx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:48:34Z</news:publication_date>
      <news:title>Avalon Holdings: A Micro-Cap Conglomerate Stuck in No-Man&#x27;s Land (NYSEAMERICAN:AWX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ODYS/odysight-ai-s-110m-speculation-a-vision-based-predictive-maintenance-moat-in-search-of-scale-nasdaq-odys</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:45:53Z</news:publication_date>
      <news:title>Odysight.ai&#x27;s $110M Speculation: A Vision-Based Predictive Maintenance Moat in Search of Scale (NASDAQ:ODYS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/KZIA/kazia-therapeutics-a-50m-lifeline-creates-a-high-risk-high-reward-window-in-oncology-s-toughest-cancers-nasdaq-kzia</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:44:19Z</news:publication_date>
      <news:title>Kazia Therapeutics: A $50M Lifeline Creates a High-Risk, High-Reward Window in Oncology&#x27;s Toughest Cancers (NASDAQ:KZIA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/STRW/strawberry-fields-reit-the-self-managed-snf-specialist-trading-at-an-unwarranted-discount-nyse-american-strw</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:40:20Z</news:publication_date>
      <news:title>Strawberry Fields REIT: The Self-Managed SNF Specialist Trading at an Unwarranted Discount (NYSE American:STRW)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ZGN/zgn-s-dtc-gamble-why-ermenegildo-zegna-is-trading-near-term-pain-for-long-term-pricing-power-nyse-zgn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:40:15Z</news:publication_date>
      <news:title>ZGN&#x27;s DTC Gamble: Why Ermenegildo Zegna Is Trading Near-Term Pain for Long-Term Pricing Power (NYSE:ZGN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ASST/strive-s-bitcoin-treasury-identity-crisis-when-innovative-financing-meets-operational-reality-nasdaq-asst</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:38:50Z</news:publication_date>
      <news:title>Strive&#x27;s Bitcoin Treasury Identity Crisis: When Innovative Financing Meets Operational Reality (NASDAQ:ASST)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FLY/firefly-s-triple-threat-can-launch-lunar-and-defense-software-justify-a-33x-sales-multiple-nasdaq-fly</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:32:52Z</news:publication_date>
      <news:title>Firefly&#x27;s Triple Threat: Can Launch, Lunar, and Defense Software Justify a 33x Sales Multiple? (NASDAQ:FLY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CLLS/astrazeneca-s-220m-bet-meets-execution-reality-cellectis-nasdaq-clls-at-a-clinical-crossroads</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:28:39Z</news:publication_date>
      <news:title>AstraZeneca&#x27;s $220M Bet Meets Execution Reality: Cellectis (NASDAQ:CLLS) at a Clinical Crossroads</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/OZ/belpointe-prep-the-opportunity-zone-fund-trading-at-half-nav-while-burning-cash-nyse-oz</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:23:57Z</news:publication_date>
      <news:title>Belpointe PREP: The Opportunity Zone Fund Trading at Half NAV While Burning Cash (NYSE:OZ)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AEVA/aeva-technologies-fmcw-lidar-s-inflection-point-meets-execution-risk-at-100-growth-nasdaq-aeva</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:20:32Z</news:publication_date>
      <news:title>Aeva Technologies: FMCW LiDAR&#x27;s Inflection Point Meets Execution Risk at 100% Growth (NASDAQ:AEVA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FUFU/cloud-mining-moat-meets-infrastructure-control-at-bitfufu-nasdaq-fufu</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:19:15Z</news:publication_date>
      <news:title>Cloud Mining Moat Meets Infrastructure Control at BitFuFu (NASDAQ:FUFU)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DG/margin-expansion-meets-rural-moat-dollar-general-s-turnaround-takes-shape-nyse-dg</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:19:14Z</news:publication_date>
      <news:title>Margin Expansion Meets Rural Moat: Dollar General&#x27;s Turnaround Takes Shape (NYSE:DG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FSEA/first-seacoast-bancorp-a-135-year-old-bank-s-costly-pivot-from-safety-to-growth-nasdaq-fsea</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:13:51Z</news:publication_date>
      <news:title>First Seacoast Bancorp: A 135-Year-Old Bank&#x27;s Costly Pivot From Safety to Growth (NASDAQ:FSEA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/YRD/yiren-digital-s-ai-native-pivot-from-credit-crisis-to-platform-regeneration-nyse-yrd</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:13:21Z</news:publication_date>
      <news:title>Yiren Digital&#x27;s AI-Native Pivot: From Credit Crisis to Platform Regeneration (NYSE:YRD)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/VSCO/victoria-s-secret-s-pricing-power-resurgence-turnaround-gains-traction-despite-tariff-headwinds-nyse-vsco</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:07:36Z</news:publication_date>
      <news:title>Victoria&#x27;s Secret&#x27;s Pricing Power Resurgence: Turnaround Gains Traction Despite Tariff Headwinds (NYSE:VSCO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MIST/cardamyst-s-commercial-gauntlet-why-milestone-s-first-mover-advantage-hinges-on-payer-access-nasdaq-mist</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:07:25Z</news:publication_date>
      <news:title>CARDAMYST&#x27;s Commercial Gauntlet: Why Milestone&#x27;s First-Mover Advantage Hinges on Payer Access (NASDAQ:MIST)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/IFRX/inflarx-s-izicopan-pivot-a-capital-efficient-bet-against-the-clock-nasdaq-ifrx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:00:47Z</news:publication_date>
      <news:title>InflaRx&#x27;s Izicopan Pivot: A Capital-Efficient Bet Against the Clock (NASDAQ:IFRX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/UNB/union-bankshares-a-5-8-dividend-yield-at-10x-earnings-but-credit-quality-is-the-make-or-break-variable-nasdaq-unb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T10:00:10Z</news:publication_date>
      <news:title>Union Bankshares: A 5.8% Dividend Yield at 10x Earnings, but Credit Quality Is the Make-or-Break Variable (NASDAQ:UNB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MSW/ming-shing-group-s-bitcoin-gamble-can-t-hide-a-broken-construction-business-nasdaq-msw</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:55:49Z</news:publication_date>
      <news:title>Ming Shing Group&#x27;s Bitcoin Gamble Can&#x27;t Hide a Broken Construction Business (NASDAQ:MSW)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SFDL/margin-expansion-meets-otc-discount-security-federal-s-quiet-transformation-otc-sfdl</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:53:25Z</news:publication_date>
      <news:title>Margin Expansion Meets OTC Discount: Security Federal&#x27;s Quiet Transformation (OTC:SFDL)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SWKH/swk-holdings-a-pure-play-life-science-finance-company-trading-at-a-discount-to-liquidation-value-nasdaq-swkh</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:52:07Z</news:publication_date>
      <news:title>SWK Holdings: A Pure-Play Life Science Finance Company Trading at a Discount to Liquidation Value (NASDAQ:SWKH)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/XPEV/xpeng-s-physical-ai-flywheel-why-first-profit-marks-the-start-not-the-end-nasdaq-xpev</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:51:01Z</news:publication_date>
      <news:title>XPeng&#x27;s Physical AI Flywheel: Why First Profit Marks the Start, Not the End (NASDAQ:XPEV)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ENBP/enb-financial-a-144-year-old-community-bank-s-strategic-inflection-point-otc-enbp</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:50:23Z</news:publication_date>
      <news:title>ENB Financial: A 144-Year-Old Community Bank&#x27;s Strategic Inflection Point (OTC:ENBP)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/VEEV/veeva-s-strategic-liberation-how-ai-and-the-iqvia-settlement-unlocked-a-new-growth-era-nyse-veev</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:46:51Z</news:publication_date>
      <news:title>Veeva&#x27;s Strategic Liberation: How AI and the IQVIA Settlement Unlocked a New Growth Era (NYSE:VEEV)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/XFOR/xfor-s-2-billion-bet-why-chronic-neutropenia-not-whim-defines-the-investment-case-nasdaq-xfor</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:43:37Z</news:publication_date>
      <news:title>XFOR&#x27;s $2 Billion Bet: Why Chronic Neutropenia, Not WHIM, Defines the Investment Case (NASDAQ:XFOR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CBNA/chain-bridge-bancorp-the-political-deposit-moat-hiding-in-plain-sight-nasdaq-cbna</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:41:16Z</news:publication_date>
      <news:title>Chain Bridge Bancorp: The Political Deposit Moat Hiding in Plain Sight (NASDAQ:CBNA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PALI/palisade-bio-s-128m-lifeline-a-targeted-pde4-inverter-takes-aim-at-ibd-s-most-untreatable-form</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:38:55Z</news:publication_date>
      <news:title>Palisade Bio&#x27;s $128M Lifeline: A Targeted PDE4 Inverter Takes Aim at IBD&#x27;s Most Untreatable Form</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/RECT/rectitude-holdings-a-green-energy-pivot-at-a-deep-value-price-nasdaq-rect</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:37:48Z</news:publication_date>
      <news:title>Rectitude Holdings: A Green Energy Pivot at a Deep Value Price (NASDAQ:RECT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AFBI/affinity-bancshares-a-niche-bank-s-certain-exit-at-fair-value-nasdaq-afbi</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:32:54Z</news:publication_date>
      <news:title>Affinity Bancshares: A Niche Bank&#x27;s Certain Exit at Fair Value (NASDAQ:AFBI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BAIDF/baidu-s-ai-metamorphosis-why-the-search-giant-is-sacrificing-today-to-own-tomorrow-s-ai-stack-nasdaq-baidf</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:32:34Z</news:publication_date>
      <news:title>Baidu&#x27;s AI Metamorphosis: Why the Search Giant Is Sacrificing Today to Own Tomorrow&#x27;s AI Stack (NASDAQ:BAIDF)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GRWG/from-retail-to-platform-growgeneration-s-margin-inflection-amid-cannabis-chaos-nasdaq-grwg</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:32:07Z</news:publication_date>
      <news:title>From Retail to Platform: GrowGeneration&#x27;s Margin Inflection Amid Cannabis Chaos (NASDAQ:GRWG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/UONE/urban-one-s-debt-lifeline-buys-time-but-can-t-stop-the-digital-erosion-nasdaq-uone</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:29:38Z</news:publication_date>
      <news:title>Urban One&#x27;s Debt Lifeline Buys Time, But Can&#x27;t Stop the Digital Erosion (NASDAQ:UONE)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SPFX/spfx-s-regional-moat-meets-scale-challenge-in-premium-finance</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:27:06Z</news:publication_date>
      <news:title>SPFX&#x27;s Regional Moat Meets Scale Challenge in Premium Finance</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LWLG/lightwave-logic-a-28-year-r-d-bet-approaches-its-moment-of-truth-nasdaq-lwlg</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:26:39Z</news:publication_date>
      <news:title>Lightwave Logic: A 28-Year R&amp;D Bet Approaches Its Moment of Truth (NASDAQ:LWLG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DNMX/dnmx-the-ai-power-infrastructure-spac-trading-below-trust-value-with-24-months-to-execute</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:22:06Z</news:publication_date>
      <news:title>DNMX: The AI Power Infrastructure SPAC Trading Below Trust Value With 24 Months to Execute</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CELZ/creative-medical-technology-clinical-validation-meets-cash-burn-at-the-regenerative-medicine-crossroads-nasdaq-celz</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:21:47Z</news:publication_date>
      <news:title>Creative Medical Technology: Clinical Validation Meets Cash Burn at the Regenerative Medicine Crossroads (NASDAQ:CELZ)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/USGO/pea-breakthrough-meets-capital-discipline-why-u-s-goldmining-s-alaska-bet-offers-asymmetric-risk-reward-nasdaq-usgo</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:21:30Z</news:publication_date>
      <news:title>PEA Breakthrough Meets Capital Discipline: Why U.S. GoldMining&#x27;s Alaska Bet Offers Asymmetric Risk/Reward (NASDAQ:USGO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ASTI/ascent-solar-a-4-35-call-option-on-space-grade-solar-survival-nasdaq-asti</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:17:54Z</news:publication_date>
      <news:title>Ascent Solar: A $4.35 Call Option on Space-Grade Solar Survival (NASDAQ:ASTI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AHT/ashford-hospitality-trust-asset-value-trapped-in-a-labyrinth-of-debt-and-conflicts-nyse-aht</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:16:36Z</news:publication_date>
      <news:title>Ashford Hospitality Trust: Asset Value Trapped in a Labyrinth of Debt and Conflicts (NYSE:AHT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SINT/sintx-technologies-a-scientifically-superior-biomaterial-at-the-brink-of-commercial-validation-or-financial-exhaustion-nasdaq-sint</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:16:25Z</news:publication_date>
      <news:title>SINTX Technologies: A Scientifically Superior Biomaterial at the Brink of Commercial Validation or Financial Exhaustion (NASDAQ:SINT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/WGRX/wellgistics-health-a-micro-cap-s-high-stakes-bet-on-tech-enabled-niche-distribution-nasdaq-wgrx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:12:16Z</news:publication_date>
      <news:title>Wellgistics Health: A Micro-Cap&#x27;s High-Stakes Bet on Tech-Enabled Niche Distribution (NASDAQ:WGRX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FINW/finwise-bancorp-the-fintech-enabler-transforming-banking-risk-into-scalable-growth-nasdaq-finw</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:07:09Z</news:publication_date>
      <news:title>FinWise Bancorp: The Fintech Enabler Transforming Banking Risk Into Scalable Growth (NASDAQ:FINW)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ATER/aterian-s-strategic-crossroads-turnaround-execution-meets-liquidation-risk-nasdaq-ater</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:05:16Z</news:publication_date>
      <news:title>Aterian&#x27;s Strategic Crossroads: Turnaround Execution Meets Liquidation Risk (NASDAQ:ATER)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CLB/core-laboratories-margin-inflection-meets-international-offshore-tailwinds-nyse-clb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T09:02:23Z</news:publication_date>
      <news:title>Core Laboratories: Margin Inflection Meets International Offshore Tailwinds (NYSE:CLB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CANG/cango-s-0-47-paradox-from-auto-finance-to-ai-infrastructure-through-bitcoin-s-minefield-nyse-cang</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T08:59:49Z</news:publication_date>
      <news:title>Cango&#x27;s $0.47 Paradox: From Auto Finance to AI Infrastructure Through Bitcoin&#x27;s Minefield (NYSE:CANG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ATAT/atour-s-lifestyle-ecosystem-how-a-hotel-chain-built-a-retail-powerhouse-worth-5-billion-nasdaq-atat</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T08:57:21Z</news:publication_date>
      <news:title>Atour&#x27;s Lifestyle Ecosystem: How a Hotel Chain Built a Retail Powerhouse Worth $5 Billion (NASDAQ:ATAT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TME/tencent-music-s-value-chain-ascension-why-the-strategic-pivot-creates-asymmetric-risk-reward-at-9x-earnings-nyse-tme</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T08:56:08Z</news:publication_date>
      <news:title>Tencent Music&#x27;s Value Chain Ascension: Why the Strategic Pivot Creates Asymmetric Risk/Reward at 9x Earnings (NYSE:TME)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/OKLO/oklo-s-nuclear-platform-gambit-can-vertical-integration-capture-the-ai-energy-supercycle-nyse-oklo</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T08:53:34Z</news:publication_date>
      <news:title>Oklo&#x27;s Nuclear Platform Gambit: Can Vertical Integration Capture the AI Energy Supercycle? (NYSE:OKLO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CLNN/clene-s-nanotech-promise-meets-a-cash-cliff-a-high-stakes-bet-on-als-biomarkers-nasdaq-clnn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T08:51:58Z</news:publication_date>
      <news:title>Clene&#x27;s Nanotech Promise Meets a Cash Cliff: A High-Stakes Bet on ALS Biomarkers (NASDAQ:CLNN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/KRKR/36kr-s-ai-powered-profitability-turnaround-from-content-publisher-to-enterprise-intelligence-platform-nasdaq-krkr</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T08:49:40Z</news:publication_date>
      <news:title>36Kr&#x27;s AI-Powered Profitability Turnaround: From Content Publisher to Enterprise Intelligence Platform (NASDAQ:KRKR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/STIM/neuronetics-vertical-integration-gamble-why-the-greenbrook-acquisition-changes-everything-nasdaq-stim</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T08:49:39Z</news:publication_date>
      <news:title>Neuronetics&#x27; Vertical Integration Gamble: Why the Greenbrook Acquisition Changes Everything (NASDAQ:STIM)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BCYC/bicycle-therapeutics-a-5-stock-at-a-strategic-crossroads-between-scientific-promise-and-commercial-reality-nasdaq-bcyc</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T08:44:39Z</news:publication_date>
      <news:title>Bicycle Therapeutics: A $5 Stock at a Strategic Crossroads Between Scientific Promise and Commercial Reality (NASDAQ:BCYC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TSAT/telesat-s-leo-gambit-can-a-government-backed-satellite-pioneer-bridge-the-geo-to-leo-divide-nasdaq-tsat</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T08:44:33Z</news:publication_date>
      <news:title>Telesat&#x27;s LEO Gambit: Can a Government-Backed Satellite Pioneer Bridge the GEO-to-LEO Divide? (NASDAQ:TSAT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PSQH/psq-holdings-a-micro-cap-fintech-pivot-betting-on-cancel-proof-payments-nyse-psqh</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T08:42:26Z</news:publication_date>
      <news:title>PSQ Holdings: A Micro-Cap FinTech Pivot Betting on &quot;Cancel-Proof&quot; Payments (NYSE:PSQH)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GLUE/molecular-glue-degraders-meet-big-pharma-validation-monte-rosa-s-path-from-platform-to-profits-nasdaq-glue</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T08:31:50Z</news:publication_date>
      <news:title>Molecular Glue Degraders Meet Big Pharma Validation: Monte Rosa&#x27;s Path from Platform to Profits (NASDAQ:GLUE)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ABEO/zevaskyn-s-commercial-inflection-a-binary-bet-on-execution-at-abeona-therapeutics-nasdaq-abeo</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T08:23:22Z</news:publication_date>
      <news:title>ZEVASKYN&#x27;s Commercial Inflection: A Binary Bet on Execution at Abeona Therapeutics (NASDAQ:ABEO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HQY/healthequity-s-margin-inflection-meets-a-legislative-supercycle-nasdaq-hqy</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T08:20:59Z</news:publication_date>
      <news:title>HealthEquity&#x27;s Margin Inflection Meets a Legislative Supercycle (NASDAQ:HQY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HUYA/huya-s-game-services-pivot-tencent-backed-transformation-creates-asymmetric-risk-reward-nyse-huya</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T08:17:31Z</news:publication_date>
      <news:title>HUYA&#x27;s Game Services Pivot: Tencent-Backed Transformation Creates Asymmetric Risk/Reward (NYSE:HUYA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LWAY/lifeway-foods-the-kefir-category-king-builds-a-manufacturing-moat-for-the-next-decade-nasdaq-lway</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T08:12:36Z</news:publication_date>
      <news:title>Lifeway Foods: The Kefir Category King Builds a Manufacturing Moat for the Next Decade (NASDAQ:LWAY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ICCM/icecure-medical-a-0-30-bet-on-cryoablation-s-fda-moat-and-the-2028-reimbursement-inflection-nasdaq-iccm</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T08:11:26Z</news:publication_date>
      <news:title>IceCure Medical: A $0.30 Bet on Cryoablation&#x27;s FDA Moat and the 2028 Reimbursement Inflection (NASDAQ:ICCM)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CHCI/comstock-s-fee-based-phoenix-how-a-housing-crisis-survivor-built-a-7-year-growth-machine</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T08:07:22Z</news:publication_date>
      <news:title>Comstock&#x27;s Fee-Based Phoenix: How a Housing Crisis Survivor Built a 7-Year Growth Machine</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CM/margin-inflection-meets-ai-powered-efficiency-cibc-s-path-to-premium-roe-nyse-cm</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T08:05:41Z</news:publication_date>
      <news:title>Margin Inflection Meets AI-Powered Efficiency: CIBC&#x27;s Path to Premium ROE (NYSE:CM)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GDS/gds-holdings-the-capital-recycling-flywheel-meets-china-s-ai-inflection-point-nasdaq-gds</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T08:04:21Z</news:publication_date>
      <news:title>GDS Holdings: The Capital Recycling Flywheel Meets China&#x27;s AI Inflection Point (NASDAQ:GDS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LGVN/longeveron-s-200-million-prv-gamble-why-q3-2026-hlhs-data-will-define-this-stem-cell-survivor-nasdaq-lgvn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:59:14Z</news:publication_date>
      <news:title>Longeveron&#x27;s $200 Million PRV Gamble: Why Q3 2026 HLHS Data Will Define This Stem Cell Survivor (NASDAQ:LGVN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SBS/sabesp-s-post-privatization-efficiency-engine-from-state-bureaucracy-to-value-creator-nyse-sbs</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:57:41Z</news:publication_date>
      <news:title>SABESP&#x27;s Post-Privatization Efficiency Engine: From State Bureaucracy to Value Creator (NYSE:SBS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GAP/gap-s-portfolio-turnaround-gains-traction-but-tariffs-and-athleta-s-drag-create-a-balanced-risk-reward-nyse-gps</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:56:27Z</news:publication_date>
      <news:title>Gap&#x27;s Portfolio Turnaround Gains Traction, But Tariffs and Athleta&#x27;s Drag Create a Balanced Risk/Reward (NYSE:GPS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ESLT/defense-supercycle-meets-operational-leverage-elbit-systems-margin-expansion-story-nasdaq-eslt</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:50:49Z</news:publication_date>
      <news:title>Defense Supercycle Meets Operational Leverage: Elbit Systems&#x27; Margin Expansion Story (NASDAQ:ESLT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BKSY/blacksky-s-real-time-intelligence-moat-why-gen-3-satellites-and-sovereign-demand-are-creating-a-financial-inflection-point-nyse-bksy</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:47:33Z</news:publication_date>
      <news:title>BlackSky&#x27;s Real-Time Intelligence Moat: Why Gen-3 Satellites and Sovereign Demand Are Creating a Financial Inflection Point (NYSE:BKSY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ASO/aso-s-self-help-engine-how-disciplined-expansion-and-tech-investment-are-building-a-k-shaped-retail-winner-nasdaq-aso</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:47:22Z</news:publication_date>
      <news:title>ASO&#x27;s Self-Help Engine: How Disciplined Expansion and Tech Investment Are Building a K-Shaped Retail Winner (NASDAQ:ASO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GOSS/gossamer-bio-a-0-37-lottery-ticket-on-a-phase-3-salvage-operation-nasdaq-goss</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:39:36Z</news:publication_date>
      <news:title>Gossamer Bio: A $0.37 Lottery Ticket on a Phase 3 Salvage Operation (NASDAQ:GOSS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ANTX/an2-therapeutics-from-mac-failure-to-multi-asset-optionality-nasdaq-antx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:36:18Z</news:publication_date>
      <news:title>AN2 Therapeutics: From MAC Failure to Multi-Asset Optionality (NASDAQ:ANTX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/IZEA/izea-s-profitability-pivot-a-public-pure-play-in-the-creator-economy-s-consolidation-phase-nasdaq-izea</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:32:13Z</news:publication_date>
      <news:title>IZEA&#x27;s Profitability Pivot: A Public Pure-Play in the Creator Economy&#x27;s Consolidation Phase (NASDAQ:IZEA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NN/nextnav-s-2-2-billion-bet-on-america-s-gps-backup-a-regulatory-moat-in-the-making-nasdaq-nn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:31:19Z</news:publication_date>
      <news:title>NextNav&#x27;s $2.2 Billion Bet on America&#x27;s GPS Backup: A Regulatory Moat in the Making (NASDAQ:NN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TRVI/trevi-therapeutics-the-first-mover-advantage-in-a-2-billion-unmet-chronic-cough-market-nasdaq-trvi</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:31:00Z</news:publication_date>
      <news:title>Trevi Therapeutics: The First-Mover Advantage in a $2 Billion Unmet Chronic Cough Market (NASDAQ:TRVI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/IPM/ipm-s-high-touch-transformation-from-video-chats-to-cybersecurity-margins-nasdaq-ipm</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:27:11Z</news:publication_date>
      <news:title>IPM&#x27;s High-Touch Transformation: From Video Chats to Cybersecurity Margins (NASDAQ:IPM)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GTLB/gitlab-s-ai-orchestration-gambit-why-the-market-is-missing-the-1-billion-devsecops-transformation-nasdaq-gtlb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:27:04Z</news:publication_date>
      <news:title>GitLab&#x27;s AI Orchestration Gambit: Why the Market Is Missing the $1 Billion DevSecOps Transformation (NASDAQ:GTLB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TTAM/vertical-integration-meets-impeccable-balance-sheet-titan-america-s-defensive-growth-formula-nyse-ttam</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:26:15Z</news:publication_date>
      <news:title>Vertical Integration Meets Impeccable Balance Sheet: Titan America&#x27;s Defensive Growth Formula (NYSE:TTAM)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FLD/bitcoin-first-ambition-meets-cash-burn-reality-at-fold-holdings-nasdaq-fld</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:26:10Z</news:publication_date>
      <news:title>Bitcoin-First Ambition Meets Cash Burn Reality at Fold Holdings (NASDAQ:FLD)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BRLT/brilliant-earth-when-ethical-moats-meet-metal-mayhem-nasdaq-brlt</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:23:02Z</news:publication_date>
      <news:title>Brilliant Earth: When Ethical Moats Meet Metal Mayhem (NASDAQ:BRLT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AXTI/axt-s-export-permit-paradox-why-china-s-controls-are-both-crushing-and-creating-a-60m-ai-opportunity-nasdaq-axti</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:19:04Z</news:publication_date>
      <news:title>AXT&#x27;s Export Permit Paradox: Why China&#x27;s Controls Are Both Crushing and Creating a $60M AI Opportunity (NASDAQ:AXTI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/VALN/lyme-or-bust-valneva-s-6-10-vaccine-bet-hinges-on-a-single-phase-3-trial-nasdaq-valn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:18:41Z</news:publication_date>
      <news:title>Lyme or Bust: Valneva&#x27;s $6.10 Vaccine Bet Hinges on a Single Phase 3 Trial (NASDAQ:VALN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CBUS/cibus-a-coiled-spring-with-a-ticking-clock-nasdaq-cbus</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:17:27Z</news:publication_date>
      <news:title>Cibus: A Coiled Spring With a Ticking Clock (NASDAQ:CBUS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CWGL/crimson-wine-group-a-fortress-balance-sheet-meets-an-industry-storm-otc-cwgl</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:15:11Z</news:publication_date>
      <news:title>Crimson Wine Group: A Fortress Balance Sheet Meets an Industry Storm (OTC:CWGL)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TELO/telomir-pharmaceuticals-a-44-million-option-on-metal-homeostasis-and-the-biology-of-aging-nasdaq-telo</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:15:09Z</news:publication_date>
      <news:title>Telomir Pharmaceuticals: A $44 Million Option on Metal Homeostasis and the Biology of Aging (NASDAQ:TELO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CAPR/capricor-s-cardiac-moat-why-dmd-cardiomyopathy-approval-could-redefine-a-1-85b-valuation-nasdaq-capr</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:10:41Z</news:publication_date>
      <news:title>Capricor&#x27;s Cardiac Moat: Why DMD Cardiomyopathy Approval Could Redefine a $1.85B Valuation (NASDAQ:CAPR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AUBN/aubn-when-a-century-old-local-moat-meets-the-digital-crossroads-nasdaq-aubn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:07:10Z</news:publication_date>
      <news:title>AUBN: When a Century-Old Local Moat Meets the Digital Crossroads (NASDAQ:AUBN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CLPT/clearpoint-neuro-s-gene-therapy-infrastructure-play-building-a-1b-platform-in-the-mri-suite</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:06:32Z</news:publication_date>
      <news:title>ClearPoint Neuro&#x27;s Gene Therapy Infrastructure Play: Building a $1B Platform in the MRI Suite</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GXAI/gxai-s-ai-mirage-when-47901-revenue-growth-masks-an-existential-cash-crisis-nasdaq-gxai</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:02:51Z</news:publication_date>
      <news:title>GXAI&#x27;s AI Mirage: When 47,901% Revenue Growth Masks an Existential Cash Crisis (NASDAQ:GXAI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HHS/harte-hanks-a-century-old-cx-provider-at-the-precipice-of-relevance-nasdaq-hhs</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T07:00:38Z</news:publication_date>
      <news:title>Harte Hanks: A Century-Old CX Provider at the Precipice of Relevance (NASDAQ:HHS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/QFIN/qfin-ai-powered-regulatory-arbitrage-meets-98-payout-ratio-in-china-s-fintech-storm</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:58:32Z</news:publication_date>
      <news:title>QFIN: AI-Powered Regulatory Arbitrage Meets 98% Payout Ratio in China&#x27;s Fintech Storm</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BEKE/beke-s-efficiency-pivot-why-china-s-real-estate-platform-is-trading-scale-for-ai-powered-profits-nyse-beke</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:57:40Z</news:publication_date>
      <news:title>BEKE&#x27;s Efficiency Pivot: Why China&#x27;s Real Estate Platform Is Trading Scale for AI-Powered Profits (NYSE:BEKE)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CNTY/missouri-s-harvest-masks-a-balance-sheet-reckoning-at-century-casinos-nasdaq-cnty</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:55:20Z</news:publication_date>
      <news:title>Missouri&#x27;s Harvest Masks a Balance Sheet Reckoning at Century Casinos (NASDAQ:CNTY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PFHO/pfho-when-a-profitable-niche-meets-a-customer-concentration-crisis-otcqb-pfho</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:53:57Z</news:publication_date>
      <news:title>PFHO: When a Profitable Niche Meets a Customer Concentration Crisis (OTCQB:PFHO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ESLA/esla-s-artemis-promise-meets-a-liquidity-crisis-a-car-t-platform-on-financial-life-support</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:53:44Z</news:publication_date>
      <news:title>ESLA&#x27;s ARTEMIS Promise Meets a Liquidity Crisis: A CAR-T Platform on Financial Life Support</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TSSI/tss-inc-s-ai-infrastructure-gambit-when-customer-concentration-becomes-competitive-moat-nasdaq-tssi</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:52:03Z</news:publication_date>
      <news:title>TSS, Inc.&#x27;s AI Infrastructure Gambit: When Customer Concentration Becomes Competitive Moat (NASDAQ:TSSI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HIND/orphan-drug-platform-emerges-from-bariatric-ashes-vyome-holdings-nasdaq-hind-bets-on-2-2b-wound-care-market</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:48:04Z</news:publication_date>
      <news:title>Orphan Drug Platform Emerges from Bariatric Ashes: Vyome Holdings (NASDAQ:HIND) Bets on $2.2B Wound Care Market</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PUK/prudential-s-asia-africa-cash-machine-why-a-180-year-insurer-trades-at-a-50-discount-to-its-growth-peers-nyse-puk</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:45:22Z</news:publication_date>
      <news:title>Prudential&#x27;s Asia-Africa Cash Machine: Why a 180-Year Insurer Trades at a 50% Discount to Its Growth Peers (NYSE:PUK)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/WB/weibo-s-ai-gamble-margin-sacrifice-for-platform-relevance-nasdaq-wb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:45:01Z</news:publication_date>
      <news:title>Weibo&#x27;s AI Gamble: Margin Sacrifice for Platform Relevance (NASDAQ:WB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NIU/niu-technologies-440-basis-points-of-margin-inflection-meets-electric-motorcycle-breakout-nasdaq-niu</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:45:00Z</news:publication_date>
      <news:title>NIU Technologies: 440 Basis Points of Margin Inflection Meets Electric Motorcycle Breakout (NASDAQ:NIU)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PLX/protalix-s-plant-based-manufacturing-moat-meets-commercial-inflection-why-elfabrio-s-monthly-dosing-approval-changes-everything-nasdaq-plx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:37:55Z</news:publication_date>
      <news:title>Protalix&#x27;s Plant-Based Manufacturing Moat Meets Commercial Inflection: Why Elfabrio&#x27;s Monthly Dosing Approval Changes Everything (NASDAQ:PLX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LFWD/lifeward-s-tightrope-medicare-reimbursement-meets-solvency-crisis-nasdaq-lfwd</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:37:51Z</news:publication_date>
      <news:title>Lifeward&#x27;s Tightrope: Medicare Reimbursement Meets Solvency Crisis (NASDAQ:LFWD)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HTHT/h-world-group-asset-light-margin-expansion-meets-brand-led-market-consolidation-nasdaq-htht</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:36:11Z</news:publication_date>
      <news:title>H World Group: Asset-Light Margin Expansion Meets Brand-Led Market Consolidation (NASDAQ:HTHT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FINV/finvolution-group-international-expansion-meets-aggressive-capital-returns-at-a-discount-finv</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:33:49Z</news:publication_date>
      <news:title>FinVolution Group: International Expansion Meets Aggressive Capital Returns at a Discount (FINV)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CING/cingulate-s-binary-bet-why-precision-timed-release-technology-faces-its-fda-moment-of-truth-nasdaq-cing</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:32:10Z</news:publication_date>
      <news:title>Cingulate&#x27;s Binary Bet: Why Precision Timed Release Technology Faces Its FDA Moment of Truth (NASDAQ:CING)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/UCL/ucloudlink-s-triple-engine-gamble-can-three-hypergrowth-businesses-outrun-macro-gravity-nasdaq-ucl</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:31:19Z</news:publication_date>
      <news:title>uCloudlink&#x27;s Triple-Engine Gamble: Can Three Hypergrowth Businesses Outrun Macro Gravity? (NASDAQ:UCL)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NSPR/stent-first-inflection-meets-make-or-break-us-launch-the-nspr-pivot-point</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:30:14Z</news:publication_date>
      <news:title>Stent-First Inflection Meets Make-or-Break US Launch: The $NSPR Pivot Point</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ZTO/zto-express-the-anti-involution-inflection-point-nyse-zto</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:27:33Z</news:publication_date>
      <news:title>ZTO Express: The Anti-Involution Inflection Point (NYSE:ZTO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/YB/yb-s-ai-insurance-engine-why-50-roe-and-4-7x-earnings-signal-a-structural-mispricing-nasdaq-yb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:24:48Z</news:publication_date>
      <news:title>YB&#x27;s AI Insurance Engine: Why 50% ROE and 4.7x Earnings Signal a Structural Mispricing (NASDAQ:YB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NEON/neonode-s-licensing-gamble-can-a-27-year-old-touch-technology-pioneer-reinvent-itself-as-an-automotive-ai-pure-play</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:22:48Z</news:publication_date>
      <news:title>Neonode&#x27;s Licensing Gamble: Can a 27-Year-Old Touch Technology Pioneer Reinvent Itself as an Automotive AI Pure-Play?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/XOMA/xoma-s-royalty-aggregation-engine-why-early-stage-focus-commands-a-premium-nasdaq-xoma</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:21:54Z</news:publication_date>
      <news:title>XOMA&#x27;s Royalty Aggregation Engine: Why Early-Stage Focus Commands a Premium (NASDAQ:XOMA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MHH/mastech-digital-s-ai-pivot-transformation-under-pressure-creates-asymmetric-risk-reward-nysemkt-mhh</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:21:30Z</news:publication_date>
      <news:title>Mastech Digital&#x27;s AI Pivot: Transformation Under Pressure Creates Asymmetric Risk/Reward (NYSEMKT:MHH)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TATT/margin-inflection-meets-mro-cycle-why-tat-technologies-nasdaq-tatt-is-poised-for-a-multi-year-run</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:19:19Z</news:publication_date>
      <news:title>Margin Inflection Meets MRO Cycle: Why TAT Technologies (NASDAQ:TATT) Is Poised for a Multi-Year Run</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PFBX/peoples-financial-a-community-bank-s-scale-trap-meets-activist-pressure-nasdaq-pfbx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:17:00Z</news:publication_date>
      <news:title>Peoples Financial: A Community Bank&#x27;s Scale Trap Meets Activist Pressure (NASDAQ:PFBX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ELA/envela-s-circular-economy-moat-why-gold-s-shine-masks-a-working-capital-squeeze-nyse-ela</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:16:42Z</news:publication_date>
      <news:title>Envela&#x27;s Circular Economy Moat: Why Gold&#x27;s Shine Masks a Working Capital Squeeze (NYSE:ELA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BBY/best-buy-s-platform-pivot-how-ads-marketplace-and-ai-are-reshaping-retail-margins-nyse-bby</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:12:11Z</news:publication_date>
      <news:title>Best Buy&#x27;s Platform Pivot: How Ads, Marketplace, and AI Are Reshaping Retail Margins (NYSE:BBY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/USIO/usio-s-cross-selling-gamble-can-a-niche-payment-processor-escape-the-scale-trap-nasdaq-usio</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T06:04:55Z</news:publication_date>
      <news:title>Usio&#x27;s Cross-Selling Gamble: Can a Niche Payment Processor Escape the Scale Trap? (NASDAQ:USIO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HD/home-depot-s-pro-ecosystem-gambit-scale-advantage-meets-housing-reality-and-balance-sheet-risk-nyse-hd</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T05:57:05Z</news:publication_date>
      <news:title>Home Depot&#x27;s Pro Ecosystem Gambit: Scale Advantage Meets Housing Reality and Balance Sheet Risk (NYSE:HD)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BZ/kanzhun-s-ai-powered-network-effect-why-boss-zhipin-s-margin-expansion-is-just-beginning-nasdaq-bz</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T05:54:32Z</news:publication_date>
      <news:title>Kanzhun&#x27;s AI-Powered Network Effect: Why BOSS Zhipin&#x27;s Margin Expansion Is Just Beginning (NASDAQ:BZ)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PCSA/processa-pharmaceuticals-a-7-million-bet-on-next-gen-chemotherapy-at-the-financial-breaking-point-nasdaq-pcsa</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T05:47:59Z</news:publication_date>
      <news:title>Processa Pharmaceuticals: A $7 Million Bet on Next-Gen Chemotherapy at the Financial Breaking Point (NASDAQ:PCSA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DOCU/docusign-s-iam-revolution-a-platform-shift-meets-capital-allocation-excellence-nasdaq-docu</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T05:41:50Z</news:publication_date>
      <news:title>DocuSign&#x27;s IAM Revolution: A Platform Shift Meets Capital Allocation Excellence (NASDAQ:DOCU)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NRGV/energy-vault-s-asset-vault-building-a-recurring-revenue-powerhouse-at-2x-industry-margins-nasdaq-nrgv</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T05:41:09Z</news:publication_date>
      <news:title>Energy Vault&#x27;s Asset Vault: Building a Recurring Revenue Powerhouse at 2x Industry Margins (NASDAQ:NRGV)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HYPR/hyperfine-s-portable-mri-inflection-why-optive-ai-changes-the-risk-reward-equation-nasdaq-hypr</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T05:37:36Z</news:publication_date>
      <news:title>Hyperfine&#x27;s Portable MRI Inflection: Why Optive AI Changes the Risk/Reward Equation (NASDAQ:HYPR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BTM/bitcoin-depot-regulatory-armageddon-creates-a-consolidation-king-nasdaq-btm</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T05:33:34Z</news:publication_date>
      <news:title>Bitcoin Depot: Regulatory Armageddon Creates a Consolidation King (NASDAQ:BTM)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SERA/from-lab-to-ledger-sera-prognostics-95-million-bet-on-medicaid-driven-preterm-birth-prevention-nasdaq-sera</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T05:19:06Z</news:publication_date>
      <news:title>From Lab to Ledger: Sera Prognostics&#x27; $95 Million Bet on Medicaid-Driven Preterm Birth Prevention (NASDAQ:SERA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DLTR/dollar-tree-s-multi-price-revolution-why-the-post-family-dollar-era-signals-structural-margin-expansion-nasdaq-dltr</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T05:05:49Z</news:publication_date>
      <news:title>Dollar Tree&#x27;s Multi-Price Revolution: Why the Post-Family Dollar Era Signals Structural Margin Expansion (NASDAQ:DLTR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/UBCP/united-bancorp-a-community-bank-s-calculated-bet-on-local-loyalty-amid-scale-and-margin-pressure-nasdaq-ubcp</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T05:02:10Z</news:publication_date>
      <news:title>United Bancorp: A Community Bank&#x27;s Calculated Bet on Local Loyalty Amid Scale and Margin Pressure (NASDAQ:UBCP)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ARX/accelerant-s-platform-pivot-how-a-data-driven-exchange-is-rewiring-specialty-insurance-nasdaq-arx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T04:57:09Z</news:publication_date>
      <news:title>Accelerant&#x27;s Platform Pivot: How a Data-Driven Exchange Is Rewiring Specialty Insurance (NASDAQ:ARX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HTFL/heartflow-s-1-1b-bet-clinical-supremacy-in-cad-diagnostics-confronts-profitability-chasm-and-doj-reckoning-nasdaq-htfl</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T04:46:25Z</news:publication_date>
      <news:title>HeartFlow&#x27;s $1.1B Bet: Clinical Supremacy in CAD Diagnostics Confronts Profitability Chasm and DOJ Reckoning (NASDAQ:HTFL)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/OSS/from-distributor-to-edge-ai-pure-play-one-stop-systems-margin-inflection-and-defense-driven-growth-nasdaq-oss</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T04:43:30Z</news:publication_date>
      <news:title>From Distributor to Edge AI Pure-Play: One Stop Systems&#x27; Margin Inflection and Defense-Driven Growth (NASDAQ:OSS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ISTR/istr-s-113m-texas-gamble-margin-inflection-meets-integration-risk-nasdaq-istr</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T04:40:49Z</news:publication_date>
      <news:title>ISTR&#x27;s $113M Texas Gamble: Margin Inflection Meets Integration Risk (NASDAQ:ISTR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DLO/dlocal-s-emerging-markets-payments-moat-why-40-billion-in-tpv-and-a-new-capital-return-program-signal-an-inflection-point-nasdaq-dlo</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T04:22:58Z</news:publication_date>
      <news:title>dLocal&#x27;s Emerging Markets Payments Moat: Why $40 Billion in TPV and a New Capital Return Program Signal an Inflection Point (NASDAQ:DLO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/OVID/ovid-therapeutics-a-leaner-focused-bet-on-neurology-s-next-wave-nasdaq-ovid</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T04:13:41Z</news:publication_date>
      <news:title>Ovid Therapeutics: A Leaner, Focused Bet on Neurology&#x27;s Next Wave (NASDAQ:OVID)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AVBH/avbh-post-ipo-balance-sheet-reset-positions-bay-area-specialist-for-double-digit-growth</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T04:13:13Z</news:publication_date>
      <news:title>AVBH: Post-IPO Balance Sheet Reset Positions Bay Area Specialist for Double-Digit Growth</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/USNA/usana-s-omni-channel-gamble-can-a-legacy-direct-seller-reinvent-itself-at-2x-ebitda-nyse-usna</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T04:12:28Z</news:publication_date>
      <news:title>USANA&#x27;s Omni-Channel Gamble: Can a Legacy Direct Seller Reinvent Itself at 2x EBITDA? (NYSE:USNA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ZUMZ/zumiez-s-margin-expansion-play-private-label-and-european-pivot-drive-recovery-nasdaq-zumz</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T03:59:28Z</news:publication_date>
      <news:title>Zumiez&#x27;s Margin Expansion Play: Private Label and European Pivot Drive Recovery (NASDAQ:ZUMZ)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NPWR/net-power-s-132m-valuation-vs-350m-cash-a-strategic-pivot-to-capture-the-ai-power-surge-nasdaq-npwr</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T03:53:14Z</news:publication_date>
      <news:title>NET Power&#x27;s $132M Valuation vs $350M Cash: A Strategic Pivot to Capture the AI Power Surge (NASDAQ:NPWR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FDMT/4d-molecular-therapeutics-when-platform-value-trades-at-cash-value-nasdaq-fdmt</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T01:22:13Z</news:publication_date>
      <news:title>4D Molecular Therapeutics: When Platform Value Trades at Cash Value (NASDAQ:FDMT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LPA/lpa-s-regional-logistics-moat-meets-mexico-inflection-a-deep-value-play-in-latam-industrial-real-estate-nyse-lpa</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T01:18:47Z</news:publication_date>
      <news:title>LPA&#x27;s Regional Logistics Moat Meets Mexico Inflection: A Deep Value Play in LatAm Industrial Real Estate (NYSE:LPA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GORO/gold-resource-s-mexican-turnaround-meets-merger-pivot-a-micro-miner-s-high-stakes-reset-nyse-a-goro</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T01:17:58Z</news:publication_date>
      <news:title>Gold Resource&#x27;s Mexican Turnaround Meets Merger Pivot: A Micro-Miner&#x27;s High-Stakes Reset (NYSE-A:GORO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HKPD/hkpd-s-6-5m-lifeline-can-a-distressed-otc-logistics-niche-player-survive-nasdaq-delisting-and-giant-competition</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T01:16:47Z</news:publication_date>
      <news:title>HKPD&#x27;s $6.5M Lifeline: Can a Distressed OTC Logistics Niche Player Survive Nasdaq Delisting and Giant Competition?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HBIA/balance-sheet-surgery-meets-iowa-dominance-hills-bancorporation-s-risk-reward-reset-otc-hbia</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T01:16:09Z</news:publication_date>
      <news:title>Balance Sheet Surgery Meets Iowa Dominance: Hills Bancorporation&#x27;s Risk-Reward Reset (OTC:HBIA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/USEA/fleet-transformation-meets-rate-recovery-united-maritime-s-capesize-gamble-nasdaq-usea</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T01:12:17Z</news:publication_date>
      <news:title>Fleet Transformation Meets Rate Recovery: United Maritime&#x27;s Capesize Gamble (NASDAQ:USEA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PUBC/purebase-s-agricultural-mirage-74-gross-margins-mask-an-existential-funding-crisis-otc-pubc</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T01:11:33Z</news:publication_date>
      <news:title>PureBase&#x27;s Agricultural Mirage: 74% Gross Margins Mask an Existential Funding Crisis (OTC:PUBC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MRKR/marker-therapeutics-a-multi-antigen-cell-therapy-bet-running-on-financial-fumes-nasdaq-mrkr</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T01:10:22Z</news:publication_date>
      <news:title>Marker Therapeutics: A Multi-Antigen Cell Therapy Bet Running on Financial Fumes (NASDAQ:MRKR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ASRV/ameriserv-s-union-moat-meets-margin-inflection-asymmetric-value-at-half-book-nasdaq-asrv</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T01:08:52Z</news:publication_date>
      <news:title>AmeriServ&#x27;s Union Moat Meets Margin Inflection: Asymmetric Value at Half Book (NASDAQ:ASRV)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DVLT/datavault-ai-s-200m-gamble-from-wireless-audio-to-blockchain-data-monetization-nasdaq-dvlt</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T01:06:16Z</news:publication_date>
      <news:title>Datavault AI&#x27;s $200M Gamble: From Wireless Audio to Blockchain Data Monetization (NASDAQ:DVLT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/VFS/vinfast-s-3-7-billion-gamble-can-vietnam-s-ev-champion-turn-global-ambition-into-profits-nasdaq-vfs</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T01:06:01Z</news:publication_date>
      <news:title>VinFast&#x27;s $3.7 Billion Gamble: Can Vietnam&#x27;s EV Champion Turn Global Ambition Into Profits? (NASDAQ:VFS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TSQ/townsquare-media-s-digital-metamorphosis-why-55-digital-revenue-changes-everything-nyse-tsq</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T01:02:38Z</news:publication_date>
      <news:title>Townsquare Media&#x27;s Digital Metamorphosis: Why 55% Digital Revenue Changes Everything (NYSE:TSQ)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SFBC/sfbc-s-margin-expansion-play-how-a-niche-washington-bank-is-engineering-54-profit-growth-through-strategic-liability-management</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T01:01:16Z</news:publication_date>
      <news:title>SFBC&#x27;s Margin Expansion Play: How a Niche Washington Bank Is Engineering 54% Profit Growth Through Strategic Liability Management</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GROY/gold-royalty-s-inflection-point-meets-valuation-reality-can-a-sub-scale-royalty-company-deliver-on-premium-expectations-nyseam-groy</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T00:55:12Z</news:publication_date>
      <news:title>Gold Royalty&#x27;s Inflection Point Meets Valuation Reality: Can a Sub-Scale Royalty Company Deliver on Premium Expectations? (NYSEAM:GROY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ANRO/alto-neuroscience-s-275m-bet-on-precision-psychiatry-can-biomarkers-beat-cns-s-7-approval-odds-nyse-anro</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T00:53:40Z</news:publication_date>
      <news:title>Alto Neuroscience&#x27;s $275M Bet on Precision Psychiatry: Can Biomarkers Beat CNS&#x27;s 7% Approval Odds? (NYSE:ANRO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ZEPP/zepp-health-s-premiumization-pivot-from-volume-pain-to-margin-gain-nasdaq-zepp</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T00:46:53Z</news:publication_date>
      <news:title>Zepp Health&#x27;s Premiumization Pivot: From Volume Pain to Margin Gain (NASDAQ:ZEPP)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/IQ/iqiyi-s-ai-gambit-can-artificial-intelligence-transform-china-s-streaming-laggard-into-a-global-content-powerhouse-nasdaq-iq</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T00:42:48Z</news:publication_date>
      <news:title>iQIYI&#x27;s AI Gambit: Can Artificial Intelligence Transform China&#x27;s Streaming Laggard into a Global Content Powerhouse? (NASDAQ:IQ)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/VNET/vnet-group-china-s-ai-infrastructure-arms-race-meets-capital-recycling-innovation-nasdaq-vnet</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T00:41:13Z</news:publication_date>
      <news:title>VNET Group: China&#x27;s AI Infrastructure Arms Race Meets Capital Recycling Innovation (NASDAQ:VNET)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ZBIO/zenas-biopharma-300m-lifeline-buys-time-but-clinical-execution-will-determine-fate-nasdaq-zbio</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T00:35:27Z</news:publication_date>
      <news:title>Zenas BioPharma: $300M Lifeline Buys Time, But Clinical Execution Will Determine Fate (NASDAQ:ZBIO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CTMX/cytomx-therapeutics-probody-platform-validation-meets-colorectal-cancer-opportunity-nasdaq-ctmx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T00:34:43Z</news:publication_date>
      <news:title>CytomX Therapeutics: PROBODY Platform Validation Meets Colorectal Cancer Opportunity (NASDAQ:CTMX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CTGO/contango-silver-gold-the-dso-model-s-cash-flow-inflection-point-nyse-ctgo</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T00:31:39Z</news:publication_date>
      <news:title>Contango Silver &amp; Gold: The DSO Model&#x27;s Cash Flow Inflection Point (NYSE:CTGO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/OLMA/olema-pharmaceuticals-a-pure-play-serd-bet-in-a-post-roche-world-nasdaq-olma</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T00:26:38Z</news:publication_date>
      <news:title>Olema Pharmaceuticals: A Pure-Play SERD Bet in a Post-Roche World (NASDAQ:OLMA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/WW/ww-international-the-14-turnaround-that-lives-or-dies-on-clinical-subscriber-growth-nasdaq-ww</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T00:23:56Z</news:publication_date>
      <news:title>WW International: The $14 Turnaround That Lives or Dies on Clinical Subscriber Growth (NASDAQ:WW)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/COYA/coya-therapeutics-when-nobel-validated-biology-meets-capital-efficient-drug-development-nasdaq-coya</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T00:22:24Z</news:publication_date>
      <news:title>Coya Therapeutics: When Nobel-Validated Biology Meets Capital-Efficient Drug Development (NASDAQ:COYA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NUVR/nuvera-s-fiber-gambit-a-120-year-old-telco-bets-its-future-on-rural-broadband-otc-nuvr</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T00:22:11Z</news:publication_date>
      <news:title>Nuvera&#x27;s Fiber Gambit: A 120-Year-Old Telco Bets Its Future on Rural Broadband (OTC:NUVR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/VEON/veon-s-digital-metamorphosis-from-frontier-telecom-to-ai-powered-platform-at-a-value-price-nasdaq-veon</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T00:20:11Z</news:publication_date>
      <news:title>VEON&#x27;s Digital Metamorphosis: From Frontier Telecom to AI-Powered Platform at a Value Price (NASDAQ:VEON)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SAIC/saic-s-margin-inflection-mission-focused-pivot-drives-first-double-digit-ebitda-target-nasdaq-saic</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T00:13:25Z</news:publication_date>
      <news:title>SAIC&#x27;s Margin Inflection: Mission-Focused Pivot Drives First Double-Digit EBITDA Target (NASDAQ:SAIC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/KINS/kingstone-s-select-advantage-turning-new-york-market-dislocation-into-durable-underwriting-profits-nasdaq-kins</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T00:12:02Z</news:publication_date>
      <news:title>Kingstone&#x27;s Select Advantage: Turning New York Market Dislocation into Durable Underwriting Profits (NASDAQ:KINS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/QNBC/merger-driven-scale-meets-margin-repair-at-qnb-corp-nasdaq-qnbc</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T00:06:23Z</news:publication_date>
      <news:title>Merger-Driven Scale Meets Margin Repair at QNB Corp (NASDAQ:QNBC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PFIS/peoples-financial-how-a-transformative-merger-and-balance-sheet-arbitrage-created-a-regional-banking-powerhouse-nasdaq-pfis</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T00:00:45Z</news:publication_date>
      <news:title>Peoples Financial: How a Transformative Merger and Balance Sheet Arbitrage Created a Regional Banking Powerhouse (NASDAQ:PFIS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BCAR/bcar-s-500m-ai-mirage-when-quantum-security-meets-spac-reality-nasdaq-bcar</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T00:00:29Z</news:publication_date>
      <news:title>BCAR&#x27;s $500M AI Mirage: When Quantum Security Meets SPAC Reality (NASDAQ:BCAR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FIP/ftai-infrastructure-from-development-gambles-to-operational-cash-flows-nasdaq-fip</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:56:01Z</news:publication_date>
      <news:title>FTAI Infrastructure: From Development Gambles to Operational Cash Flows (NASDAQ:FIP)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SRI/stoneridge-s-mirroreye-revolution-a-turnaround-story-trading-at-cyclical-valuations-nasdaq-sri</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:54:09Z</news:publication_date>
      <news:title>Stoneridge&#x27;s MirrorEye Revolution: A Turnaround Story Trading at Cyclical Valuations (NASDAQ:SRI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/WTI/w-t-offshore-s-regulatory-liberation-and-acquisition-engine-a-gulf-of-america-cash-flow-story-nyse-wti</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:45:53Z</news:publication_date>
      <news:title>W&amp;T Offshore&#x27;s Regulatory Liberation and Acquisition Engine: A Gulf of America Cash Flow Story (NYSE:WTI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FVCB/margin-inflection-meets-niche-dominance-fvcb-s-concentrated-bet-on-dc-metro-banking-nasdaq-fvcb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:43:59Z</news:publication_date>
      <news:title>Margin Inflection Meets Niche Dominance: FVCB&#x27;s Concentrated Bet on DC Metro Banking (NASDAQ:FVCB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/OBT/orange-county-bancorp-margin-expansion-meets-wealth-management-upside-in-hudson-valley-s-premier-business-bank-nasdaq-obt</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:41:12Z</news:publication_date>
      <news:title>Orange County Bancorp: Margin Expansion Meets Wealth Management Upside in Hudson Valley&#x27;s Premier Business Bank (NASDAQ:OBT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FLL/full-house-resorts-a-regional-casino-turnaround-story-at-an-inflection-point-nasdaq-fll</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:36:56Z</news:publication_date>
      <news:title>Full House Resorts: A Regional Casino Turnaround Story at an Inflection Point (NASDAQ:FLL)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LAB/standard-biotools-a-90m-turnaround-creates-a-lean-proteomics-pure-play-at-an-inflection-point-nasdaq-lab</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:36:13Z</news:publication_date>
      <news:title>Standard BioTools: A $90M Turnaround Creates a Lean Proteomics Pure-Play at an Inflection Point (NASDAQ:LAB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CUE/cue-biopharma-s-0-18-gamble-betting-the-farm-on-autoimmune-platform-value-before-cash-runs-out-nasdaq-cue</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:34:24Z</news:publication_date>
      <news:title>Cue Biopharma&#x27;s $0.18 Gamble: Betting the Farm on Autoimmune Platform Value Before Cash Runs Out (NASDAQ:CUE)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TRST/trustco-bank-s-low-cost-moat-why-conservative-banking-creates-compelling-asymmetry-nasdaq-trst</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:32:19Z</news:publication_date>
      <news:title>TrustCo Bank&#x27;s Low-Cost Moat: Why Conservative Banking Creates Compelling Asymmetry (NASDAQ:TRST)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/EVEX/eve-holding-how-embraer-s-aerospace-dna-could-create-a-durable-uam-moat-nyse-evex</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:29:53Z</news:publication_date>
      <news:title>Eve Holding: How Embraer&#x27;s Aerospace DNA Could Create a Durable UAM Moat (NYSE:EVEX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NGS/ngs-converting-warehouses-into-horsepower-at-the-bottom-of-the-well</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:26:50Z</news:publication_date>
      <news:title>NGS: Converting Warehouses into Horsepower at the Bottom of the Well</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BDTX/black-diamond-s-masterkey-gamble-partnership-capital-meets-brain-penetrant-egfr-innovation-nasdaq-bdtx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:25:53Z</news:publication_date>
      <news:title>Black Diamond&#x27;s MasterKey Gamble: Partnership Capital Meets Brain-Penetrant EGFR Innovation (NASDAQ:BDTX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TLS/turnaround-execution-meets-ai-compliance-telos-corporation-s-federal-cybersecurity-inflection-nasdaq-tls</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:24:02Z</news:publication_date>
      <news:title>Turnaround Execution Meets AI Compliance: Telos Corporation&#x27;s Federal Cybersecurity Inflection (NASDAQ:TLS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AREN/the-arena-group-a-publishing-turnaround-morphs-into-a-profitable-data-platform-nyse-aren</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:22:35Z</news:publication_date>
      <news:title>The Arena Group: A Publishing Turnaround Morphs Into a Profitable Data Platform (NYSE:AREN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BWNB/from-ashes-to-ai-power-babcock-wilcox-s-2-4b-data-center-bet-redefines-the-turnaround-nyse-bwnb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:20:57Z</news:publication_date>
      <news:title>From Ashes to AI Power: Babcock &amp; Wilcox&#x27;s $2.4B Data Center Bet Redefines the Turnaround (NYSE:BWNB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/EMYB/embassy-bancorp-community-banking-moat-meets-margin-inflection-in-pennsylvania-s-lehigh-valley-nasdaq-emyb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:18:36Z</news:publication_date>
      <news:title>Embassy Bancorp: Community Banking Moat Meets Margin Inflection in Pennsylvania&#x27;s Lehigh Valley (NASDAQ:EMYB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HDSN/hudson-technologies-the-reclamation-moat-meets-an-execution-pivot-nasdaq-hdsn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:18:00Z</news:publication_date>
      <news:title>Hudson Technologies: The Reclamation Moat Meets an Execution Pivot (NASDAQ:HDSN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BMBL/bumble-s-3-36-bet-quality-reset-meets-distressed-valuation-nasdaq-bmbl</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:12:55Z</news:publication_date>
      <news:title>Bumble&#x27;s $3.36 Bet: Quality Reset Meets Distressed Valuation (NASDAQ:BMBL)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FF/futurefuel-s-policy-paralysis-when-integration-meets-regulatory-uncertainty-nyse-ff</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:12:07Z</news:publication_date>
      <news:title>FutureFuel&#x27;s Policy Paralysis: When Integration Meets Regulatory Uncertainty (NYSE:FF)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/EFSI/efsi-s-strategic-repositioning-paying-upfront-for-uncertain-payoff-nasdaq-efsi</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:06:55Z</news:publication_date>
      <news:title>EFSI&#x27;s Strategic Repositioning: Paying Upfront for Uncertain Payoff (NASDAQ:EFSI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ARDT/margin-repair-meets-regional-moats-ardent-health-s-55m-bet-on-operational-excellence-nasdaq-ardt</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:00:18Z</news:publication_date>
      <news:title>Margin Repair Meets Regional Moats: Ardent Health&#x27;s $55M Bet on Operational Excellence (NASDAQ:ARDT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DELL/dell-s-ai-factory-the-43-billion-backlog-transforming-a-pc-giant-nyse-dell</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T23:00:01Z</news:publication_date>
      <news:title>Dell&#x27;s AI Factory: The $43 Billion Backlog Transforming a PC Giant (NYSE:DELL)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/KLTR/kaltura-s-ai-pivot-from-video-utility-to-agentic-experience-platform-nasdaq-kltr</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T22:57:07Z</news:publication_date>
      <news:title>Kaltura&#x27;s AI Pivot: From Video Utility to Agentic Experience Platform (NASDAQ:KLTR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GETY/getty-images-ai-licensing-paradox-meets-distressed-valuation-at-a-content-empire-nyse-gety</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T22:56:38Z</news:publication_date>
      <news:title>Getty Images: AI Licensing Paradox Meets Distressed Valuation at a Content Empire (NYSE:GETY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/IOT/samsara-s-data-flywheel-why-the-connected-operations-platform-is-hitting-an-inflection-point-nyse-iot</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T22:49:43Z</news:publication_date>
      <news:title>Samsara&#x27;s Data Flywheel: Why the Connected Operations Platform Is Hitting an Inflection Point (NYSE:IOT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AGRO/adecoagro-s-fertilizer-gambit-from-cyclical-landowner-to-south-america-s-cash-generation-machine-nyse-agro</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T22:47:33Z</news:publication_date>
      <news:title>Adecoagro&#x27;s Fertilizer Gambit: From Cyclical Landowner to South America&#x27;s Cash Generation Machine (NYSE:AGRO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ATRA/atara-biotherapeutics-a-royalty-stream-in-regulatory-limbo-nasdaq-atra</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T22:39:53Z</news:publication_date>
      <news:title>Atara Biotherapeutics: A Royalty Stream in Regulatory Limbo (NASDAQ:ATRA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GLBS/fleet-transformation-meets-cyclical-headwinds-globus-maritime-s-2-37-bet-on-dry-bulk-recovery-nasdaq-glbs</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T22:39:24Z</news:publication_date>
      <news:title>Fleet Transformation Meets Cyclical Headwinds: Globus Maritime&#x27;s $2.37 Bet on Dry Bulk Recovery (NASDAQ:GLBS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CATX/lead-212-s-last-mile-advantage-why-perspective-therapeutics-alpha-platform-could-redefine-radiopharma-nyse-catx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T22:35:04Z</news:publication_date>
      <news:title>Lead-212&#x27;s Last-Mile Advantage: Why Perspective Therapeutics&#x27; Alpha Platform Could Redefine Radiopharma (NYSE:CATX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FFWM/first-foundation-s-merger-finale-caps-a-brutal-balance-sheet-rebirth-nasdaq-ffwm</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T22:23:19Z</news:publication_date>
      <news:title>First Foundation&#x27;s Merger Finale Caps a Brutal Balance Sheet Rebirth (NASDAQ:FFWM)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/STOK/stoke-therapeutics-partnership-capital-meets-genetic-upregulation-promise-nasdaq-stok</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T22:20:20Z</news:publication_date>
      <news:title>Stoke Therapeutics: Partnership Capital Meets Genetic Upregulation Promise (NASDAQ:STOK)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ULH/ulh-s-industrial-logistics-moat-building-margin-resilience-through-specialized-services</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T22:12:47Z</news:publication_date>
      <news:title>ULH&#x27;s Industrial Logistics Moat: Building Margin Resilience Through Specialized Services</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CSBB/margin-expansion-meets-digital-disruption-risk-at-csb-bancorp-otc-csbb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T22:12:37Z</news:publication_date>
      <news:title>Margin Expansion Meets Digital Disruption Risk at CSB Bancorp (OTC:CSBB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ATNI/margin-inflection-meets-rural-moat-monetization-at-atn-international-nasdaq-atni</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T22:03:14Z</news:publication_date>
      <news:title>Margin Inflection Meets Rural Moat Monetization at ATN International (NASDAQ:ATNI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HFFG/hf-foods-group-niche-dominance-meets-digital-transformation-at-a-crossroads-nasdaq-hffg</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T22:01:12Z</news:publication_date>
      <news:title>HF Foods Group: Niche Dominance Meets Digital Transformation at a Crossroads (NASDAQ:HFFG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SAMG/silvercrest-s-margin-sacrifice-building-an-institutional-powerhouse-while-paying-shareholders-to-wait-nasdaq-samg</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:57:59Z</news:publication_date>
      <news:title>Silvercrest&#x27;s Margin Sacrifice: Building an Institutional Powerhouse While Paying Shareholders to Wait (NASDAQ:SAMG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LUDG/ludwig-enterprises-a-5-7m-bet-on-mrna-diagnostics-faces-existential-capital-crisis-otc-ludg</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:51:23Z</news:publication_date>
      <news:title>Ludwig Enterprises: A $5.7M Bet on mRNA Diagnostics Faces Existential Capital Crisis (OTC:LUDG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DOUG/douglas-elliman-s-luxury-pivot-why-a-debt-free-balance-sheet-changes-everything-nyse-doug</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:46:14Z</news:publication_date>
      <news:title>Douglas Elliman&#x27;s Luxury Pivot: Why a Debt-Free Balance Sheet Changes Everything (NYSE:DOUG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GHI/greystone-housing-impact-investors-a-50-discount-to-book-value-amid-a-strategic-pivot-to-stability-nyse-ghi</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:44:17Z</news:publication_date>
      <news:title>Greystone Housing Impact Investors: A 50% Discount to Book Value Amid a Strategic Pivot to Stability (NYSE:GHI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DCGO/docgo-s-last-mile-healthcare-gamble-can-platform-integration-outrun-a-liquidity-crisis-nasdaq-dcgo</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:42:26Z</news:publication_date>
      <news:title>DocGo&#x27;s Last-Mile Healthcare Gamble: Can Platform Integration Outrun a Liquidity Crisis? (NASDAQ:DCGO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MX/magnachip-s-power-pivot-a-turnaround-bet-on-55-new-products-and-a-30-margin-dream-nyse-mx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:40:54Z</news:publication_date>
      <news:title>Magnachip&#x27;s Power Pivot: A Turnaround Bet on 55 New Products and a 30% Margin Dream (NYSE:MX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PLBY/plby-s-capital-light-transformation-licensing-leverage-meets-deleveraging-at-an-inflection-point-nasdaq-plby</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:37:09Z</news:publication_date>
      <news:title>PLBY&#x27;s Capital-Light Transformation: Licensing Leverage Meets Deleveraging at an Inflection Point (NASDAQ:PLBY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FTK/flotek-s-data-driven-margin-revolution-how-a-chemistry-supplier-became-a-high-margin-analytics-powerhouse-nyse-ftk</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:34:26Z</news:publication_date>
      <news:title>Flotek&#x27;s Data-Driven Margin Revolution: How a Chemistry Supplier Became a High-Margin Analytics Powerhouse (NYSE:FTK)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HLLY/holley-s-turnaround-accelerates-margin-recovery-meets-debt-reduction-nyse-hlly</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:32:17Z</news:publication_date>
      <news:title>Holley&#x27;s Turnaround Accelerates: Margin Recovery Meets Debt Reduction (NYSE:HLLY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CPSS/credit-repair-meets-ai-leverage-consumer-portfolio-services-nasdaq-cpss-at-an-inflection-point</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:28:19Z</news:publication_date>
      <news:title>Credit Repair Meets AI Leverage: Consumer Portfolio Services (NASDAQ:CPSS) at an Inflection Point</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SMBK/smartfinancial-s-organic-growth-engine-margin-inflection-meets-disciplined-expansion-in-the-southeast-nasdaq-smbk</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:25:50Z</news:publication_date>
      <news:title>SmartFinancial&#x27;s Organic Growth Engine: Margin Inflection Meets Disciplined Expansion in the Southeast (NASDAQ:SMBK)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CBNK/capital-bancorp-s-niche-lending-moats-meet-their-ifh-integration-test-nasdaq-cbnk</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:24:52Z</news:publication_date>
      <news:title>Capital Bancorp&#x27;s Niche Lending Moats Meet Their IFH Integration Test (NASDAQ:CBNK)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SMC/summit-midstream-s-double-e-pipeline-and-portfolio-reset-a-path-to-100m-ebitda-growth-nasdaq-smc</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:20:07Z</news:publication_date>
      <news:title>Summit Midstream&#x27;s Double E Pipeline and Portfolio Reset: A Path to $100M EBITDA Growth (NASDAQ:SMC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CYPH/cypherpunk-technologies-a-levered-zcash-bet-with-a-nasdaq-gun-to-its-head-nasdaq-cyph</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:18:20Z</news:publication_date>
      <news:title>Cypherpunk Technologies: A Levered Zcash Bet With a Nasdaq Gun to Its Head (NASDAQ:CYPH)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MYPS/myps-a-0-48-lottery-ticket-on-sweepstakes-turnaround</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:15:27Z</news:publication_date>
      <news:title>MYPS: A $0.48 Lottery Ticket on Sweepstakes Turnaround</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FCCO/first-community-s-cre-tightrope-when-local-loyalty-meets-regulatory-reality-nasdaq-fcco</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:14:15Z</news:publication_date>
      <news:title>First Community&#x27;s CRE Tightrope: When Local Loyalty Meets Regulatory Reality (NASDAQ:FCCO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GOAI/ai-arbitrage-at-micro-scale-why-eva-live-s-82-growth-hides-existential-risk-nasdaq-goai</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:11:21Z</news:publication_date>
      <news:title>AI Arbitrage at Micro Scale: Why Eva Live&#x27;s 82% Growth Hides Existential Risk (NASDAQ:GOAI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BZFD/buzzfeed-s-existential-gamble-can-ai-innovation-save-a-media-company-from-its-own-balance-sheet-nasdaq-bzfd</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:11:09Z</news:publication_date>
      <news:title>BuzzFeed&#x27;s Existential Gamble: Can AI Innovation Save a Media Company from Its Own Balance Sheet? (NASDAQ:BZFD)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ASRT/rolvedon-s-runway-why-assertio-s-oncology-pivot-creates-asymmetric-upside-nasdaq-asrt</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:11:01Z</news:publication_date>
      <news:title>ROLVEDON&#x27;s Runway: Why Assertio&#x27;s Oncology Pivot Creates Asymmetric Upside (NASDAQ:ASRT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BCML/baycom-corp-the-cre-concentration-gambit-at-0-95x-book-nasdaq-bcml</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:03:42Z</news:publication_date>
      <news:title>BayCom Corp: The CRE Concentration Gambit at 0.95x Book (NASDAQ:BCML)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AVD/american-vanguard-s-2-42-turnaround-from-chemical-chaos-to-specialty-ag-value-nyse-avd</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:03:21Z</news:publication_date>
      <news:title>American Vanguard&#x27;s $2.42 Turnaround: From Chemical Chaos to Specialty Ag Value (NYSE:AVD)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/EGY/vaalco-energy-africa-s-hidden-value-play-emerges-from-transition-nyse-egy</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:01:33Z</news:publication_date>
      <news:title>VAALCO Energy: Africa&#x27;s Hidden Value Play Emerges From Transition (NYSE:EGY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AP/ampco-pittsburgh-strategic-amputation-creates-margin-inflection-but-financial-fragility-remains-the-binding-constraint-nyse-ap</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T21:01:23Z</news:publication_date>
      <news:title>Ampco-Pittsburgh: Strategic Amputation Creates Margin Inflection, But Financial Fragility Remains the Binding Constraint (NYSE:AP)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FRST/primis-financial-s-digital-deposit-engine-a-path-to-1-roa-and-beyond-nasdaq-frst</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T20:57:29Z</news:publication_date>
      <news:title>Primis Financial&#x27;s Digital Deposit Engine: A Path to 1% ROA and Beyond (NASDAQ:FRST)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CWCO/cwco-a-water-infrastructure-platform-hiding-in-plain-sight-with-a-147m-hawaii-catalyst-on-the-horizon-nasdaq-cwco</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T20:57:22Z</news:publication_date>
      <news:title>CWCO: A Water Infrastructure Platform Hiding in Plain Sight, With a $147M Hawaii Catalyst on the Horizon (NASDAQ:CWCO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ITIC/investors-title-the-tiny-title-insurer-with-a-margin-moat-and-a-dividend-discipline-nasdaq-itic</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T20:55:18Z</news:publication_date>
      <news:title>Investors Title: The Tiny Title Insurer With a Margin Moat and a Dividend Discipline (NASDAQ:ITIC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/RLYB/rallybio-s-3-65-lifeline-the-brutal-math-of-a-biotech-fire-sale-nasdaq-rlyb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T20:51:24Z</news:publication_date>
      <news:title>Rallybio&#x27;s 3.65% Lifeline: The Brutal Math of a Biotech Fire Sale (NASDAQ:RLYB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MCBS/metrocity-bankshares-niche-dominance-meets-scale-catalyst-in-undervalued-ethnic-banking-play-nasdaq-mcbs</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T20:50:15Z</news:publication_date>
      <news:title>MetroCity Bankshares: Niche Dominance Meets Scale Catalyst in Undervalued Ethnic Banking Play (NASDAQ:MCBS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GDOT/green-dot-s-1-1b-breakup-unlocking-embedded-finance-value-amid-regulatory-transformation-nasdaq-gdot</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T20:47:28Z</news:publication_date>
      <news:title>Green Dot&#x27;s $1.1B Breakup: Unlocking Embedded Finance Value Amid Regulatory Transformation (NASDAQ:GDOT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PANL/pangaea-logistics-building-a-premium-priced-integrated-platform-in-a-commodity-ocean-nasdaq-panl</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T20:45:46Z</news:publication_date>
      <news:title>Pangaea Logistics: Building a Premium-Priced Integrated Platform in a Commodity Ocean (NASDAQ:PANL)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/KSPI/kaspi-kz-kazakhstan-s-super-app-fortress-faces-turkish-expansion-test-nasdaq-kspi</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T20:43:39Z</news:publication_date>
      <news:title>Kaspi.kz: Kazakhstan&#x27;s Super App Fortress Faces Turkish Expansion Test (NASDAQ:KSPI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AGEN/agenus-s-3-bet-unprecedented-cancer-data-meets-financial-distress-in-a-make-or-break-year-nasdaq-agen</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T20:34:33Z</news:publication_date>
      <news:title>Agenus&#x27;s $3 Bet: Unprecedented Cancer Data Meets Financial Distress in a Make-or-Break Year (NASDAQ:AGEN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/XRX/debt-meets-reinvention-xerox-s-high-stakes-turnaround-at-1-26-nasdaq-xrx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T20:22:08Z</news:publication_date>
      <news:title>Debt Meets Reinvention: Xerox&#x27;s High-Stakes Turnaround at $1.26 (NASDAQ:XRX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BSVN/bank7-s-disciplined-niche-superior-returns-meet-growth-reality-check-nasdaq-bsvn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T20:21:10Z</news:publication_date>
      <news:title>Bank7&#x27;s Disciplined Niche: Superior Returns Meet Growth Reality Check (NASDAQ:BSVN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MVST/microvast-s-margin-miracle-meets-liquidity-reality-why-execution-alone-won-t-save-this-battery-play-nasdaq-mvst</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T20:16:05Z</news:publication_date>
      <news:title>Microvast&#x27;s Margin Miracle Meets Liquidity Reality: Why Execution Alone Won&#x27;t Save This Battery Play (NASDAQ:MVST)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/WALD/wald-at-the-crossroads-can-a-spac-beauty-platform-fix-its-operations-before-debt-and-distractions-derail-the-story</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T20:06:28Z</news:publication_date>
      <news:title>WALD at the Crossroads: Can a SPAC Beauty Platform Fix Its Operations Before Debt and Distractions Derail the Story?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MUX/mcewen-inc-a-copper-gold-transformation-story-with-200-upside-as-los-azules-ipo-approaches-nyse-mux</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T19:59:35Z</news:publication_date>
      <news:title>McEwen Inc.: A Copper-Gold Transformation Story With 200% Upside As Los Azules IPO Approaches (NYSE:MUX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/RLX/rlx-technology-from-china-crisis-to-global-smokeless-leader-why-76-international-revenue-changes-everything-nyse-rlx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T19:57:35Z</news:publication_date>
      <news:title>RLX Technology: From China Crisis to Global Smokeless Leader—Why 76% International Revenue Changes Everything (NYSE:RLX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/EEX/emerald-holding-s-portfolio-surgery-will-the-patient-thrive-or-just-survive-nyse-eex</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T19:52:53Z</news:publication_date>
      <news:title>Emerald Holding&#x27;s Portfolio Surgery: Will the Patient Thrive or Just Survive? (NYSE:EEX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/KYIV/kyivstar-war-hardened-dominance-meets-digital-acceleration-in-ukraine-s-recovery-nasdaq-kyiv</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T19:46:32Z</news:publication_date>
      <news:title>Kyivstar: War-Hardened Dominance Meets Digital Acceleration in Ukraine&#x27;s Recovery (NASDAQ:KYIV)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ACIU/ac-immune-s-precision-prevention-platform-a-high-stakes-bet-on-neurodegenerative-disease-economics-nasdaq-aciu</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T19:46:09Z</news:publication_date>
      <news:title>AC Immune&#x27;s Precision Prevention Platform: A High-Stakes Bet on Neurodegenerative Disease Economics (NASDAQ:ACIU)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FORR/forrester-s-ai-gamble-can-a-40-year-research-firm-reinvent-itself-before-its-core-fades-nasdaq-forr</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T19:34:22Z</news:publication_date>
      <news:title>Forrester&#x27;s AI Gamble: Can a 40-Year Research Firm Reinvent Itself Before Its Core Fades? (NASDAQ:FORR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/COFS/choiceone-financial-post-merger-scale-meets-community-banking-moat-nasdaq-cofs</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T19:21:19Z</news:publication_date>
      <news:title>ChoiceOne Financial: Post-Merger Scale Meets Community Banking Moat (NASDAQ:COFS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HBIO/harvard-bioscience-surgical-turnaround-meets-translational-science-opportunity-nasdaq-hbio</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T19:20:33Z</news:publication_date>
      <news:title>Harvard Bioscience: Surgical Turnaround Meets Translational Science Opportunity (NASDAQ:HBIO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SHIM/shimmick-s-margin-inflection-can-a-specialized-water-contractor-trade-at-0-3x-sales-nasdaq-shim</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T19:19:37Z</news:publication_date>
      <news:title>Shimmick&#x27;s Margin Inflection: Can a Specialized Water Contractor Trade at 0.3x Sales? (NASDAQ:SHIM)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HLN/haleon-s-margin-inflection-meets-oral-health-dominance-nyse-hln</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T19:14:49Z</news:publication_date>
      <news:title>Haleon&#x27;s Margin Inflection Meets Oral Health Dominance (NYSE:HLN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/USEG/u-s-energy-s-22m-bet-can-a-micro-cap-oil-survivor-become-america-s-next-helium-champion-nasdaq-useg</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T19:13:30Z</news:publication_date>
      <news:title>U.S. Energy&#x27;s $22M Bet: Can a Micro-Cap Oil Survivor Become America&#x27;s Next Helium Champion? (NASDAQ:USEG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BRNS/barinthus-biotherapeutics-a-24-million-wager-on-autoimmune-innovation-at-the-edge-of-solvency-nasdaq-brns</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T19:06:44Z</news:publication_date>
      <news:title>Barinthus Biotherapeutics: A $24 Million Wager on Autoimmune Innovation at the Edge of Solvency (NASDAQ:BRNS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/USCB/uscb-s-niche-banking-moat-meets-margin-inflection-in-south-florida-s-growth-epicenter-nasdaq-uscb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T18:59:04Z</news:publication_date>
      <news:title>USCB&#x27;s Niche Banking Moat Meets Margin Inflection in South Florida&#x27;s Growth Epicenter (NASDAQ:USCB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/JMSB/margin-expansion-meets-capital-return-jmsb-s-disciplined-growth-reaches-an-inflection-point-nasdaq-jmsb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T18:57:43Z</news:publication_date>
      <news:title>Margin Expansion Meets Capital Return: JMSB&#x27;s Disciplined Growth Reaches an Inflection Point (NASDAQ:JMSB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NWFL/portfolio-repositioning-meets-ai-powered-efficiency-at-norwood-financial-nasdaq-nwfl</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T18:52:02Z</news:publication_date>
      <news:title>Portfolio Repositioning Meets AI-Powered Efficiency at Norwood Financial (NASDAQ:NWFL)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MNSB/core-banking-revival-at-a-discount-mainstreet-bancshares-strategic-pivot-to-profitability-nasdaq-mnsb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T18:49:53Z</news:publication_date>
      <news:title>Core Banking Revival at a Discount: MainStreet Bancshares&#x27; Strategic Pivot to Profitability (NASDAQ:MNSB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CBAN/colony-bankcorp-from-rural-roots-to-1-roa-a-community-bank-s-blueprint-for-scalable-excellence-nyse-cban</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T18:46:46Z</news:publication_date>
      <news:title>Colony Bankcorp: From Rural Roots to 1% ROA—A Community Bank&#x27;s Blueprint for Scalable Excellence (NYSE:CBAN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TK/teekay-s-fleet-renewal-arbitrage-capturing-geopolitical-premiums-in-a-debt-free-tanker-play-nyse-tk</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T18:31:12Z</news:publication_date>
      <news:title>Teekay&#x27;s Fleet Renewal Arbitrage: Capturing Geopolitical Premiums in a Debt-Free Tanker Play (NYSE:TK)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CHMG/chmg-s-45m-capital-gambit-can-a-192-year-old-community-bank-outrun-its-concentration-risk</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T18:30:07Z</news:publication_date>
      <news:title>CHMG&#x27;s $45M Capital Gambit: Can a 192-Year-Old Community Bank Outrun Its Concentration Risk?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/OVBC/ohio-valley-banc-corp-margin-inflection-meets-community-banking-moat-nasdaq-ovbc</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T18:20:39Z</news:publication_date>
      <news:title>Ohio Valley Banc Corp: Margin Inflection Meets Community Banking Moat (NASDAQ:OVBC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BMNM/bimini-capital-s-asset-management-metamorphosis-a-1-6b-bet-on-fee-stability-over-rate-risk-otc-bmnm</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T18:09:33Z</news:publication_date>
      <news:title>Bimini Capital&#x27;s Asset Management Metamorphosis: A $1.6B Bet on Fee Stability Over Rate Risk (OTC:BMNM)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CBFV/cbfv-margin-inflection-meets-strategic-pivot-at-a-pennsylvania-community-bank-nasdaq-cbfv</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T18:06:02Z</news:publication_date>
      <news:title>CBFV: Margin Inflection Meets Strategic Pivot at a Pennsylvania Community Bank (NASDAQ:CBFV)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MRBK/meridian-s-profitability-paradox-why-this-tiny-bank-s-19-margins-hide-growing-pains-nasdaq-mrbk</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T17:59:53Z</news:publication_date>
      <news:title>Meridian&#x27;s Profitability Paradox: Why This Tiny Bank&#x27;s 19% Margins Hide Growing Pains (NASDAQ:MRBK)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NECB/northeast-community-bancorp-when-construction-lending-excellence-meets-a-40-valuation-discount-nasdaq-necb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T17:47:22Z</news:publication_date>
      <news:title>Northeast Community Bancorp: When Construction Lending Excellence Meets a 40% Valuation Discount (NASDAQ:NECB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FMCB/farmers-merchants-bancorp-prudent-growth-commands-a-premium-otc-fmcb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T17:43:24Z</news:publication_date>
      <news:title>Farmers &amp; Merchants Bancorp: Prudent Growth Commands a Premium (OTC:FMCB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HBNC/horizon-bancorp-s-300m-transformation-how-a-152-year-old-bank-engineered-a-commercial-banking-powerhouse-nasdaq-hbnc</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T17:42:51Z</news:publication_date>
      <news:title>Horizon Bancorp&#x27;s $300M Transformation: How a 152-Year-Old Bank Engineered a Commercial Banking Powerhouse (NASDAQ:HBNC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CLOQ/cyberloq-s-zero-revenue-dilemma-can-a-niche-mfa-platform-survive-the-fraud-prevention-arms-race-otc-cloq</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T17:41:16Z</news:publication_date>
      <news:title>CyberloQ&#x27;s Zero-Revenue Dilemma: Can a Niche MFA Platform Survive the Fraud Prevention Arms Race? (OTC:CLOQ)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NEN/regional-moat-meets-financial-pressure-new-england-realty-s-scale-challenge-nyse-nen</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T17:34:18Z</news:publication_date>
      <news:title>Regional Moat Meets Financial Pressure: New England Realty&#x27;s Scale Challenge (NYSE:NEN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/XBIT/xbiotech-s-750m-question-can-true-human-antibodies-deliver-a-second-act-nasdaq-xbit</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T17:28:39Z</news:publication_date>
      <news:title>XBiotech&#x27;s $750M Question: Can True Human Antibodies Deliver a Second Act? (NASDAQ:XBIT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NPK/defense-boom-meets-housewares-bust-national-presto-s-1-75b-backlog-can-t-mask-margin-collapse-nyse-npk</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T17:22:17Z</news:publication_date>
      <news:title>Defense Boom Meets Housewares Bust: National Presto&#x27;s $1.75B Backlog Can&#x27;t Mask Margin Collapse (NYSE:NPK)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BTMD/turnaround-execution-at-a-cyclical-low-biote-s-practitioner-platform-faces-its-moment-of-truth-nasdaq-btmd</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T17:20:35Z</news:publication_date>
      <news:title>Turnaround Execution at a Cyclical Low: Biote&#x27;s Practitioner Platform Faces Its Moment of Truth (NASDAQ:BTMD)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FDBC/fdbc-s-margin-inflection-how-a-122-year-old-community-bank-is-engineering-2026-upside-through-disciplined-repositioning</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T17:19:21Z</news:publication_date>
      <news:title>FDBC&#x27;s Margin Inflection: How a 122-Year-Old Community Bank Is Engineering 2026 Upside Through Disciplined Repositioning</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HNVR/hnvr-credit-cleanup-and-niche-dominance-position-community-bank-for-sustained-performance</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T17:19:01Z</news:publication_date>
      <news:title>HNVR: Credit Cleanup and Niche Dominance Position Community Bank for Sustained Performance</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HTB/margin-expansion-meets-strategic-retrenchment-hometrust-bancshares-pivot-from-growth-to-profitability-nasdaq-htb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T17:12:13Z</news:publication_date>
      <news:title>Margin Expansion Meets Strategic Retrenchment: HomeTrust Bancshares&#x27; Pivot from Growth to Profitability (NASDAQ:HTB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/RBKB/rhinebeck-bancorp-s-quiet-transformation-a-165-year-old-bank-reinvents-itself-for-the-digital-age-nasdaq-rbkb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T16:43:12Z</news:publication_date>
      <news:title>Rhinebeck Bancorp&#x27;s Quiet Transformation: A 165-Year-Old Bank Reinvents Itself for the Digital Age (NASDAQ:RBKB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/WOOF/petco-s-profitability-pivot-services-moat-meets-margin-repair-nasdaq-woof</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T16:40:06Z</news:publication_date>
      <news:title>Petco&#x27;s Profitability Pivot: Services Moat Meets Margin Repair (NASDAQ:WOOF)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/KRT/karat-packaging-margin-recovery-meets-market-share-gains-in-eco-friendly-packaging-nasdaq-krt</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T16:37:38Z</news:publication_date>
      <news:title>Karat Packaging: Margin Recovery Meets Market Share Gains in Eco-Friendly Packaging (NASDAQ:KRT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DXF/eason-technology-s-identity-crisis-can-a-serial-transformer-find-its-footing-before-the-nyse-door-closes-nyse-dxf</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T16:31:43Z</news:publication_date>
      <news:title>Eason Technology&#x27;s Identity Crisis: Can a Serial Transformer Find Its Footing Before the NYSE Door Closes? (NYSE:DXF)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/WMT/walmart-s-ai-powered-omnichannel-profit-engine-why-the-1-trillion-retailer-is-just-getting-started-nyse-wmt</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T16:23:39Z</news:publication_date>
      <news:title>Walmart&#x27;s AI-Powered Omnichannel Profit Engine: Why the $1 Trillion Retailer Is Just Getting Started (NYSE:WMT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ACDC/vertical-integration-under-duress-profrac-s-100m-cost-test-meets-fuel-efficient-tech-advantage-nasdaq-acdc</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T16:19:49Z</news:publication_date>
      <news:title>Vertical Integration Under Duress: ProFrac&#x27;s $100M Cost Test Meets Fuel-Efficient Tech Advantage (NASDAQ:ACDC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LOCO/el-pollo-loco-s-turnaround-recipe-margin-recovery-meets-franchise-led-growth-nasdaq-loco</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T16:15:51Z</news:publication_date>
      <news:title>El Pollo Loco&#x27;s Turnaround Recipe: Margin Recovery Meets Franchise-Led Growth (NASDAQ:LOCO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BPRN/princeton-bancorp-post-acquisition-earnings-inflection-meets-cre-concentration-risk-nasdaq-bprn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T16:07:56Z</news:publication_date>
      <news:title>Princeton Bancorp: Post-Acquisition Earnings Inflection Meets CRE Concentration Risk (NASDAQ:BPRN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ESQ/litigation-banking-dominance-meets-strategic-inflection-why-esquire-financial-s-niche-moat-is-about-to-scale-nasdaq-esq</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T16:04:17Z</news:publication_date>
      <news:title>Litigation Banking Dominance Meets Strategic Inflection: Why Esquire Financial&#x27;s Niche Moat Is About to Scale (NASDAQ:ESQ)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/EP/empire-petroleum-s-liquidity-squeeze-tests-its-mature-asset-optimization-strategy-nyse-ep</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T16:04:08Z</news:publication_date>
      <news:title>Empire Petroleum&#x27;s Liquidity Squeeze Tests Its Mature Asset Optimization Strategy (NYSE:EP)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FOA/finance-of-america-the-reverse-mortgage-leader-s-technology-driven-turnaround-nyse-foa</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T16:03:32Z</news:publication_date>
      <news:title>Finance of America: The Reverse Mortgage Leader&#x27;s Technology-Driven Turnaround (NYSE:FOA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CBIO/the-partnership-paradox-why-crescent-biopharma-s-china-deal-both-validates-and-traps-its-keytruda-challenge-nasdaq-cbio</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T15:55:53Z</news:publication_date>
      <news:title>The Partnership Paradox: Why Crescent Biopharma&#x27;s China Deal Both Validates and Traps Its Keytruda Challenge (NASDAQ:CBIO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ALTO/alto-ingredients-margin-inflection-meets-regulatory-arbitrage-nasdaq-alto</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T15:51:04Z</news:publication_date>
      <news:title>Alto Ingredients: Margin Inflection Meets Regulatory Arbitrage (NASDAQ:ALTO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/WEYS/weyco-group-tariff-turmoil-tests-a-119-year-old-footwear-fortress-nasdaq-weys</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T15:45:59Z</news:publication_date>
      <news:title>Weyco Group: Tariff Turmoil Tests a 119-Year-Old Footwear Fortress (NASDAQ:WEYS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/EHGO/ehgo-s-0-22-ai-gamble-can-a-loss-making-office-supplier-become-an-enterprise-ai-player</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T15:44:50Z</news:publication_date>
      <news:title>EHGO&#x27;s $0.22 AI Gamble: Can a Loss-Making Office Supplier Become an Enterprise AI Player?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ISBA/margin-momentum-meets-valuation-reality-at-isabella-bank-nasdaq-isba</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T15:40:46Z</news:publication_date>
      <news:title>Margin Momentum Meets Valuation Reality at Isabella Bank (NASDAQ:ISBA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GYRE/china-s-fibrosis-franchise-how-gyre-engineered-a-profitable-pipeline-engine-nasdaq-gyre</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T15:40:09Z</news:publication_date>
      <news:title>China&#x27;s Fibrosis Franchise: How Gyre Engineered a Profitable Pipeline Engine (NASDAQ:GYRE)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ASAN/asana-s-ai-pivot-can-consumption-based-revenue-rescue-a-decelerating-growth-story-nyse-asan</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T15:39:15Z</news:publication_date>
      <news:title>Asana&#x27;s AI Pivot: Can Consumption-Based Revenue Rescue a Decelerating Growth Story? (NYSE:ASAN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ABL/abacus-global-management-the-life-settlements-leader-building-a-fee-empire-at-a-deep-discount-nyse-abx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T15:30:16Z</news:publication_date>
      <news:title>Abacus Global Management: The Life Settlements Leader Building a Fee Empire at a Deep Discount (NYSE:ABX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/OPBK/op-bancorp-s-korean-american-moat-when-community-loyalty-meets-scale-disadvantage-nasdaq-opbk</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T15:30:12Z</news:publication_date>
      <news:title>OP Bancorp&#x27;s Korean-American Moat: When Community Loyalty Meets Scale Disadvantage (NASDAQ:OPBK)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/RCON/rcon-s-high-reward-niche-can-a-tiny-automation-specialist-survive-china-s-oilfield-giants-and-pivot-to-green-nasdaq-rcon</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T15:30:11Z</news:publication_date>
      <news:title>RCON&#x27;s High-Reward Niche: Can a Tiny Automation Specialist Survive China&#x27;s Oilfield Giants and Pivot to Green? (NASDAQ:RCON)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DSX/diana-shipping-s-genco-gambit-a-mid-tier-dry-bulk-operator-s-bid-to-escape-scale-purgatory-nyse-dsx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T15:25:29Z</news:publication_date>
      <news:title>Diana Shipping&#x27;s Genco Gambit: A Mid-Tier Dry Bulk Operator&#x27;s Bid to Escape Scale Purgatory (NYSE:DSX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FSBW/community-bank-discount-meets-credit-quality-stress-the-fsbw-risk-reward-equation-nasdaq-fsbw</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T15:24:59Z</news:publication_date>
      <news:title>Community Bank Discount Meets Credit Quality Stress: The FSBW Risk/Reward Equation (NASDAQ:FSBW)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/UHG/united-homes-group-a-merger-arbitrage-with-asymmetric-downside-risk-nasdaq-uhg</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T15:24:49Z</news:publication_date>
      <news:title>United Homes Group: A Merger Arbitrage with Asymmetric Downside Risk (NASDAQ:UHG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NTIP/network-1-technologies-a-37m-cash-shell-with-binary-litigation-outcomes-nasdaq-ntip</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T15:19:09Z</news:publication_date>
      <news:title>Network-1 Technologies: A $37M Cash Shell with Binary Litigation Outcomes (NASDAQ:NTIP)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BMRC/balance-sheet-surgery-reveals-a-resurgent-franchise-at-bank-of-marin-nasdaq-bmrc</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T15:18:04Z</news:publication_date>
      <news:title>Balance Sheet Surgery Reveals a Resurgent Franchise at Bank of Marin (NASDAQ:BMRC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FRAF/margin-inflection-meets-community-moat-at-franklin-financial-services-nasdaq-fraf</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T15:15:55Z</news:publication_date>
      <news:title>Margin Inflection Meets Community Moat at Franklin Financial Services (NASDAQ:FRAF)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DLNG/dynagas-lng-partners-a-deleveraging-triumph-confronts-a-sanctions-cliff-nyse-dlng</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T15:14:32Z</news:publication_date>
      <news:title>Dynagas LNG Partners: A Deleveraging Triumph Confronts a Sanctions Cliff (NYSE:DLNG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/KLC/kindercare-s-enrollment-crisis-meets-market-consolidation-opportunity-nyse-klc</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:54:29Z</news:publication_date>
      <news:title>KinderCare&#x27;s Enrollment Crisis Meets Market Consolidation Opportunity (NYSE:KLC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CRVO/cervomed-s-critical-inflection-phase-3-readiness-meets-a-cash-crucible-in-lewy-body-dementia-nasdaq-crvo</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:53:19Z</news:publication_date>
      <news:title>CervoMed&#x27;s Critical Inflection: Phase 3 Readiness Meets a Cash Crucible in Lewy Body Dementia (NASDAQ:CRVO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FIGR/figure-technology-solutions-blockchain-powered-marketplace-transformation-meets-valuation-reality-check-nasdaq-figr</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:52:01Z</news:publication_date>
      <news:title>Figure Technology Solutions: Blockchain-Powered Marketplace Transformation Meets Valuation Reality Check (NASDAQ:FIGR)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BLND/blend-labs-ai-autopilot-solving-the-11000-mortgage-problem-from-a-position-of-financial-strength-nasdaq-blnd</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:46:15Z</news:publication_date>
      <news:title>Blend Labs&#x27; AI Autopilot: Solving the $11,000 Mortgage Problem from a Position of Financial Strength (NASDAQ:BLND)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BIOX/biox-s-royalty-gambit-transforming-through-argentina-s-storm-nasdaq-biox</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:45:55Z</news:publication_date>
      <news:title>BIOX&#x27;s Royalty Gambit: Transforming Through Argentina&#x27;s Storm (NASDAQ:BIOX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ANVS/annovis-bio-s-2-28-gamble-can-a-multi-target-neurodegeneration-drug-outrun-its-q3-2026-cash-cliff-nyse-anvs</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:40:05Z</news:publication_date>
      <news:title>Annovis Bio&#x27;s $2.28 Gamble: Can a Multi-Target Neurodegeneration Drug Outrun Its Q3 2026 Cash Cliff? (NYSE:ANVS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ASPN/aspen-aerogels-from-ev-crash-to-capital-light-turnaround-nasdaq-aspn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:34:57Z</news:publication_date>
      <news:title>Aspen Aerogels: From EV Crash to Capital-Light Turnaround (NASDAQ:ASPN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CRML/critical-metals-a-3-billion-strategic-asset-trapped-in-a-1-billion-pre-revenue-shell-nasdaq-crml</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:34:48Z</news:publication_date>
      <news:title>Critical Metals: A $3 Billion Strategic Asset Trapped in a $1 Billion Pre-Revenue Shell (NASDAQ:CRML)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BCAL/california-bancorp-merger-synergies-meet-balance-sheet-repair-in-a-consolidating-market-nasdaq-bcal</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:28:27Z</news:publication_date>
      <news:title>California BanCorp: Merger Synergies Meet Balance Sheet Repair in a Consolidating Market (NASDAQ:BCAL)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LPSN/liveperson-s-debt-surgery-sets-stage-for-high-risk-ai-turnaround-nasdaq-lpsn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:22:21Z</news:publication_date>
      <news:title>LivePerson&#x27;s Debt Surgery Sets Stage for High-Risk AI Turnaround (NASDAQ:LPSN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NOEM/co2-energy-transition-corp-a-69-million-call-option-on-energy-transition-m-a-with-a-ticking-clock-nasdaq-noem</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:21:54Z</news:publication_date>
      <news:title>CO2 Energy Transition Corp: A $69 Million Call Option on Energy Transition M&amp;A With a Ticking Clock (NASDAQ:NOEM)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AMTX/aemetis-a-32-million-cash-flow-inflection-hides-behind-a-mountain-of-debt-nasdaq-amtx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:21:35Z</news:publication_date>
      <news:title>Aemetis: A $32 Million Cash Flow Inflection Hides Behind a Mountain of Debt (NASDAQ:AMTX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/WBI/waterbridge-s-infrastructure-moat-meets-margin-inflection-why-scale-creates-pricing-power-nyse-wbi</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:20:45Z</news:publication_date>
      <news:title>WaterBridge&#x27;s Infrastructure Moat Meets Margin Inflection: Why Scale Creates Pricing Power (NYSE:WBI)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BIAF/cypath-lung-s-high-stakes-gamble-can-bioaffinity-technologies-execute-its-pivot-before-cash-runs-dry-nasdaq-biaf</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:17:19Z</news:publication_date>
      <news:title>CyPath Lung&#x27;s High-Stakes Gamble: Can bioAffinity Technologies Execute Its Pivot Before Cash Runs Dry? (NASDAQ:BIAF)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/KPLT/katapult-s-marketplace-gambit-can-a-consumer-driven-pivot-outrun-a-ticking-debt-clock-nasdaq-kplt</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:15:48Z</news:publication_date>
      <news:title>Katapult&#x27;s Marketplace Gambit: Can a Consumer-Driven Pivot Outrun a Ticking Debt Clock? (NASDAQ:KPLT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PCB/pcb-bancorp-community-banking-moat-meets-cre-concentration-crossroads-nasdaq-pcb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:14:15Z</news:publication_date>
      <news:title>PCB Bancorp: Community Banking Moat Meets CRE Concentration Crossroads (NASDAQ:PCB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/RERE/atrenew-s-margin-inflection-meets-multi-category-acceleration-the-circular-economy-platform-thesis-nyse-rere</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:14:06Z</news:publication_date>
      <news:title>ATRenew&#x27;s Margin Inflection Meets Multi-Category Acceleration: The Circular Economy Platform Thesis (NYSE:RERE)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CPB/cpb-rao-s-premiumization-meets-snacks-margin-collapse-at-trough-valuation-nasdaq-cpb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:11:49Z</news:publication_date>
      <news:title>CPB: Rao&#x27;s Premiumization Meets Snacks Margin Collapse at Trough Valuation (NASDAQ:CPB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/KMDA/kamada-s-plasma-independence-premium-why-vertical-integration-and-capital-return-transform-the-specialty-biopharma-risk-reward-nasdaq-kmda</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:08:55Z</news:publication_date>
      <news:title>Kamada&#x27;s Plasma Independence Premium: Why Vertical Integration and Capital Return Transform the Specialty Biopharma Risk/Reward (NASDAQ:KMDA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/VRCA/verrica-pharmaceuticals-a-turnaround-story-with-two-shots-at-dermatology-s-biggest-prizes-nasdaq-vrca</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:07:21Z</news:publication_date>
      <news:title>Verrica Pharmaceuticals: A Turnaround Story with Two Shots at Dermatology&#x27;s Biggest Prizes (NASDAQ:VRCA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BWAY/brainsway-s-platform-gambit-how-minority-investments-and-deep-tms-dominance-are-rewiring-mental-health-delivery-nasdaq-bway</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:07:18Z</news:publication_date>
      <news:title>BrainsWay&#x27;s Platform Gambit: How Minority Investments and Deep TMS Dominance Are Rewiring Mental Health Delivery (NASDAQ:BWAY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DNN/denison-mines-canada-s-isr-breakthrough-creates-asymmetric-upside-at-the-production-threshold-nyse-dnn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:03:27Z</news:publication_date>
      <news:title>Denison Mines: Canada&#x27;s ISR Breakthrough Creates Asymmetric Upside at the Production Threshold (NYSE:DNN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/RCKY/rocky-brands-manufacturing-reshoring-and-dtc-surge-create-asymmetric-upside-nasdaq-rcky</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:01:23Z</news:publication_date>
      <news:title>Rocky Brands&#x27; Manufacturing Reshoring and DTC Surge Create Asymmetric Upside (NASDAQ:RCKY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SGMT/sagimet-s-fasn-gambit-can-a-late-entrant-win-the-mash-market-with-superior-biology-nasdaq-sgmt</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T14:00:59Z</news:publication_date>
      <news:title>Sagimet&#x27;s FASN Gambit: Can a Late Entrant Win the MASH Market with Superior Biology? (NASDAQ:SGMT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NERV/minerva-neurosciences-a-binary-bet-on-schizophrenia-s-negative-symptoms-with-12-months-of-runway-nasdaq-nerv</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T13:54:49Z</news:publication_date>
      <news:title>Minerva Neurosciences: A Binary Bet on Schizophrenia&#x27;s Negative Symptoms With 12 Months of Runway (NASDAQ:NERV)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/KFY/korn-ferry-s-talent-suite-inflection-why-a-55-year-old-executive-search-giant-is-becoming-a-saas-platform-nyse-kfy</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T13:49:55Z</news:publication_date>
      <news:title>Korn Ferry&#x27;s Talent Suite Inflection: Why a 55-Year-Old Executive Search Giant Is Becoming a SaaS Platform (NYSE:KFY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TG/tredegar-s-aluminum-renaissance-meets-film-headwinds-manufacturing-excellence-at-a-discount-nyse-tg</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T13:45:22Z</news:publication_date>
      <news:title>Tredegar&#x27;s Aluminum Renaissance Meets Film Headwinds: Manufacturing Excellence at a Discount (NYSE:TG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/HMY/harmony-gold-s-copper-gold-inflection-why-quality-ounces-and-countercyclical-diversification-are-reshaping-the-investment-case-nyse-hmy</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T13:39:08Z</news:publication_date>
      <news:title>Harmony Gold&#x27;s Copper-Gold Inflection: Why Quality Ounces and Countercyclical Diversification Are Reshaping the Investment Case (NYSE:HMY)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MG/mistras-group-a-margin-expansion-story-disguised-as-a-cyclical-services-stock-nyse-mg</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T13:37:56Z</news:publication_date>
      <news:title>Mistras Group: A Margin-Expansion Story Disguised as a Cyclical Services Stock (NYSE:MG)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SSSS/ai-infrastructure-s-hidden-value-suro-capital-s-monetization-inflection-point-nasdaq-ssss</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T13:36:31Z</news:publication_date>
      <news:title>AI Infrastructure&#x27;s Hidden Value: SuRo Capital&#x27;s Monetization Inflection Point (NASDAQ:SSSS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MRVL/marvell-s-ai-infrastructure-gambit-from-diversified-chipmaker-to-hyperscale-enabler-nasdaq-mrvl</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T13:34:09Z</news:publication_date>
      <news:title>Marvell&#x27;s AI Infrastructure Gambit: From Diversified Chipmaker to Hyperscale Enabler (NASDAQ:MRVL)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PGC/peapack-gladstone-s-private-banking-pivot-deposit-momentum-vs-cre-concentration-risk-nasdaq-pgc</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T13:25:33Z</news:publication_date>
      <news:title>Peapack-Gladstone&#x27;s Private Banking Pivot: Deposit Momentum vs. CRE Concentration Risk (NASDAQ:PGC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TTGT/techtarget-s-margin-inflection-why-ai-driven-b2b-marketing-data-is-hitting-an-inflection-point-nasdaq-ttgt</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T13:25:00Z</news:publication_date>
      <news:title>TechTarget&#x27;s Margin Inflection: Why AI-Driven B2B Marketing Data Is Hitting an Inflection Point (NASDAQ:TTGT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BWEN/broadwind-s-strategic-pivot-from-wind-dependence-to-power-generation-diversification-nasdaq-bwen</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T13:20:41Z</news:publication_date>
      <news:title>Broadwind&#x27;s Strategic Pivot: From Wind Dependence to Power Generation Diversification (NASDAQ:BWEN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TH/target-hospitality-from-government-contracts-to-ai-infrastructure-a-740m-bet-on-the-future-of-remote-workforce-housing-nasdaq-th</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T13:13:57Z</news:publication_date>
      <news:title>Target Hospitality: From Government Contracts to AI Infrastructure—A $740M Bet on the Future of Remote Workforce Housing (NASDAQ:TH)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PKBK/parke-bancorp-s-profitability-paradox-when-small-bank-efficiency-meets-scale-constraints-nasdaq-pkbk</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T13:13:30Z</news:publication_date>
      <news:title>Parke Bancorp&#x27;s Profitability Paradox: When Small-Bank Efficiency Meets Scale Constraints (NASDAQ:PKBK)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PEBK/pebk-s-community-banking-moat-why-this-113-year-old-bank-s-local-dominance-is-both-its-strength-and-its-limitation-nasdaq-pebk</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T13:09:58Z</news:publication_date>
      <news:title>PEBK&#x27;s Community Banking Moat: Why This 113-Year-Old Bank&#x27;s Local Dominance Is Both Its Strength and Its Limitation (NASDAQ:PEBK)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FWRD/forward-air-margin-inflection-meets-strategic-optionality-at-a-distressed-valuation-nasdaq-fwrd</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T13:07:16Z</news:publication_date>
      <news:title>Forward Air: Margin Inflection Meets Strategic Optionality at a Distressed Valuation (NASDAQ:FWRD)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TZOO/tzoo-s-membership-pivot-a-high-stakes-bet-on-recurring-revenue-at-the-cost-of-today-s-profits-nasdaq-tzoo</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T13:04:15Z</news:publication_date>
      <news:title>TZOO&#x27;s Membership Pivot: A High-Stakes Bet on Recurring Revenue at the Cost of Today&#x27;s Profits (NASDAQ:TZOO)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ACU/acme-united-s-tariff-tested-supply-chain-a-small-cap-industrial-building-unfair-advantages-nasdaq-acu</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T13:03:23Z</news:publication_date>
      <news:title>Acme United&#x27;s Tariff-Tested Supply Chain: A Small-Cap Industrial Building Unfair Advantages (NASDAQ:ACU)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TGT/target-s-5-billion-execution-gamble-turnaround-or-value-trap-nyse-tgt</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T12:55:36Z</news:publication_date>
      <news:title>Target&#x27;s $5 Billion Execution Gamble: Turnaround or Value Trap? (NYSE:TGT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/VGZ/vista-gold-s-425m-pivot-how-a-smaller-mine-plan-unlocks-billion-dollar-value-nyse-vgz</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T12:55:29Z</news:publication_date>
      <news:title>Vista Gold&#x27;s $425M Pivot: How a Smaller Mine Plan Unlocks Billion-Dollar Value (NYSE:VGZ)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/LCNB/lcnb-corp-community-banking-s-acquisition-driven-revival-meets-digital-disruption-at-a-discount-nasdaq-lcnb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T12:53:53Z</news:publication_date>
      <news:title>LCNB Corp: Community Banking&#x27;s Acquisition-Driven Revival Meets Digital Disruption at a Discount (NASDAQ:LCNB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/MDB/mongodb-s-atlas-engine-and-ai-platform-shift-a-2b-run-rate-meets-the-next-computing-era-nasdaq-mdb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T12:50:27Z</news:publication_date>
      <news:title>MongoDB&#x27;s Atlas Engine and AI Platform Shift: A $2B Run Rate Meets the Next Computing Era (NASDAQ:MDB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CINT/ci-t-s-ai-productivity-arbitrage-why-10x-gains-are-reshaping-the-it-services-model-nyse-cint</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T12:47:42Z</news:publication_date>
      <news:title>CI&amp;T&#x27;s AI Productivity Arbitrage: Why 10x Gains Are Reshaping the IT Services Model (NYSE:CINT)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CCNE/cnb-financial-s-essa-gamble-scale-efficiency-and-the-execution-tightrope-nasdaq-ccne</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T12:46:58Z</news:publication_date>
      <news:title>CNB Financial&#x27;s ESSA Gamble: Scale, Efficiency, and the Execution Tightrope (NASDAQ:CCNE)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FHTX/foghorn-s-chromatin-gamble-can-platform-validation-offset-cash-burn-in-the-protein-degrader-race-nasdaq-fhtx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T12:38:07Z</news:publication_date>
      <news:title>Foghorn&#x27;s Chromatin Gamble: Can Platform Validation Offset Cash Burn in the Protein Degrader Race? (NASDAQ:FHTX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ODC/oil-dri-s-capital-recapture-transforming-clay-into-durable-cash-flow-nyse-odc</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T12:36:27Z</news:publication_date>
      <news:title>Oil-Dri&#x27;s Capital Recapture: Transforming Clay into Durable Cash Flow (NYSE:ODC)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/GRDN/guardian-pharmacy-services-margin-expansion-meets-the-silver-tsunami-nyse-grdn</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T12:33:16Z</news:publication_date>
      <news:title>Guardian Pharmacy Services: Margin Expansion Meets the Silver Tsunami (NYSE:GRDN)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PLRX/pliant-therapeutics-a-192-million-integrin-platform-trading-at-fire-sale-prices-nasdaq-plrx</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T12:32:17Z</news:publication_date>
      <news:title>Pliant Therapeutics: A $192 Million Integrin Platform Trading at Fire-Sale Prices (NASDAQ:PLRX)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/THM/international-tower-hill-mines-a-118m-lifeline-for-alaska-s-marginal-gold-giant-nasdaq-thm</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T12:26:47Z</news:publication_date>
      <news:title>International Tower Hill Mines: A $118M Lifeline for Alaska&#x27;s Marginal Gold Giant (NASDAQ:THM)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TBBB/tbbb-s-self-funding-discount-engine-why-negative-working-capital-and-private-labels-power-an-unstoppable-growth-flywheel-nyse-tbbb</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T12:25:54Z</news:publication_date>
      <news:title>TBBB&#x27;s Self-Funding Discount Engine: Why Negative Working Capital and Private Labels Power an Unstoppable Growth Flywheel (NYSE:TBBB)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SST/system1-s-google-dependency-crisis-masks-a-high-margin-products-gem-nasdaq-sst</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T12:22:57Z</news:publication_date>
      <news:title>System1&#x27;s Google Dependency Crisis Masks a High-Margin Products Gem (NASDAQ:SST)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/TNYA/tenaya-therapeutics-cardiac-gene-therapy-at-the-crossroads-of-data-and-dollars-nasdaq-tnya</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T12:17:58Z</news:publication_date>
      <news:title>Tenaya Therapeutics: Cardiac Gene Therapy at the Crossroads of Data and Dollars (NASDAQ:TNYA)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/INBK/first-internet-bancorp-balance-sheet-repair-meets-digital-banking-upside-nasdaq-inbk</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T12:11:42Z</news:publication_date>
      <news:title>First Internet Bancorp: Balance Sheet Repair Meets Digital Banking Upside (NASDAQ:INBK)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CDXS/codexis-the-eco-synthesis-pivot-from-enzyme-supplier-to-rna-manufacturing-platform-nasdaq-cdxs</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T12:11:29Z</news:publication_date>
      <news:title>Codexis: The ECO Synthesis Pivot—From Enzyme Supplier to RNA Manufacturing Platform (NASDAQ:CDXS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DSP/viant-s-ai-powered-independence-why-the-ad-tech-underdog-is-ready-to-challenge-the-walled-gardens-nasdaq-dsp</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T12:06:27Z</news:publication_date>
      <news:title>Viant&#x27;s AI-Powered Independence: Why the Ad Tech Underdog Is Ready to Challenge the Walled Gardens (NASDAQ:DSP)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/SCM/ridgepost-catalyst-meets-sbic-moat-why-stellus-capital-s-30-discount-creates-asymmetric-upside-nyse-scm</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T11:43:25Z</news:publication_date>
      <news:title>Ridgepost Catalyst Meets SBIC Moat: Why Stellus Capital&#x27;s 30% Discount Creates Asymmetric Upside (NYSE:SCM)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/CRWE/crwe-a-16-million-mirage-built-on-777-of-revenue-otc-crwe</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T11:37:28Z</news:publication_date>
      <news:title>CRWE: A $16 Million Mirage Built on $777 of Revenue (OTC:CRWE)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ARIS/aris-mining-high-grade-margins-and-the-path-to-tier-1-gold-production-nyse-aris</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T11:37:03Z</news:publication_date>
      <news:title>Aris Mining: High-Grade Margins and the Path to Tier-1 Gold Production (NYSE:ARIS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/PL/news/planet-labs-announces-indefinite-withholding-of-iran-conflict-imagery-following-us-request</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-05T00:00:00Z</news:publication_date>
      <news:title>Planet Labs Announces Indefinite Withholding of Iran Conflict Imagery Following U.S. Request</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/VRSK/news/verisk-analytics-files-proxy-statement-rejecting-john-cheveddens-writtenconsent-proposal</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T00:00:00Z</news:publication_date>
      <news:title>Verisk Analytics Files Proxy Statement Rejecting John Chevedden’s Written‑Consent Proposal</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ULS/news/hithium-receives-first-ul-solutions-certification-for-625mwh-batteryenergystorage-system</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T00:00:00Z</news:publication_date>
      <news:title>HiTHIUM Receives First UL Solutions Certification for 6.25‑MWh Battery‑Energy‑Storage System</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/RCMT/news/rcm-technologies-reports-strong-q4-2025-results</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T00:00:00Z</news:publication_date>
      <news:title>RCM Technologies Reports Strong Q4 2025 Results</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/NFLX/news/netflix-secures-us-commercial-streaming-rights-for-tyson-fury-vs-makhmudov-fight</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T00:00:00Z</news:publication_date>
      <news:title>Netflix Secures U.S. Commercial Streaming Rights for Tyson Fury vs. Makhmudov Fight</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/META/news/meta-pauses-collaboration-with-aitraining-startup-mercor-after-supplychain-breach</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T00:00:00Z</news:publication_date>
      <news:title>Meta Pauses Collaboration with AI‑Training Startup Mercor After Supply‑Chain Breach</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/WIX/news/wix-completes-modified-dutch-auction-tender-offer-buying-back-nearly-30-of-shares</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T00:00:00Z</news:publication_date>
      <news:title>Wix Completes Modified Dutch Auction Tender Offer, Buying Back Nearly 30% of Shares</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/VVOS/news/vivos-therapeutics-raises-239-million-in-private-placement-securing-199-stake</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T00:00:00Z</news:publication_date>
      <news:title>Vivos Therapeutics Raises $2.39 Million in Private Placement, Securing 19.9% Stake</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/IBO/news/impact-biomedical-inc-receives-goingconcern-audit-opinion-for-2025-annual-report</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T00:00:00Z</news:publication_date>
      <news:title>Impact BioMedical Inc. Receives Going‑Concern Audit Opinion for 2025 Annual Report</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ESPR/news/esperion-therapeutics-completes-acquisition-of-corstasis-therapeutics-adding-firstinclass-nasal-diur</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T00:00:00Z</news:publication_date>
      <news:title>Esperion Therapeutics Completes Acquisition of Corstasis Therapeutics, Adding First‑in‑Class Nasal Diuretic Enbumyst to Portfolio</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FSLR/news/first-solar-secures-117mw-ohio-project-as-geronimo-power-commences-operations</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T00:00:00Z</news:publication_date>
      <news:title>First Solar Secures 117‑MW Ohio Project as Geronimo Power Commences Operations</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/FOUR/news/shift4-payments-declares-150-dividend-on-6-series-a-mandatory-convertible-preferred-stock</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T00:00:00Z</news:publication_date>
      <news:title>Shift4 Payments Declares $1.50 Dividend on 6% Series A Mandatory Convertible Preferred Stock</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/DNLI/news/denali-therapeutics-regains-full-rights-to-dnl593-after-takeda-terminates-collaboration</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T00:00:00Z</news:publication_date>
      <news:title>Denali Therapeutics Regains Full Rights to DNL593 After Takeda Terminates Collaboration</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/BRZE/news/wunderkind-announces-integration-with-braze-to-enhance-identitybased-customer-journeys</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T00:00:00Z</news:publication_date>
      <news:title>Wunderkind Announces Integration with Braze to Enhance Identity‑Based Customer Journeys</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AIG/news/aig-joins-40-b-us-reinsurance-guarantee-program-for-strait-of-hormuz-shipping</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T00:00:00Z</news:publication_date>
      <news:title>AIG Joins $40 B U.S. Reinsurance Guarantee Program for Strait of Hormuz Shipping</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ANVS/news/annovis-bio-secures-us-patent-for-buntanetapbased-treatment-of-brain-infectioninduced-neurological-i</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T00:00:00Z</news:publication_date>
      <news:title>Annovis Bio Secures U.S. Patent for Buntanetap‑Based Treatment of Brain Infection‑Induced Neurological Injuries</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/ARHS/news/arhaus-opens-19300squarefoot-ashburn-showroom-expanding-premium-retail-footprint</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T00:00:00Z</news:publication_date>
      <news:title>Arhaus Opens 19,300‑Square‑Foot Ashburn Showroom, Expanding Premium Retail Footprint</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://everyticker.com/quote/AMR/news/alpha-metallurgical-resources-miner-fatality-at-horse-creek-eagle-mine-raises-safety-and-regulatory-</loc>
    <news:news>
      <news:publication>
        <news:name>BeyondSPX</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-04T00:00:00Z</news:publication_date>
      <news:title>Alpha Metallurgical Resources Miner Fatality at Horse Creek Eagle Mine Raises Safety and Regulatory Concerns</news:title>
    </news:news>
  </url>
</urlset>